Supporting men who use anabolic steroids: A sequential multi-methods study by Bates, G
 
 
Supporting men who use anabolic steroids: A sequential 
multi-methods study 
 
 
 
Geoff Bates 
 
A thesis submitted in partial fulfilment of the requirements of 
Liverpool John Moores University for the degree of Doctor of 
Philosophy 
 
April 2019 
  
1 
 
Abstract 
Background 
An increasing amount of research exploring use of anabolic androgenic steroids (AAS) 
has been undertaken over the past three decades and, in recent years, there has been 
a growing awareness of this form of substance use on a societal level and as a public 
health problem in the UK. However, there have been few public health interventions 
aiming to respond to this and there is little evidence-based guidance available to support 
health professionals working with users. 
Aim 
The aim of the research was to identify ways that intervention providers can influence 
men who use AAS and support them to improve their health and manage risk. To achieve 
this the research explored factors that influence users’ choices, and identified priorities 
and opportunities for interventions. 
Methodology 
The research followed a sequential design over four studies, where findings informed 
the development of subsequent studies.  Study 1 was a systematic review examining the 
content and effectiveness of interventions with the intention of influencing AAS use. 
Study 2 was the development of an evidence-based socioecological framework through 
which to explore factors that influence AAS users’ behaviours and to identify 
opportunities for interventions. Study 3 used largely unstructured interviews with 33 
stakeholders with a range of expertise and experiences with AAS to identify priorities to 
address and potential interventions in response to these. Semi-structured interviews in 
study 4 followed up these findings with 12 men who use AAS who ranged from new 
users to very experienced users. These qualitative studies were analysed using thematic 
analysis, which moved from an initial inductive and data driven approach to one that 
was more deductive as interviews became more structured. The Behaviour Change 
Wheel model informed the research and in particular the principle of developing an in 
depth understanding of a behaviour in order to influence it. The findings from the four 
studies supported the development of a conceptual map exploring the provision of 
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support and information to users. A complex systems approach to understanding health 
behaviours underpinned the map and identification of potential interventions in 
response to the priorities identified. 
Results 
A range of priorities to support users to improve their health and manage risk emerged. 
Opportunities to respond to these were identified, supported by the development of 
the conceptual map of support and information provision. This map is intended for 
stakeholders to use in the development of effective responses in their local 
communities. Applying a systems approach to the provision of support to AAS users 
helps recognise the competing and complex influences on users across the 
socioecological spectrum and supports a thorough understanding of their behaviours. 
The findings indicate the need to go beyond the current provision of support services in 
the form of needle and syringe programmes and steroids clinics to respond to the 
priorities identified. Involving influential individuals or role models as change agents 
within users’ social networks and important environments such as gyms will increase 
opportunity to influence AAS choices and norms, and subsequently reduce risk of poor 
health outcomes amongst this population.   
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Chapter 1: Introduction 
Anabolic androgenic steroids 
Anabolic androgenic steroids (AAS) are synthetically produced variants of the male 
hormone testosterone, most commonly used to promote muscle growth and fat loss. 
They are the most prominent of a broader range of substances known as image and 
performance enhancing drugs (IPEDs) that include drugs used to modify appearance or 
physical, cognitive and sexual performance. Beyond increasing muscle and changing 
body weight, IPEDs are used for a range of reasons including to change skin colour, 
enhance sexual function, prevent fatigue and to counter the side effects related to AAS. 
Many people who use IPEDs will not use AAS, but people who use AAS frequently use 
other IPEDs as part of a complex regimen of substance use during their cycle1 (Sagoe et 
al., 2015, Bates and McVeigh, 2016). In the literature, there is great overlap between 
the two terms, with IPEDs a common term focusing on people using drugs for muscle 
enhancement purposes. The focus of this research is specifically on people who use AAS 
for muscle enhancement (from here on referred to as ‘users’2) rather than the wider 
population of IPED users. For example, someone who uses AAS and other IPEDs such as 
the peptide hormone Human Growth Hormone is relevant to the research, but someone 
who injects the synthetic hormone Melanotan for skin tanning or uses Sildenafil (Viagra) 
for sexual enhancement and does not also use AAS is not.  
Since the middle of the 20th century, AAS have been prescribed for a range of medical 
purposes, for example in hormone replacement therapies. Historically, use of these 
substances outside medical settings has been most strongly associated with ‘doping’ to 
enhance sporting performance amongst elite athletes and in particular in sports such as 
                                                          
1 The cycle includes an ‘on’ period where a person uses AAS, typically lasting from a few weeks to many 
months, followed by an ‘off’ period without using AAS to give the body a break before starting another 
‘on’ period. The length of ‘on’ and ‘off’ cycle periods varies greatly and, in some cases, individuals may 
progress to long-term continuous use with little or no ‘off’ cycle. 
2 The term ‘users’ when referring to people who use any drug is controversial and can be seen as 
stigmatizing. Using terms such as ‘people who use AAS’ help to overcome these issues. However, for 
reasons of brevity and to help the flow of the text, ‘users’ will be used throughout when referring to this 
population. 
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athletics, cycling, power lifting and bodybuilding where strength, power, endurance and 
muscularity are highly valued. The association between AAS and improvements in 
sporting performance and aesthetics are well established (Bhasin  et al., 1996), with 
large doses alongside physical training leading to substantial increases in muscularity 
(Hartgens and Kuipers, 2004).  In sport the harms of drug use to competition itself and 
to the sense of fair play has long been a topic of debate (Fraleigh, 1984, Todd, 1987). 
Scandals in the past decade, such as with the cyclist Lance Armstrong and the 
identification of state-sponsored doping in Russia, highlights that AAS and, more widely, 
IPED use amongst athletes remains a concern.  The use of a range of substances 
including AAS are prohibited in sport. Consequences to athletes from using them include 
lengthy bans from competition, damage to reputation and limiting future earnings in 
accordance with the World Anti-Doping Agency’s (WADA) Prohibited List (WADA, 2017).  
Beyond elite sport AAS use3 has been reported since the 1980s (Buckley et al., 1988, 
Johnson et al., 1989) and evidence suggests that globally it is increasingly widespread 
outside of sports environments (Sagoe et al., 2014b, Pope et al., 2014a, McVeigh and 
Begley, 2016). It is now acknowledged that participation in sport is not the primary risk 
factor for AAS use (Harmer, 2010) and probably has not been for some time. Indeed, in 
an article exploring the history of AAS, Kanayama and Pope state that, “By the end of 
the 1980s, the typical AAS user was no longer an elite athlete, and indeed often even a 
competitive athlete at all, but instead a young man in a local gym who simply wanted to 
get stronger and look more muscular” (page 4) (Kanayama and Pope, 2017). The 
overarching motivation for AAS use in most cases is associated with desire to develop 
an attractive and healthy physique or to enhance muscle growth and physical strength 
(Sagoe et al., 2014a, Brennan et al., 2016), but the reasons driving this appear to 
represent a broad and complex range of factors (Bates et al., 2018). Users make up a 
heterogeneous population amongst which exists much variation in terms of drug use 
and lifestyles (Christiansen et al., 2016, Zahnow et al., 2018) and it is difficult to describe 
a ‘typical’ user. People who use AAS include a diverse range of individuals. This includes 
                                                          
3 In the related literature, terms such as ‘misuse’ and ‘abuse’ are frequently applied to describe non-
medical AAS use. However, such terms apply a presumption about the nature of this i.e. that it is 
necessarily harmful and ‘bad’. Therefore, ‘use’ is the preferred term here and should be interpreted as 
any AAS use not prescribed by a medical professional.  
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what Kanayama and Pope describe as “ordinary rank and file male gym clients” (pg 5) 
who are motivated by aesthetic changes (Kanayama and Pope, 2017), recreational 
athletes (Sagoe et al., 2014b) and those working in environments such as the police and 
nighttime economy where strength and size can be highly valued (Hoberman, 2017, 
Hoberman, 2015, Maycock, 1999, Midgley et al., 2001).  
Why is this research needed? 
Prevalence 
Globally the lifetime prevalence of AAS has been estimated at 3.3%, with higher 
prevalence amongst males (6.4%) (Sagoe et al., 2014b). However, the true extent of AAS 
use is difficult to estimate. Evidence on prevalence of AAS use in the UK is very limited, 
but data from the crime survey in England and Wales suggests that use has increased 
slightly in the past decade (Home Office, 2018). Data from needle and syringe 
programmes (NSP) also indicates that AAS use may be increasing with the numbers of 
users accessing such services growing substantially over the past 25 years, and in some 
parts of the country users makes up the largest client group (McVeigh and Begley, 2016). 
However, this does not necessarily indicate an increase in prevalence and could, for 
example, instead be the result of better engagement and recruitment strategies 
(Vinther and Christiansen, 2017). While the evidence on prevalence remains limited, the 
evidence base more generally related to AAS and understanding those who use them 
has increased substantially over the past two decades (McVeigh and Begley, 2016). One 
effect of this increased research focus, alongside greater recognition in society of AAS 
use and desire to increase muscularity amongst men, particularly young men, is that it 
may give the illusion that use is increasing when actually it may simply indicate greater 
awareness. However, even if we recognise that no accurate indication of prevalence 
exists and are unclear the extent to which use may or may not be increasing, there is 
clear evidence of continued widespread use both in the UK and internationally. Further, 
there is no expectation for a coming decline in AAS use or the desire to increase 
muscularity amongst men (Kanayama and Pope, 2017). 
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Associated harms to health 
While the evidence on harms from using AAS has increased substantially in recent years 
it still generally represents an emerging evidence base with many gaps. Although AAS 
can be used without adverse consequences, such as when used therapeutically, risk of 
harm is expected to increase with the far greater doses observed when AAS are used 
outside of clinical settings (Harmer, 2010). However, there is little evidence of the 
association between dose and risk. Much of the evidence of health harms amongst users 
comes from observational studies, and in particular case reports, over the past thirty 
years. It is beyond these studies, which rely on self-reported information about doses 
and types of AAS, to ascertain the level of use that is associated with particular harms 
and therefore the picture is somewhat incomplete. However, there is an ever-increasing 
evidence-base exploring related harms seeking to address this. Use is associated with a 
range of acute and chronic adverse consequences (Pope et al., 2014b) that range greatly 
from cosmetic (e.g. acne) to critical (e.g. cardiovascular disease, liver function) with 
evidence of potential psychological harms (e.g. increased aggression, mania) (ACMD, 
2010b). The quality and nature of the evidence on these different areas of health varies, 
but in some it is becoming more substantial. For example, the link between use and 
damage to the reproductive system following AAS withdrawal (Christou et al., 2017, El 
Osta et al., 2016) and adverse cardiovascular events including raised blood lipid levels, 
hypertension, changes in cardiac function and myocardial infarction (Pereira dos Santos 
et al., 2014, Baggish et al., 2017, Thiblin et al., 2015) are increasingly supported through 
research. Additionally, it is suggested that as the AAS users who started using in the 
1980s and 1990s get older, the long-term effects from these substances on conditions 
normally associated with onset in middle or older ages may emerge (Pope et al., 2014b). 
Associated risk behaviours 
Beyond the harms to health directly attributable to AAS, users can be at risk through a 
variety of related behaviours that vary greatly, which reinforces the heterogeneous 
nature of this group of substance users. For many, their cycles can be complex and they 
may use a variety of AAS and other IPEDs at any one time or progressively (Bates and 
McVeigh, 2016, Sagoe et al., 2015). The majority of users inject their drugs and are 
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exposed to risks such as injection site injury, infection and blood-borne viruses (BBVs) 
(ACMD, 2010b). The quality of illicitly produced AAS cannot be controlled, with many 
users sourcing their drugs from underground ‘laboratories’ (Brennan et al., 2018, van de 
Ven, 2016) where contamination and mislabeling of products is common (Evans-Brown 
et al., 2009) in comparison to those which are prepared pharmaceutically. Evidence of 
injection site infections and injuries amongst AAS injectors (Hope et al., 2014) are 
indications of the impact of bacterial contamination in purchased products. In the UK, 
there is evidence of HIV, hepatitis B and C infections within this population (Hope et al., 
2013, Hope et al., 2016) and indications of low testing uptake (Bates and McVeigh, 2016, 
Hope et al., 2013) suggests that such infections may go undiagnosed. Generally, studies 
have identified good practice relating to sharing of injecting equipment, but amongst 
users there is evidence of equipment sharing albeit to typically low levels (ACMD, 2010a, 
Bates et al., 2014) and engagement in risky sexual practices (Hope et al., 2013) that 
highlights the possibility of BBV transmission within and beyond this population. There 
is evidence that users consume a range of psychoactive substances, especially alcohol, 
cocaine and cannabis (Sagoe et al., 2015). Differences in attitudes towards substance 
use may reflect the range of attitudes towards risk and health amongst users, as 
explored in a recent typology of steroid users (Christiansen et al., 2016). For example, 
many users will report never drinking alcohol, for example because it would interfere 
with their training regimes, while others consume very large quantities (Bates and 
McVeigh, 2016).  
Mental health and wellbeing 
Dependence on AAS has been theorised since the 1980s (Kashkin and Kleber, 1989, 
Brower et al., 1989), but has been the subject of greater focus and definition over the 
past decade, primarily through the work of Pope, Kanayama and colleagues (Kanayama 
et al., 2009a, Kanayama et al., 2009b). They have suggested that nearly one third of 
users will develop a form of dependence (Pope et al., 2014a) characterised by 
continuous use for long periods of time despite, in some cases, the presence of adverse 
effects. Often this involves continuous administration of high doses. There are 
similarities and differences with other dependence on other substances. Key differences 
include that while over time users may increase their dose, the development of a 
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physical tolerance to AAS through repeated use is unclear. Additionally there is no 
immediate benefit from use comparable to that from using many psychoactive 
substances and nor are there typically immediate adverse effects. However, use may be 
associated with short-term increases in self-confidence and muscularity, and adverse 
effects can emerge quickly. Similarly to dependence on substances such as tobacco, 
alcohol or opiates, motivation for AAS use can be to avoid withdrawal symptoms that 
arise following discontinuation, such as loss of libido, depressed mood and fatigue 
(Kanayama et al., 2009b).  
A common concern for users is that through cessation they will lose the physical gains 
associated with their steroid use (Griffiths 2016), which can drive continuous use, 
dedication to physical training and nutrition, and time sourcing and researching steroids. 
While this has been discussed in the context of AAS dependence, there is an established 
broader association with a preoccupation with appearance and muscularity. It has been 
argued that the behaviours applied to increase muscularity amongst men with a body 
image disorder can represent an ‘addiction to body image’ (Foster et al., 2015), which 
shares many characteristics with the proposed diagnostic criteria for AAS dependence 
(Kanayama et al., 2009b). It is in many ways difficult to distinguish between dependence 
on AAS and this preoccupation with enhancing muscularity and changing body shape. 
Indeed, use of AAS in some individuals has been associated with body image disorders 
such as muscle dysmorphia and a high drive for muscularity (Kanayama et al., 2006, 
Rohman, 2009). Traditionally, research into body dissatisfaction has focused on females 
and the desire to lose body weight. However, more recently researchers have explored 
body image concerns amongst males and identified issues relating to self-evaluation as 
being too small and desiring to increase muscularity (Frederick et al., 2007, Pope et al., 
2000). As with body image disorders amongst females, male body image concerns of 
this type can range from a dissatisfaction with appearance and desire to change 
physique to psychiatric conditions where support and treatment may be required.  
Muscle dysmorphia is characterised by the perception of oneself as being too small and 
the obsession with becoming more muscular amongst individuals who have a significant 
amount of muscle (Grieve, 2007). It was first described in the academic literature as 
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‘reverse anorexia’ (Pope et al., 1993) reflecting the similarity with individuals suffering 
from anorexia nervosa who perceive that they need to lose weight. It was later renamed 
by the same authors as muscle dysmorphia (Pope et al., 1997). Muscle dysmorphia is 
included in the fifth edition of the Diagnostic Manual of Mental Disorders (DSM-5) and 
is considered as part of the wider group of psychiatric conditions known as body 
dysmorphic disorders, where an individual is preoccupied with a perceived defect in 
their appearance that may lead to impaired behavioural functioning (Phillips and Crino, 
2001). That there is a relationship between AAS and muscle dysmorphia is well 
established, but the direction of that relationship is unclear (Rohman, 2009). Logically it 
would appear reasonable to suggest that body image disorders may motivate use 
amongst individuals who desire to be more muscular. Someone who is highly dissatisfied 
with their muscularity is likely to desire to take steps to rectify this, and muscle 
dysmorphia and negative body image during adolescence have been associated with 
long-term use in adulthood (Kanayama et al., 2006, Pope et al., 2012). However, it may 
also be possible that AAS use and immersion in a sub-culture where individuals will 
frequently have ideals of muscularity and strength reinforced could lead to, or enhance, 
body image disturbances and appearance concerns remain for many users who may 
have been using for prolonged periods of time (Cohen et al., 2007).  
Responding to AAS use and related harms 
It has long been recognised that interventions are required in response to AAS use 
(Council on Scientific Affairs, 1988, Nutter, 1993) and increasing evidence of the harms 
to health, and greater awareness about users through the portrayal of muscularity and 
AAS in media and cultural contexts, further supports this. It is not surprising therefore 
that there has been an increased focus on this group of substance users amongst UK 
policy makers in recent years. For example, in the latest review of guidance for the 
provision of NSPs for people who inject drugs, the National Institute for Health and Care 
Excellence (NICE) specifically looked at IPED users (National Institute for Health and Care 
Excellence, 2014) and current UK drug policy includes a section about this same group 
(Independent Expert Working Group, 2017). The public health response in the UK to AAS 
use has largely been the provision of injecting equipment to reduce transmission of 
16 
 
BBVs. Attempts to engage with users and provide harm reduction have typically 
followed models of service delivery developed for other substance users. Primarily, 
support services have included NSPs in pharmacies and substance use services. In some 
locations specialist AAS or IPED clinics exist that offer support through staff experienced 
with, or knowledgeable about, AAS and services that vary greatly, but include those such 
as nutrition and training advice, health checks and blood tests to engage with users. 
These specialist clinics have long been championed as part of efforts to provide 
healthcare and support to this population (Morrison, 1994, O'Connor, 1995, Korkia and 
Stimson, 1994).   
There is a lack of any evidence on the effectiveness of such approaches or, more broadly, 
other interventions focussing on AAS users with the aim of reducing demand or harms. 
What intervention evaluations there have been have focussed on preventing initiation, 
rather than on those people who are already using AAS for whom harm reduction and 
behaviour change strategies are needed. Internationally, a relatively small number of 
interventions that explicitly aim to prevent initiation of IPEDs in young people has been 
implemented and evaluated. Frequently these have been in the context of reducing use 
amongst athletes. Preventing initiation amongst athlete populations matches WADA’s 
aims to ensure athletes participate in doping-free sports and to support their health 
(WADA, 2018), but educational approaches are given little attention and are poorly 
funded in comparison to drug testing and detection policies that underpin the anti-
doping approach (Backhouse, 2015). Beyond sport, as the focus on use amongst non-
athletes has grown, and the evidence on potential harms to health and the association 
between AAS and mental health is increasingly recognised, the justification for 
prevention interventions from a public health perspective increases. Steroids and other 
IPEDs are not typically however included in substance use prevention programmes, such 
as those delivered to adolescents in school and family settings internationally (Bates et 
al., 2017b). As initiation of AAS typically occurs during adulthood (Sagoe et al., 2014a), 
such programmes may not necessarily be the optimal approach for prevention. 
Additionally, the low overall prevalence of AAS amongst the population in general may 
suggest that prevention targeted towards those more likely to use may be a more 
effective and cost-effective approach than any universal programme.  
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Beyond the scarcity of evaluations of interventions, there is also a lack of evidence to 
inform future interventions such as what they should be trying to achieve; how, where 
and when to implement them; who should deliver them; and what factors will be likely 
to increase effectiveness. While there has been a substantial amount of research looking 
at factors such as the characteristics and behaviours of people who use AAS and their 
motivations and health, there are a lack of frameworks that bring this evidence together, 
which could directly inform intervention approaches. Consequently, while designing 
theoretically based interventions is associated with increased effectiveness (Glanz and 
Bishop, 2010), there is little evidence on which to base recommendations for policy in 
this area or to inform the development of new interventions. While this study did not 
involve the development of an intervention, it was informed by The Behaviour Change 
Wheel (BCW) (Michie et al., 2014). The BCW is a model of behaviour change and a 
framework to guide intervention development, particularly those aiming to change 
health behaviours, encourages the user to think outside of what seems obvious or 
matches their preconceptions.  
Rather than developing interventions based upon personal experiences or 
presumptions, the model encourages the user through a systematic and rigorous 
process to choose options based upon evidence and theory. For example regarding what 
the target of any intervention should be, what needs to happen for this behaviour to 
change, and how this change can be brought about (Michie et al., 2014, Michie et al., 
2011). The authors describe the guide as particularly valuable to inform the early stages 
of intervention development in a process such as the Medical Research Council’s 
Guidance on Complex Interventions (Craig et al., 2008). Michie and colleagues (Michie 
et al., 2014) go on to state that the guide is “a way of harnessing whatever 
understanding exists and identifying valuable areas for extending that understanding” 
(pg14). The initial stages of the BCW guide were particularly relevant to this study, 
focussing on understanding and defining the problem that needs to be addressed. The 
authors state that “if the assessment is not thorough, the formulation of the problem is 
less likely to be accurate, and the intervention less likely to be effective” (pg25). The 
steps within this stage involve using rigorous methods to identify the problems that 
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need to be addressed and being specific about what needs to change and in whom, and 
what needs to happen in order for this change to occur.  
Research aims and objectives 
The aim of this research was to explore ways that intervention providers can influence 
decision-making amongst men who use AAS to improve their health and manage their 
risk. The following objectives were developed to address the gaps in the current 
evidence base and to inform the development of interventions.  
i) To identify how interventions seeking to influence AAS use have tried to 
change decision-making, and the effectiveness of these approaches.  
ii) To bring together factors that influence AAS use from different sources and 
in different environments into one framework to support intervention 
development. 
iii) To identify opportunities for health professionals and other potential 
intervention providers to influence users’ decisions and choices. 
iv) To explore what interventions need to address in order to improve health 
amongst AAS users and to help them manage their risk, and how this might 
be achieved. 
A fifth objective was established later in the research, reflecting the findings from the 
four studies. 
v) To map the support that users seek and encounter and, using this, identify 
approaches to improve the provision of support and information.   
Research design 
A sequential design over four studies, summarised in figure 1, was developed to address 
the objectives outlined previously. This included two literature-based studies (studies 1 
& 2) and two qualitative studies (studies 3 & 4). Study 1 was a systematic review 
examining the content and effectiveness of interventions that have been carried out 
with the intention of influencing AAS use. In study 2, a review of predominantly 
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qualitative evidence was used to develop a socioecological framework through which to 
explore factors that influence men’s decision making regarding their AAS use and to 
identify opportunities for interventions. Study 3 used a focus group and unstructured 
interviews with stakeholders with a range of expertise and experiences with AAS to 
explore priorities for interventions to improve health and reduce risk, and identify how 
these priorities might be addressed. Study 4 used semi-structured interviews with users 
to follow up on findings from study 3, and continued to identify needs and opportunities 
for interventions and support. The final stage in the research, the development of a 
conceptual map of information provision and support, and identification of approaches 
to improve this, was developed to reflect the needs and evidence gaps identified in the 
studies carried out and through reflection on the findings of the research.  
Pragmatic and reactive approach 
Following the principles of pragmatism, in this study the design and methods were 
developed according to the research question (Johnson and Onwuegbuzie, 2004) to 
ensure that the methods used throughout the study addressed the gaps in evidence 
identified in the most appropriate manner. This led to the evidence reviews in studies 1 
and 2 and qualitative methods used in studies 3 and 4, which reflected the identified 
need for an inductive driven research design. The approach used in this study has much 
in common with the  ‘methodological eclecticism’ aspect of mixed methods (Johnson 
and Onwuegbuzie, 2004, Teddlie and Tashakkori, 2010), which recognises the 
importance of flexibility and drawing upon different methods and perspectives to 
research a topic, rather than rigidly sticking to a favoured approach. It has been argued 
that mixed methods do not necessarily have to include elements from both quantitative 
and qualitative paradigms (Morse, 2010b), but it is typically defined as research that 
combines both qualitative and quantitative research (Johnson et al., 2007). This research 
however combined evidence from two evidence reviews and two qualitative studies and 
more closely resembled a multimethod design, defined as “the conduct of two or more 
research methods, each conducted rigorously and complete in itself, in one project” (pg 
190) (Morse, 2010a). Within a sequential multimethod design, a QUALqual approach 
consists of one dominant qualitative study supplemented by a second qualitative project 
that follows on from the first. This was the approach taken for the qualitative studies 
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Figure 1: Research design 
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and was appropriate for the inductive nature of this research (Morse, 2010a). 
Collectively, the aim of these studies was to explore what AAS interventions should 
address and how they can do. The first qualitative study, study 3, was the more 
substantial and generated ideas from stakeholders, which were then followed up on in 
study 4 with users, who were likely to offer different perspectives.  
The two evidence review studies were a significant part of this research, yet their 
inclusion does not necessarily sit within the mixed or multimethod study designs as they 
are traditionally described. Both reviews were predominantly qualitative in the 
approach to synthesising the evidence. The systematic review in study 1 sought 
evidence on the effectiveness of AAS interventions and therefore included studies based 
upon quantitative methods, while the literature included in study 2 was predominantly 
based on qualitative and survey methods. While methodologies have been developed 
for undertaking systematic reviews based upon mixed methods (Pearson et al., 2015), 
mixed method or multimethod study designs are typically discussed in the context of 
undertaking primary research. However, as demonstrated in figure 1, during this 
research multiple methods were applied in a sequential process with the findings of 
studies driving the approach and focus of subsequent studies.  
An advantage of the pragmatic approach and sequential methodological framework 
used was that the researcher was able to be reactive throughout the study. Sequential 
designs enable researchers to respond proactively to emerging results that were not 
anticipated and are therefore particularly useful where the researcher has not decided 
on how the research will progress at the start (Plano Clark and Badiee, 2010). Much of 
the research design was not predetermined and changed as the study progressed. 
Throughout the research, a series of current tools and guidance were used to support 
the development of studies and the reporting of results to ensure transparency of the 
approaches and methods used. 
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Changes to the research design 
Initially it was planned to use the findings from study 1 to identify effective intervention 
approaches and this would lead towards the development of an intervention targeting 
people who use AAS. To support this it was provisionally intended to undertake a second 
systematic review exploring experiences of steroid use and then a study using Q 
methodology (McKeown and Thomas, 2013) to identify what factors are important in 
users’ choices. However, the research changed substantially during the first systematic 
review (study 1), undertaken in response to objective 1. One of the findings from this 
related to the limited number of settings and populations that intervention providers 
have considered when trying to influence steroid use. This raised the importance of 
considering other environments and people that may be important in this decision-
making and the subsequent development of the socioecological framework (study 2) as 
a priority to inform intervention development. Amongst the different studies included 
in the systematic review, the range of ideas selected to inform intervention 
development and what these interventions aim to achieve indicated that many different 
factors were potentially important. Reflecting on this and the other evidence included 
in these first two studies led to conclusions that the evidence base was undeveloped 
and included substantial gaps that needed to be addressed before any specific 
intervention could be addressed if it was to be effective. In particular, it appeared 
unclear what the priorities for any interventions should be or, in other words, what 
interventions with this population should actually be trying to achieve and what factors 
need to be addressed to achieve these aims. These reflections led to the formation of 
research objectives 2, 3 and 4. 
The shift in the research towards consideration of how a wide range of influences across 
the socioecological spectrum influences AAS choices happened concurrently to the 
researcher’s learning and interest in the BCW approach. Both these approaches 
emphasise the need to consider the bigger picture when thinking about how to bring 
about changes in any behaviour and led to the development of an interest in complex 
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systems thinking4 and its importance in developing interventions (Hawe et al., 2009). 
This had a significant impact on the direction of this work and eventually led to the 
development of the conceptual map at the end of the research. The focus of the BCW 
guidance on understanding behaviour in order to change and influence it were 
particularly relevant to the position the researcher found themselves in after the 
systematic review. The authors emphasise that too frequently interventions are based 
upon the personal opinions or experiences of those developing them, rather than 
thorough understanding of the behaviour in question based upon evidence (Michie et 
al., 2014). This resonated with findings from the systematic review carried out in this 
research that highlighted a lack of theory and evidence used in the development of AAS 
interventions and a lack of recognition for the wider socioecological influences upon AAS 
use. The original plan for the research to develop an intervention no longer seemed 
feasible. There seemed to be many potential options, but a lack of evidence to support 
any one option over another, which the researcher had concluded was a limitation of 
the interventions already evaluated. There did not appear to be clarity on exactly what 
outcomes any intervention should be looking to achieve and with whom, what 
behaviours should be targeted as part of this process and in what ways they need to 
change.  
The question of what such an intervention should actually be trying to change was a 
particularly important influence on the direction of the research. The systematic review 
identified that interventions evaluated to date were mainly of a preventative nature 
with school-based athletes, and in a sports context outright prevention is justified by the 
zero tolerance attitude to doping and performance enhancement. A harm reduction 
approach appears greatly at odds with such an attitude. In a public health context and 
when applied to the general population there seemed to be more scope for harm 
reduction work with AAS users, but there remained a lack of evidence to support an 
                                                          
4 Systems represent a number of interacting components that are directly or indirectly connected to one 
another. Applying this approach to understanding a behaviour leads to understanding that rather than 
being isolated and distinct, all behaviours are influenced by other factors such as behaviours, individuals 
and environments. Consequently, it is important to understand the system rather than only individual 
components within it. This has clear implications for those developing behaviour change interventions. 
Further discussion and definition of this systems approach and how it applies to AAS use and intervention 
development is provided in chapter 3. 
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intervention of this nature or specifically what it should look to achieve. Additionally, 
the interventions identified offered little clarity about what prevention interventions 
needed to focus on and change in order to reduce initiation. It was concluded therefore 
that more work to understand and define what AAS interventions are needed for and 
should be looking to achieve in a public health context was needed before effective 
approaches could be developed. As the research progressed, the need and opportunity 
for interventions based on reducing harm and discontinuing AAS use became more 
defined and justified. On prevention however, the picture remained less clear and 
consequently the research became increasingly focussed on those already using AAS 
rather than preventing initiation.   
There are several further examples of how the sequential framework was important in 
the development of the study and how studies were integrated with each other. The 
robust examination of the literature in both evidence reviews (studies 1 and 2) helped 
to identify the evidence gaps and research needs that led to the development of the 
remaining research in this study. The sampling approach to identify stakeholders to be 
interviewed (study 3) was informed by the socioecological framework developed (study 
2), with participants targeted in part to represent the potential environments that 
people who use AAS experience and are influenced in. Findings from study 2 were also 
used as prompts during stakeholder interviews (study 3) and in the development of the 
semi-structured interview schedule for interviews with people who use AAS (study 4). 
The final stage in the research reflected the priorities identified during the studies, which 
led to the development of objective 5. Findings from the separate studies were used in 
the creation of the conceptual map of information provision and surrounding discussion 
and identification of how information provision could be improved. 
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Chapter 2: A systematic review of the behaviour change strategies 
used in interventions aiming to influence use of AAS 
Rationale and outline 
That interventions to influence use of AAS are required has long been recognised 
(Council on Scientific Affairs, 1988, Nutter, 1993). The rationale for such interventions 
has included for health reasons and from a sporting perspective to reduce cheating and 
ensure fair play. Over the past 30 years, a number of studies have evaluated attempts 
to influence decision-making relating to AAS, which provide a useful starting point when 
looking to understand what influences users and what types of interventions targeting 
them are likely to be effective. Beyond exploring whether these interventions have been 
effective at achieving their goals, understanding which messages and intervention 
components work, or do not work, with this population will provide valuable evidence 
to understand how to influence their decisions. Over the past decade, developments in 
the field of behaviour change science support researchers to unpick interventions and 
to systematically examine their components (Michie and Prestwich, 2010, Michie et al., 
2013, Michie et al., 2011). For interventions to be effective, appropriate behaviour 
change mechanisms must be identified and the application of theory in their 
development is recommended to guide this (Craig et al., 2008). Examining the 
components and the application of theory in interventions provides insight into the 
nature of these interventions and it may be possible to identify approaches that are 
likely to be effective or ineffective. 
While useful summaries of the evidence base exist, previous examinations of this 
literature have focussed on prevention approaches only (Backhouse et al., 2014, Bahrke, 
2012) and not considered those who are already users. Additionally, they have not 
examined the content of these interventions and there are a number of recent 
evaluations of relevant interventions published since these reviews. This systematic 
review therefore aimed to address these gaps by analysing interventions that have 
sought to prevent use of AAS, or to reduce use or harms amongst those already using 
them. Comprehensive searches in bibliographic databases, supplemented by reviewing 
key websites and reference lists of relevant works, identified 14 interventions that met 
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review inclusion criteria. Interventions were predominantly preventative and delivered 
within school sport settings, but targeted a wide range of mediating factors. 
Interventions were generally educational in nature, but prevention efforts with 
components in addition to information provision alone appeared more promising. 
Interventions for populations other than young athletes are needed to reduce demand 
and to reduce harms amongst users. In addition to the scarcity of evidence, the findings 
are also limited by the methodological weaknesses of studies. Future interventions 
should be developed, implemented and reported with reference to current guidance to 
develop the evidence base. 
Methods 
Aims 
The review aimed to systematically identify the behaviour change strategies applied in 
interventions that have sought to prevent or reduce use of AAS, or reduce associated 
harms. This included the characteristics and components of interventions and their 
settings and target populations, and the utilisation of theory in intervention 
development, delivery and evaluation. Additionally the review aimed to identify 
whether particular behaviour change strategies are associated with reducing use or 
harms. 
Validity and quality 
Although there are many types of systematic reviews, they are characterised by a need 
for transparency and rigorous methods (Gough et al., 2017). Consequently, efforts were 
made to ensure rigour in this review. Protocols outlining the purpose and methods of a 
review are an important first step in undertaking a systematic review (Moher et al., 
2009, Gough et al., 2017). A full protocol was developed and registered on the 
PROSPERO International Register of Systematic Reviews (ID CRD42016051204), an 
online resource to share review protocols for health related projects. The protocol was 
registered prior to the review beginning and is available via PROSPERO at 
www.crd.york.ac.uk/prospero/display_record.php?RecordID=51204). The protocol 
described the search strategy, inclusion criteria, processes for selecting and evaluating 
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studies, and analysis approach. A range of guidance is available to support the 
production of high quality reviews, which typically set out a number of discrete 
processes to follow. There is great overlap between the different guidelines, which 
typically include the same steps, but may be tailored towards different types of reviews 
(for example, reviews of randomised controlled trials, qualitative evidence, mixed 
methods). Guidance from the Cochrane Collaboration is appropriate for reviews that 
deal with questions of effectiveness (Higgins and Green, 2011), but most applicable to a 
narrow set of study designs. Scoping searches for this review confirmed expectations of 
a small evidence base and studies of mixed design and quality. The Joanna Briggs 
Institute (JBI) Method for Systematic Review Research (Aromataris and Munn, 2017) is 
suitable for reviews that look to include a range of study designs (Godfrey and Harrison, 
2015), so was suitable to guide this review.  
Additionally, two tools were used during the production of the review. Firstly, the JBI 
Critical Appraisal Checklist for Systematic Reviews and Research Syntheses (Aromataris 
and Munn, 2017), a tool to appraise systematic reviews using 11 criteria, was referred 
to during the review to ensure validity and reliability of methods. Secondly, the 
Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) checklist, 
which aims to support reviewers write up their reviews and report adequate detail on 
all important aspects of the review (Moher et al., 2009), was used during the writing up 
process. The completed PRISMA checklist for this review is provided in appendix 1. 
Finally, training on identifying behaviour change techniques and functions was 
undertaken prior to beginning the review through the behaviour change taxonomy 
training website (http://www.bct-taxonomy.com/), developed by the authors of these 
tools. 
The approach to undertaking the review and decisions on key aspects such as the search 
strategy, inclusion criteria and analysis approach was supported by discussion and 
feedback from supervisors. A researcher with experience and knowledge relating to AAS 
and interests in psychology and behaviour change was invited to join the review team 
and supported the review by acting as ‘second reviewer’ on study selection and data 
extraction (including the identification of behaviour change techniques and intervention 
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function) on a sample of the studies. This was carried out in accordance with the 
guidance described above to reduce risk of bias and human error. An article based upon 
the review was submitted to the Journal of Health Psychology (Bates et al., 2017a) and 
feedback from peer reviewers was used in the production of the review. Much of this 
chapter replicates the text of the published article. Although this text is taken directly 
from the article, it has not been put in quotations to support the readability of the 
chapter. The article was written by the researcher who wrote this thesis, with the other 
authors’ inputs coming in the study design stage and/or limited to commenting on drafts 
of the article. Confirmation of author input is provided in appendix 2. 
Search strategy  
A comprehensive search for relevant studies was undertaken in December 2016 in the 
following databases: the Cochrane Library, MEDLINE, PsycINFO, Sports Discus, the Social 
Science Citation Index and Conference Proceedings Citation Index. Search strategies 
were developed based on combinations of free text and controlled vocabulary terms 
adapted to each database but included variations of: anabolic steroid, performance 
enhancing, doping, muscle enhancing, IPED, PIED, PED, sport, athletes, gym, fitness, 
school, bodybuilding, weight training and prison. Initially a search strategy was 
developed to search in MEDLINE and this was adapted for searching in other databases. 
The MEDLINE search strategy is provided in Appendix 3. Further, steps were undertaken 
to identify any additional articles not picked up during database searching, including 
‘grey’ literature. This included reviewing the publication lists of organisations including 
the Advisory Council on the Misuse of Drugs, US Anti-Doping Agency, UK Anti-Doping, 
Druginfo and the US National Institute on Drug Abuse, as well as the bibliographies of 
key literature reviews relevant to this review (Backhouse et al., 2014, Petróczi et al., 
2014, Bahrke, 2012), and of included articles.  
Inclusion criteria and study selection 
Studies published from 1990-2016 were eligible for inclusion to include the time period 
since early calls for AAS prevention interventions (Council on Scientific Affairs, 1988, 
Nutter, 1993). Inclusion criteria were controlled studies of interventions that aimed to 
reduce use of drugs taken to enhance muscularity, performance or appearance, or to 
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reduce harms or improve health in users. This included studies focussing on the use of 
steroids specifically, but also studies that applied broader terms to the substances they 
focussed on such as ‘performance enhancing drugs’, or ‘doping’. These terms are 
strongly associated with AAS, but can also include other drugs used alone or alongside 
these, so are referred to here under the umbrella of IPEDs. Universal interventions and 
those targeted to any populations including, but not restricted to, young people, gym 
users, bodybuilders, athletes and men who have sex with men were eligible for 
inclusion. Studies were included where an intervention was compared with no 
intervention or a control intervention, and outcomes relating to the use of IPEDs or 
intentions, attitudes, norms or knowledge relating to IPED use, were reported.  
The researcher screened titles and abstracts of all identified articles, with a sample of 
10% screened independently by a second reviewer with experience in systematic review 
and IPED research to determine eligibility for inclusion against the pre-determined 
criteria. The full text of articles included at this stage were downloaded and screened 
for eligibility in the same way. Reviewer agreement on inclusion and exclusion was 100% 
on the samples screened by the second reviewer at both stages. 
Data extraction and quality assessment 
The methodological quality of studies was assessed using criteria set out in the Effective 
Public Health Practice Project (EPHPP) quality assessment tool (Thomas et al., 2004). 
This tool is appropriate to use in systematic reviews of effectiveness interventions 
evaluated using a range of methodologies (Deeks et al., 2003, Jackson and Waters, 
2005). Study strengths and weaknesses were considered alongside the discussion of 
findings. The data extraction process was developed to gather as much information as 
possible on the nature of interventions. Data relating to study design, population and 
methodology, intervention characteristics, study outcomes and process outcomes were 
extracted using a form in Microsoft Access designed for this review. All data extraction 
and quality assessment was checked by the same second reviewer who had screened a 
sample of studies. Discrepancies at all stages were resolved through discussion.  
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Identification of behaviour change strategies 
In addition to understanding whether interventions have been effective, the review 
aimed to identify the behaviour change strategies applied within these interventions 
and whether these were linked with effectiveness. Three tools developed to unpick the 
content and development of interventions were used: The Behaviour Change Taxonomy 
(Michie et al., 2015), BCW (Michie et al., 2011) and Theory Coding Tool (Michie and 
Prestwich, 2010). All three have been used in systematic reviews to identify the content 
of interventions and their theoretical development. Using these tools supported 
understanding of what the interventions identified in this review aimed to do, their 
theoretical underpinnings and development, and what was actually delivered.  
The theoretical basis of interventions were examined using the Theory Coding Tool 
(Michie and Prestwich, 2010) designed to identify the extent to which theory is used in 
the development, implementation and evaluation of interventions. Behaviour change 
techniques (BCTs) were grouped according to the revised Behaviour Change Technique 
Taxonomy (Michie et al., 2013), a hierarchically structured taxonomy of 93 BCTs. BCTs 
are defined as the smallest components of an intervention and were recorded when 
explicitly reported by article authors (Behaviour Change Technique Taxonomy v1). The 
Taxonomy has been applied in systematic reviews to identify BCTs associated with 
effective approaches designed to influence a variety of behaviours including obesity 
management, physical activity, sexual health, alcohol use and cardiac rehabilitation 
(Martin et al., 2013, Burns et al., 2016, Heron et al., 2016, Prestwich et al., 2016, Bird et 
al., 2013). To help understand behaviour change strategies the BCW (Michie et al., 2011) 
was used to identify the behaviour change function(s) in each intervention. The tool 
includes nine distinct functions that interventions can perform in order to change 
behaviour (education, persuasion, incentivisation, coercion, training, restriction, 
environmental restructuring, modelling and enablement). Where further information 
on intervention content was required, authors of studies published since 2000 were 
contacted. Five of six authors contacted responded with additional information not 
included in published articles. 
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Analysis 
Results relating to identification of behaviour change approaches, theoretical constructs 
and behaviour change techniques are presented in structured tables and as a narrative 
summary. Findings relating to intervention effectiveness on relevant outcomes are 
summarised in tables. For the outcome of intervention impact on IPED use, effect sizes 
are reported and where not available in articles these were calculated where possible. 
Due to a combination of factors including variation between studies in design, 
intervention approach and outcome measures, meta-analysis was not appropriate to 
examine intervention effectiveness. 
Results 
After deduplication, 12,857 articles were identified through database and 
supplementary searches. The study selection process is summarised in Figure 2, with 23 
articles eligible for inclusion in the review. These 23 articles covered 17 studies that 
evaluated 14 distinct interventions (two interventions were evaluated at pilot and full 
study stage, and one intervention was trialled and evaluated with two populations). 
Summary of identified studies 
The characteristics of the 14 interventions are summarised in table 1. The interventions 
were predominantly delivered in educational settings to young athletes and 
preventative in nature. They commonly sought to influence behaviour by providing 
messages about IPEDs and associated harms. A range of other approaches were applied 
usually alongside IPED education including the development of skills and knowledge to 
encourage healthy alternatives to IPED use, wider health promotion, changing of 
appearance norms, the development of positive morals and values, and drug testing. 
Only 2 of 14 interventions were delivered outside of educational settings, one that 
targeted adolescents in the community (Nilsson et al., 2004, Nilsson et al., 2001) and 
one that targeted adolescent and adult gym users (Jalilian et al., 2011). This gym-based 
study was the only one that included a substantial proportion of users, although even in 
this case the vast majority of participants (approx. 80%) were non-users. Further details 
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on intervention characteristics that were useful in understanding the nature and 
delivery of interventions are summarised in appendix 4. 
In 11 of 14 interventions, the primary aim was to reduce use of, or risk factors for, IPED 
use. In addition, ATHENA (Elliot et al., 2004) was a health promotion intervention aiming 
to reduce disordered eating and IPED use; and both a university-based drug education 
programme (Tricker and Connolly, 1996) and the SATURN programme (Goldberg et al., 
2003, Goldberg et al., 2007) aimed to reduce substance use (including IPEDs) amongst 
student athletes. The ATHENA and ATLAS programmes were evaluated at short- and 
long-term follow up (two and one years respectively) and the German anti-doping 
intervention (Wippert and Fließer, 2016) was evaluated up to two years following the 
intervention. All other studies included follow up at 3 months following intervention 
completion or less.  
Summary of study quality 
Overall ratings of study quality are presented in Table 1 with full details of the findings 
from the quality assessment process available in appendix 5. Overall, three studies were 
rated strong, five studies were rated moderate and nine studies were rated weak using 
the EPHPP tool. Across the studies, common areas of weakness were withdrawals and 
drop outs, particularly across studies that recruited from school sports teams; and 
potential for selection bias, typically as a result of a lack of reporting relating to how 
many potential participants agreed to take part in the study. Further, in seven studies 
important differences between groups identified at baseline measurements were not 
reported or addressed.  
33 
 
Figure 2: Flow of studies through the review 
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Table 1: Summary of included articles 
Intervention 
description (Control 
group) 
Citation(s) 
(Country) 
Participants and 
setting 
Design 
(sample 
size) 
Quality 
rating 
IPED Outcomes 
(follow up length) 
Summary of results 
Anti-doping culture 
promotion 
(General health 
education) 
Barkoukis et 
al., 2016 
(Greece) 
Male and female 
adolescents at 
school 
RCT  
(218) 
Moderate 
Doping attitudes; 
Perceived 
prevalence of 
doping in 
professional 
athletes 
(Post-intervention) 
No intervention impact on doping 
attitudes, or perceived prevalence of 
doping amongst athletes in Greece. 
 
Online doping 
ethical decision 
making training 
(Usual education; no 
intervention)  
Elbe & 
Brandt, 2016 
(Germany) 
Male adolescent 
athletes at 
school  
 
CBA  
(69) 
 
Weak 
Doping attitudes 
(Post-intervention) 
Slight increase in undesirable attitudes 
towards doping following ethical 
training, although attitudes remained 
negative towards doping.  
ATHENA: health 
promotion 
intervention 
(Information 
pamphlet) 
Elliot et al., 
2004, 2006, 
2008; Ranby  
et al., 2009 
(USA) 
Female 
adolescent 
athletes at 
school  
 
RCT  
(928) 
Moderate 
Use of body 
shaping substances; 
AAS intentions, 
knowledge & 
norms; Body image 
(Post-intervention, 
2 years) 
At short-term evaluation ATHENA had a 
positive effect on initiation of body 
shaping substances, but there was no 
long-term effect. Intentions to use AAS 
and creatine were reduced compared to 
the control group at long-term 
evaluation. Short-term knowledge of 
AAS effects increased compared to 
controls, but perceptions of peers’ use 
of IPEDs and coach and peer attitudes 
to body weight were mixed across 8 
measures. At long-term evaluation 
ATHENA participants favoured a heavier 
body shape compared to controls. 
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Intervention 
description (Control 
group) 
Citation(s) 
(Country) 
Participants and 
setting 
Design 
(sample 
size) 
Quality 
rating 
IPED Outcomes 
(follow up length) 
Summary of results 
Brief educational 
intervention with 
handout 
(Handout only; no 
intervention) 
Goldberg et 
al,, 1990 
(USA) 
Male adolescent 
athletes at 
school  
RCT  
(190) 
Weak 
AAS attitudes & 
knowledge 
(2 weeks) 
Attitudes towards AAS improved slightly 
in all groups. Knowledge of AAS adverse 
effects increased compared to handout 
only controls on 3/13 measures and to 
no intervention controls on 6/13 
measures.  
Brief educational 
intervention with 
handout; Fear based 
education 
intervention with 
handout 
(No intervention) 
Goldberg et 
al., 1991 
(USA) 
Male adolescent 
athletes at 
school  
RCT 
(192) 
Weak 
AAS attitudes, 
belief in negative 
consequences of 
AAS use 
(2 weeks) 
No impact of the balanced or fear based 
education on attitudes towards 
personal AAS use across 7 measures. 
Greater belief in adverse effects for 
participants who received the balanced 
intervention compared to fear based 
education or control groups. No change 
in belief in adverse effects amongst the 
fear based education group. 
ATLAS (Pilot): steroid 
education and 
nutrition and 
strength training 
(No intervention)  
Goldberg et 
al., 1996a 
(USA) 
Male adolescent 
athletes at 
school  
CBA  
(120) 
Weak 
AAS intentions & 
attitudes; Ability to 
resist AAS offers 
(Post-intervention) 
Compared to controls intention to use 
AAS was reduced slightly on 2 
measures. Impact on attitudes and 
beliefs about AAS and AAS norms were 
mixed across measures and ability to 
resist drugs did not change. Perception 
of body image and knowledge about 
AAS effects and alternatives were 
improved compared to controls. 
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Intervention 
description (Control 
group) 
Citation(s) 
(Country) 
Participants and 
setting 
Design 
(sample 
size) 
Quality 
rating 
IPED Outcomes 
(follow up length) 
Summary of results 
ATLAS: steroid 
education and 
nutrition and 
strength training 
(Information 
pamphlet) 
Goldberg et 
al., 1996b; 
2000; 
Mackinnon 
2001 
(USA) 
Male adolescent 
athletes at 
school  
RCT 
(3,207) 
Strong 
Use of AAS; AAS 
attitudes, 
intentions, 
knowledge & 
norms; body image; 
ability to resist AAS 
offers 
(Post-intervention, 
1 year) 
There were fewer new incidences of 
AAS use and lower intentions to use 
amongst ATLAS participants compared 
to controls at end of season and 1 year 
follow up. Attitudes and knowledge 
regarding AAS favoured ATLAS 
participants at both times. Impacts on 
normative beliefs and perceptions 
about others’ AAS attitudes were 
mixed. Short-term benefits for drug 
resistance skills were not maintained at 
1-year evaluation. 
SATURN: random 
drug testing 
programme 
(No intervention)  
Goldberg et 
al., 2003 
(Pilot) 
(USA) 
Male adolescent 
athletes at 
school  
 
CBA 
(276) 
Weak 
Ergogenic drug use 
(including AAS); 
drug attitudes & 
norms 
(Post-intervention) 
 
There was no effect on initiation of 
ergogenic drugs. There was a small 
reduction in past month use in both 
groups. SATURN participants were more 
likely to have undesirable perceptions 
of others’ drug use and attitudes, 
beliefs about drug consequences and 
drug testing and greater risk taking. 
Goldberg et 
al., 2007 
(Full study) 
(USA) 
Male adolescent 
athletes at 
school  
RCT 
(1,396) 
Moderate 
Drug use (including 
AAS), drug 
attitudes & norms 
(Post-intervention) 
There was no impact on past month 
drug use, but past year use was lower 
for SATURN participants on 2 of 4 time 
points. SATURN participants were more 
likely to have undesirable perceptions 
of others’ attitudes to drug use and 
drug testing, and a greater desire to 
take risks than controls. 
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Intervention 
description (Control 
group) 
Citation(s) 
(Country) 
Participants and 
setting 
Design 
(sample 
size) 
Quality 
rating 
IPED Outcomes 
(follow up length) 
Summary of results 
AAS education 
(No intervention) 
Jalilian et al., 
2008 
(Iran) 
Male adolescent 
and adult 
community gym 
members 
RCT 
(120) 
Moderate 
Use of AAS; AAS 
intentions, 
attitudes, norms & 
knowledge 
(Post-intervention) 
AAS use was reduced in both groups, 
but by a greater amount amongst the 
intervention group. 
Intentions to use AAS were reduced in 
the intervention group only. Attitudes 
and knowledge about AAS changed in a 
favourable direction in both groups, but 
changes were greater in the 
intervention group. There was no 
impact on subjective norms. 
Health education 
intervention  
(No intervention) 
Laure & 
Lecerf, 1999 
(France) 
Male and female 
adolescent 
athletes at 
school  
CBA 
(287) 
Weak 
Attitudes & beliefs 
about doping 
(3 months) 
Impacts were mixed with the 
intervention having a positive impact on 
some of the 35 measures amongst the 
intervention group and no impact on 
other measures.  
Health education 
intervention  
(Information 
provision; no 
intervention) 
Laure & 
Lecerf, 2002 
(France) 
Male and female 
adolescent 
athletes at 
school  
CBA 
(379) 
Moderate 
Attitudes & beliefs 
about doping 
(3 months) 
Across 35 measures education 
intervention participants had reduced 
risk factors and increased protective 
factors for doping compared to 
information only and no intervention 
controls. There was no impact of the 
information only intervention compared 
to controls.  
Appearance and 
social norms 
focussed program  
(Not applicable) 
Nilsson et 
al., 2001, 
2004 
(Sweden) 
Male adolescents 
in the 
community 
CCS  
(345) 
Weak 
Use of AAS: tablets, 
injection  
(Post-intervention) 
The proportions of participants using 
injectable and oral AAS were reduced in 
the community following the 
intervention for injectable AAS (1.9% 
reduction) and oral AS (1.3% reduction) 
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Intervention 
description (Control 
group) 
Citation(s) 
(Country) 
Participants and 
setting 
Design 
(sample 
size) 
Quality 
rating 
IPED Outcomes 
(follow up length) 
Summary of results 
Hercules: anti-
doping education 
alone or with 
strength training (No 
intervention) 
Sagoe et al., 
2016 
(Norway) 
Male and female 
adolescents at 
school 
 
RCT 
(202) 
Strong 
AAS intentions & 
knowledge; doping 
attitudes 
Satisfaction with 
appearance; ability 
to resist AAS offers 
(Post-intervention) 
Intentions to use AAS increased slightly 
following the education & training 
intervention, but there were no 
significant differences compared to 
education alone or control groups. 
There was no intervention impact on 
attitudes towards doping, ability to 
reject AAS offers or appearance 
satisfaction, but knowledge about AAS 
and AAS consequences increased 
following both education and training, 
and education alone, interventions.  
AAS education 
(Not reported)  
Trenhaile et 
al., 1997 
(USA) 
Male pre-
adolescent 
athletes at 
school 
 
RCT 
(35) 
Strong 
AAS attitudes & 
knowledge;  
self esteem; peer 
resistance  
(Post-intervention) 
Attitudes and knowledge about AAS 
were improved following the 
intervention and changed favourably 
compared with controls. No 
intervention impact reported on esteem 
or peer resistance. 
 
Drug education  
(No intervention) 
Tricker & 
Connolly 
1996 
(USA) 
Male and female 
adolescent 
athletes at 
University 
CBA 
(635) 
Weak 
AAS intentions & 
attitudes; drug 
knowledge 
(Post-intervention) 
Intervention participants had lower 
intentions to use AAS on 1/3 measures 
and more desirable attitudes about AAS 
on 2/2 measures than controls. No 
intervention impact on knowledge 
about performance enhancing drugs or 
other substances. 
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Intervention 
description (Control 
group) 
Citation(s) 
(Country) 
Participants and 
setting 
Design 
(sample 
size) 
Quality 
rating 
IPED Outcomes 
(follow up length) 
Summary of results 
Anti-doping 
activities + 
curriculum  
(Curriculum only) 
Wippert & 
Fleißer 2016  
(Germany) 
Male adolescent 
athletes at 
school 
 
CS 
(213) 
Weak 
Doping knowledge 
(Up to 2 years) 
Knowledge about doping was greater 
amongst those who received the anti-
doping activities in addition to regular 
curriculum  
RCT=Randomised controlled trial. CCS = Cohort cross sectional study. CS=Cross sectional study. CBA=Controlled before and after study. AAS=Anabolic steroids.  
40 
 
Amongst nine studies that reported random allocation to groups, in only one study was 
the method of randomisation described (Elliot et al., 2004). There were few reports of 
any process evaluation and consequently it was typically impossible to determine to 
what extent the intervention was delivered as intended or was received by participants 
allocated to receive it, or if there was any contamination between groups. Across studies 
there was no attempt reported to blind participants, intervention deliverers or 
researchers to allocated conditions, although due to the nature of the interventions this 
would have been difficult and it is quite rare in equivalent public health interventions of 
a similar nature. This assessment of quality suggests that generally the evidence base is 
methodologically fairly weak and that, with exceptions, interventions to influence AAS 
use have not typically been evaluated using robust and reliable methodologies. 
Therefore caution must be used when interpreting results and considering the 
implications of these. 
Behaviour change strategies 
Five of the nine intervention functions in the BCW (Michie et al., 2011) were identified 
across the studies in different combinations, presented in figure 3. These interventions 
applied predominantly educational strategies to influence IPED use and risk factors. The 
most frequently identified functions were education (12 of 14 interventions), persuasion 
(7 of 14 interventions) and training (5 of 14 interventions) in different combinations. 
Training elements of interventions included information about weight training 
techniques (n=4) and skills to resist IPEDs (n=3). Two interventions included exercise 
sessions where weight lifting techniques were demonstrated and practiced in addition 
to an educational programme (Goldberg et al., 1996b, Goldberg et al., 1996a, Sagoe et 
al., 2016). 
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Figure 3: Intervention functions 
   
 
Across the interventions, 18 BCTs were identified (range 1 to 7), applied in many 
different combinations as presented in Table 2. Identification of BCTs was often difficult 
due to brief and imprecise reporting of interventions. Therefore it is possible that further 
BCTs were applied that could not be verified here. The most frequently identified BCTs 
involved   information provision (‘Information on social and environmental 
consequences’, n=9; ‘Information about health consequences’, n=8), followed by 
‘Instruction on how to perform the behaviour’ (n=5), reflecting the educational function 
of interventions identified. Smaller numbers of studies additionally included BCTs to 
influence social norms (such as the use of credible sources to deliver talks, information 
about others’ perceptions about AAS use) or self-regulating behaviour (such as goal 
setting, and self-monitoring). Most studies included between two and four BCTs, with 
more than four BCTs identified in only the ATLAS (Goldberg et al., 1996b, Goldberg et 
al., 1996a) and ATHENA (Elliot et al., 2004) programmes.  
Interventions with multiple intervention functions and those that included higher 
numbers of BCTs tended to be associated with more encouraging results. More 
42 
 
promising studies appeared likely to include a combination of education through 
information provision about IPEDs with components designed to develop skills, change 
social norms, or encourage goal setting. Two interventions associated with reductions 
in IPED use (Elliot et al., 2004, Nilsson et al., 2004) were the only interventions where 
participants received information on other people’s perceptions about healthy 
behaviours (‘Information about others’ approval’). Interventions associated with 
increases in undesirable attitudes (Elbe and Brand, 2016, Goldberg et al., 2003, Goldberg 
et al., 2007) and perceived norms (Goldberg et al., 2003, Goldberg et al., 2007) were 
studies for which just one BCT was identified, and were not educational. 
The theory coding tool (Michie and Prestwich, 2010) was applied to all papers. Generally 
theoretical constructs were poorly reported. The theoretical bases of six interventions 
were identified with specific theories including ethical reasoning theory (Elbe and Brand, 
2016), the theory of planned behaviour (TPB) (Jalilian et al., 2011), social learning theory 
(SLT) (Goldberg et al., 1996b, Goldberg et al., 1996a) and a combination of SLT and the 
health belief model (Sagoe et al., 2016). In the mediation analysis of ATHENA, models of 
behaviour including the TPB, social cognitive theory and the information, motivation, 
behaviour model were described (Ranby et al., 2009). Although no specific theories were 
described, the Greek anti-doping education intervention (Barkoukis et al., 2016) was 
based upon establishing social norms and sporting values. For all other studies, no 
theoretical bases were described, and it was therefore not possible to determine 
whether relevant constructs were used in the development or evaluation of 
interventions. The rationale or theoretical bases for control groups were not described 
in any study. 
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Table 2: Behaviour change techniques applied 
Study 
Goal setting 
(behaviour) 
Self-
monitoring 
Instruction 
on how to 
perform the 
behaviour 
Information 
about health 
consequences 
Salience of 
consequences 
Information 
about social & 
environmental 
consequences 
Demonstration 
of behaviour 
Information 
about 
others’ 
approval 
Behaviour
al practice/ 
rehearsal 
Behaviour 
substitution 
Credible 
source 
Restructuring 
the physical 
environment 
Framing/ 
reframing 
Punishment 
1    √  √    √     
2             √  
3 √ √ √   √  √ √    √  
4    √           
5    √ √ √         
6 √  √ √  √ √  √   √   
7              √ 
8   √ √      √ √    
9      √ √        
10    √ √ √  √       
11   √ √  √   √      
12 √  √ √           
13      √    √ √    
14      √     √    
1=Barkoukis et al. (2016). 2=Elbe & Brand (2016). 3=Elliot et al. (2004). 4=Goldberg et al. (1990). 5=Goldberg et al. (1991). 6=Goldberg et al. (1996a; 
1996b). 7=Goldberg et al. (2003; 2007). 8=Jalilian et al. (2011). 9=Laure & Lecerf (1999; 2002). 10=Nilsson et al. (2001; 2004). 11=Sagoe et al. (2016).  
12=Trenhaile et al.  (1997). 13=Tricker & Connolly (1996). 14=Wippert & Fleißer (2016). 
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There was evidence for the six studies where a theoretical basis was identified that 
theory had been used to develop intervention techniques. All six studies measured 
theory relevant constructs at evaluation, and in four studies (Goldberg et al., 1996b, 
Sagoe et al., 2016, Jalilian et al., 2011, Barkoukis et al., 2016) outcomes were discussed, 
to at least some extent, in relation to theory. The ATLAS intervention had the most 
explicit links between theory and intervention development and evaluation, and 
mediation analysis further explored theoretical constructs underpinning the 
intervention (MacKinnon et al., 2001). 
Intervention effectiveness 
Evaluations of 5/15 interventions measured changes in IPED use, summarised in Table 
3. Potential to reduce use was limited by low numbers of users at baseline and short-
term follow-up and, although positive intervention effects on IPED use were reported, 
effect sizes (where available) were small. Evaluation of the only intervention targeting 
adults alongside adolescents in a gym reported a reduction in AAS use, but findings were 
limited by small sample size and short-term follow up (Jalilian et al., 2011). Evaluation 
of a community wide programme indicated that use of AAS may have reduced slightly 
(Nilsson et al., 2004), but findings were limited by the cross-sectional study design. There 
were also indications that the ATLAS and ATHENA interventions had positive impacts on 
IPED use. Short-term evaluation of ATHENA (Elliot et al., 2004) indicated fewer new 
users of ‘body shaping drugs’ amongst girls who received the intervention. However, 
this measure included supplements as well as AAS, and there was no effect of the 
intervention on the similar long-term outcome of ‘steroid and creatine use’ (Ranby et 
al., 2009). Use of AAS increased slightly following the ATLAS intervention, but at a lower 
rate than amongst controls (Goldberg et al., 1996b). Numbers reporting AAS use were 
low throughout the evaluation however and the differences between groups were not 
statistically significant.  
Evaluation of the pilot study of random drug testing in a small sample of school athletes 
was suggested to have had a positive impact upon past month IPED use (Goldberg et al., 
2003). However, there was no impact on new users and evaluation of the pilot and  
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Table 3: Changes in IPED use 
Citation(s) 
Study design 
Outcome (follow 
up time) 
Sample size Measure Pre-intervention Post-intervention  Summary 
I  C   I C I  C  
Elliot et al., 2004; 
Ranby et al., 2009 
(ATHENA) 
RCT 
Initiation of body 
shaping drug use 
(post-season) 
457 471  Not 
reported 
Not 
reported 
Not 
reported 
Not 
reported 
Lower initiation of body 
shaping substances, including 
AAS, amongst ATHENA 
students, risk ratio =1.55 (1.03, 
1.21) 
Steroid and 
creatine use (2 
years) 
406 411 Mean 
(SD) 
Not 
reported 
Not 
reported 
0.02 
(0.2) 
0.02 
(0.2) 
No impact on steroid or 
creatine use compared to 
controls, beta coefficient 
=0.001. 
Goldberg et al., 
1996b; 2000 
(ATLAS) 
RCT 
Lifetime AAS use 
(post-season) 
1,145 1,317 % 1.0 1.5 1.5 2.5 Lifetime use of AAS increased 
at a lower rate amongst ATLAS 
students following the 
intervention compared to 
control at both time points 
(Effect size not calculable). 
Lifetime AAS use 
(post-season) 
591 700 % 1.0 1.5 1.7 3.4 
Goldberg et al., 
2003 (SATURN) 
CBA 
New use ergogenic 
drugs (post-
season) 
62 95 Mean 
(SD) 
0.00 0.00 0.11 
(0.31) 
0.10 
(0.30) 
The SATURN intervention had 
no effect on initiation of 
ergogenic drugs, Cohen’s d= 
0.03 (-0.28, 0.36). 
Past month use 
ergogenic drugs 
(post-season) 
Mean 
(SD) 
0.05 
(0.22) 
0.05 
(0.22) 
0.03 
(0.18) 
0.11 
(0.32) 
Reduction in past month use of 
ergogenic drugs amongst 
SATURN participants Cohen’s 
d= -0.30 (-0.62, -0.02). 
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Citation(s) 
Study design 
Outcome (follow 
up time) 
Sample size Measure Pre-intervention Post-intervention  Summary 
Jalilian et al., 
2011 (AS 
education 
intervention) 
RCT 
AAS use (2 
months) 
60 60 % 18.3 21.7 10.0 18.3 Use of AAS was reduced in 
both groups, but there was a 
greater increase amongst those 
who received the intervention, 
Cohen’s d= -0.39; CI -0.98, 
0.20. 
Nilsson et al., 
2001; 2004 
(appearance 
norms-based 
intervention) 
CCS 
Oral AAS use (2 
years)1 
450 332 % 6.6 4.7 The proportions of participants 
using injectable and oral AAS 
were reduced in the 
community following the 
intervention (Effect size not 
calculable). 
Injectable AAS 
use (2 years)1 
450 340 % 2.4 1.1 
 
RCT=randomised controlled trial. CBA=controlled before and after study. CCS=cross sectional cohort study. I=intervention group. C=control group. AAS=anabolic 
steroids. RCT=randomised controlled trial. CCS=cohort cross sectional. CS=cross sectional. SD=standard deviation. NR=not reported in article. d=cohen’s d. RR=risk 
ratio. 1Data is reported separately for 16 and 17 year olds in the cited articles and combined here. 
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follow up studies suggested risk factors increased (Goldberg et al., 2003, Goldberg et al., 
2007). Across studies, other outcomes commonly assessed included intentions to use 
IPEDs, and a range of measures of attitudes, knowledge and subjective norms (as 
summarised in Table 1). Knowledge of IPEDs was generally improved following 
interventions; however, impact was less clear on intentions, attitudes and subjective 
norms with small changes in the desired direction on some measures. 
Intervention fidelity in delivery 
Evaluation of ATHENA identified that, on average, teams included 81% of intended 
intervention content in each session (Elliot et al., 2004). In no other studies was any 
indication of intervention fidelity reported. As such, it was not possible to determine 
whether interventions were delivered or received in the intended manner, or using the 
BCTs and strategies identified.  
Discussion 
This review examined the nature and findings of interventions that have sought to 
reduce use of, or harms associated with, AAS over more than two decades. In 1996 the 
authors of one of these interventions noted that in comparison to other substances, 
there had been little research into AAS prevention (Goldberg et al., 1996a). Over twenty 
years later, during which time concerns about prevalence and harms outside of sport 
have become more widely discussed and a substantial amount of research examining 
the topic has taken place (McVeigh and Begley, 2016), the findings of this review suggest 
that this statement still holds true. While there is a growing body of evidence regarding 
aetiology, epidemiology and related harms, it would appear that little is known on how 
to influence use of these substances or bring about changes in behaviour, particularly 
outside of sporting environments. While typically underpinned by the need to provide 
information, prevention interventions have been tested that attempt to induce change 
in AAS or other IPED use through targeting many different behavioural risk and 
protective factors, such as  focussing on ethics and values, harms, healthy alternatives, 
body image and social norms. Since the studies in the 1990s by Goldberg and colleagues, 
these interventions do not generally appear to have built upon what has preceded them 
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and the evidence therefore largely consists of a series of ‘one off’ interventions that vary 
greatly in focus. There is no indication of the coherent development of a body of 
evidence since the first studies investigating AAS prevention, and consequently there 
are no clear messages emerging on what approaches are likely to be effective or 
ineffective. 
Providing reliable information to influence choices has clearly been considered an 
important need by those developing interventions in this area. These interventions have 
typically tried to influence young people before they initiate use and prevalence was 
very low across studies, limiting the potential to demonstrate effectiveness with short-
term follow-up measures. Additionally, while school years may be associated with onset 
of use for a minority of users, initiation has more frequently been reported from 20-30 
years of age (Pope et al., 2014a, Sagoe et al., 2014a), an age that interventions have very 
rarely targeted. As young people move from school into new environments, they are 
likely to be exposed to different opportunities, social expectations and pressures, which 
may affect motivation and factors that influence their decisions. Here interventions 
were based almost exclusively within educational settings and provide little insight into 
how to provide information or otherwise intervene with intentions to reduce use 
amongst, or provide support to, people in other environments such as health services, 
fitness settings or local communities.  
While it is feasible that interventions associated with effects on potential mediators may 
have positive impacts on future use, further testing of key theoretical concepts in 
experimental situations is required. For interventions with the stated aim of changing 
AAS or other IPED use, it is important that this outcome be measured. While secondary 
outcomes such as body image perceptions or social norms may be important and are 
therefore worthy of including, many potentially important factors may influence choices 
relating to AAS. Therefore, improvements in, for example, body image perception or 
positive group norms may not be an indication that the intervention has influenced use. 
Additionally, the studies here were generally based on the idea that people will make 
rational decisions, and therefore that increasing motivation to avoid AAS and pursue 
healthy alternatives will reduce use. However, decisions about health and behaviour are 
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not always rational and based upon a simple assessment of costs and benefits. Recent 
theories of motivation and decision making such as PRIME theory (West, 2006) and the 
Prototype-Willingness Model (Gerrard et al., 2008) emphasise the importance of factors 
beyond ones beliefs and values such as external social factors and internal urges and needs. 
This suggests that more consideration of the nature of information provision is required where 
the intention is to influence behaviour and choices. 
Research implications 
Interventions to date have focussed predominantly on young athletes. There remains a 
need to develop effective interventions to respond to use in both professional and 
amateur sport, and the lack of studies evaluating interventions in these environments 
outside of schools suggests that any current approaches need to be evaluated using 
robust study designs. The evidence on prevention or the provision of information, 
support or other interventions to those already using AAS outside of the sporting 
domain is lacking. Interventions are required in response to use of IPEDs, particularly 
AAS, to enhance muscularity and appearance for non-sporting reasons. These 
interventions will likely require different strategies than those targeting athletes hoping 
to improve sporting performance and therefore the strategies applied within school 
sport settings may not be transferable to the wider population. For example, recent 
interventions that focus on influencing ethical decisions (Elbe and Brand, 2016) and 
creating a sense of fair play and morality (Barkoukis et al., 2016) make sense in the 
context of competitive sport, but seem less important outside of this environment. 
Evidence is needed not just on what factors interventions should focus on, but what 
exactly they want to achieve. Amongst sporting organisations the emphasis of policies 
in this area lies on developing and supporting a zero tolerance approach to doping, with 
efforts to identify and take action against athletes caught using AAS or any of a 
substantial number of banned substances (WADA, 2017).  
It is less clear what the aims are of interventions outside elite sport should be, or what 
the needs are of those who use them. Therefore, evidence is needed on what 
interventions should be trying to achieve with users based upon assessment of their 
needs and gaps in the current provision of support and services. It should also be noted 
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that despite the broad search terms applied in this review very little evidence on IPEDs 
other than AAS was identified, indicating that research on approaches to tackle issues 
relating to misuse of drugs used alone or alongside AAS, such as melanotan and fat 
burning drugs, is lacking. To inform future interventions, research is required to increase 
understanding on which factors influence AAS decision-making amongst different 
populations. For example, although limited through its cross-sectional design, a 
community-based intervention included in this review sought to establish norms around 
steroids and appearance, and was associated with small reductions in use (Nilsson et al., 
2004). If identified that social norms and peer expectations are significant factors 
influencing use then future interventions should test how to target these constructs. A 
substantial body of literature exists that has explored motivations for AAS use and the 
experiences of men using these substances, yet there is a lack of models or frameworks 
bringing this information together to support understanding of decision making in 
important environments, and for intervention development.  
Methodological and reporting limitations 
It was intended to examine intervention effectiveness in the context of BCTs and theory 
applied and interventions that appeared more promising typically included higher 
numbers of BCTs and multiple intervention functions. Establishing norms regarding 
others’ perceptions of AAS use, a concept further supported by mediation analyses of 
ATHENA and ATLAS interventions (Ranby et al., 2009, MacKinnon et al., 2001), and 
including an element of skills training, either weight training or imparting resistance 
skills alongside educational components, may be promising approaches. However while 
some BCTs appeared to be associated with more effective interventions, interpretation 
of these findings was often made difficult by ambiguous or brief descriptions of 
intervention content and components. Consequently, caution is needed when 
interpreting findings regarding intervention approaches that appeared more promising. 
A limitation of this review may be the application of recent tools to identify BCTs and 
theory application, as it is recognised that studies published before new guidance and 
tools were available may be less likely to meet these standards. However, use of these 
tools enabled the examination of studies in a consistent manner and identification of 
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strengths and weaknesses of the evidence base. It is likely that additional BCTs were 
applied in these interventions that could not be identified with sufficient confidence.  
The weakness of the evidence base is not just a reflection of the scarcity of evaluated 
interventions, but of their reporting. Since the publication of the earliest articles 
included within this review, a range of tools, guidance and checklists have been 
developed to support the development, delivery and reporting of interventions (Michie 
et al., 2013, Hoffmann et al., 2014, Des Jarlais et al., 2004). The development, delivery 
and evaluation of future interventions should be grounded in theory (Craig et al., 2008, 
Glanz and Bishop, 2010) and reporting should enable the reader to identify how and why 
the interventions were designed, and which mediating variables were targeted. 
Additionally, reporting of intervention fidelity, participant understanding of 
interventions and detail regarding comparison conditions was largely missing in the 
studies included in this review. Intervention fidelity can act as a moderating factor on 
why interventions are effective or ineffective and should be evaluated and reported 
(Bartholomew and Mullen, 2011, Gearing et al., 2011). It is recognised that authors are 
restricted in the amount of information they can provide in articles, but can make 
supporting information such as protocols and manuals freely accessible elsewhere 
(Abraham et al., 2014). This will increase transparency, understanding of what has been 
implemented and replicability. Only through the accumulation of replicable and well-
reported interventions will a meaningful and rich evidence base emerge.  
Conclusion  
This review highlights that despite the substantial increase in research around AAS over 
the past three decades, and identification of use outside of professional sport, there is 
little evidence on how to prevent or reduce use, or provide support to people using AAS. 
What evidence there is comes predominantly from a set of stand-alone interventions 
delivered to school-based athletes that focus on a wide range of mediating factors. 
There is a clear need to respond to the very different issues of use outside of sporting 
environments. In addition to prevention, evidence is needed on how to provide support 
or intervene in different environments and with adult populations. For example, 
approaches to influence men who have already started using AAS or who have been 
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using for a long period of time. Increasing understanding on factors that influence 
choices and establishing consensus on the support needs of users that interventions can 
respond to is needed. Finally, a more consistent and rigorous approach to the 
development and reporting of interventions, with reference to the tools and guidance 
developed over the past decade in the field of behaviour change science, is required to 
establish the evidence base in this area.  
Box 1: Additional studies published since completion of the review 
Following the completion of this review in May 2017, three further studies have been 
published that would have met the review inclusion criteria. All three were of a 
preventative nature, targeted adolescents and delivered in schools. One study from 
Italy evaluated an intervention designed to improve media literacy (Lucidi et al., 
2017) and one study from Spain evaluated an educational programme based on 
WADA principles (Medina et al., 2019), despite presenting the study in the context of 
preventing use outside of sporting contexts. One study from Australia replicated the 
ATLAS program with non-athletes (Yager et al., 2018). A fourth study published in 
2018 appears relevant, but would not have been included in the review as it is 
available in Farsi only, with only the abstract available in English (Asr et al., 2018).  
While these studies add to the range of approaches that interventions have 
employed, their inclusion would not have changed the implications and conclusions 
in this review, particularly given the similarity in setting and population to other 
approaches already considered. None of the three evaluated impact on any IPED use, 
presumably due to the age of participants. These additional studies add to the 
evidence base on IPED prevention, but do not support the development of a clearer 
picture in terms of what types of approaches are likely to be effective at reducing 
use. Additionally they do not address the other gaps identified here, such as 
interventions to reduce harms amongst users.  
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Chapter 3: An evidence-based socioecological framework to 
understand men’s use of AAS and inform interventions. 
Rationale and outline. 
An important step in informing behaviour change interventions is thinking about all the 
potential behaviours and factors that interventions could target and different 
opportunities for delivering them. Stage 2 in the BCW framework, ‘Select the target 
behaviour’, recognises that all behaviours exist as part of, and are therefore affected by, 
a system of related behaviours, individuals and stimuli (Michie et al., 2014). The BCW 
suggests considering all the relevant options that could address the identified problem 
in order to select a behaviour to target through intervention rather than just those that 
appear most logical or obvious. To do this it is necessary to consider a wide range factors 
that influence AAS use.  
Findings in study 1 indicate that interventions in this field to date have predominantly 
focussed on individuals and have largely ignored the influences of external factors. 
Research into men’s use of AAS over the past three decades has, however, identified 
many factors that contribute to decision-making in this area. There is though a lack of 
theoretical frameworks to synthesise this research and guide practice, such as 
interventions to change use or provide support to users, and consequently researchers 
may not consider the importance of potentially significant factors. Further, 
interventions have generally been implemented in school, and predominantly school 
sport, settings. Other environments need to be considered, particularly for interventions 
that aim to influence people who are already using rather than preventing uptake.  
To address these gaps a socioecological framework is presented based upon the 
international literature examining steroid use, the majority of which was identified from 
three recently published systematic reviews. This framework proposes that use of AAS 
is the result of the interaction of a range of factors at the individual, social network, 
institutional, community and societal levels that are likely to change over time and with 
experience. Viewed through this framework it is clear that AAS use can be a complex 
behaviour with many influential environments and relationships, impacting on a diverse 
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population in different ways and at different times. The implications of findings for 
engaging with, and providing information to, users and delivering further interventions 
are discussed, such as the identification of important transition times and influencing 
norms within social groups and communities. Important environments that appear 
influential on AAS choices and that may be important settings or routes for interventions 
are identified. The approach is informed and inspired by socioecological theory and a 
systems approach to support the understanding of complex behaviours. 
Socioecological models 
In order to understand a behaviour it is important to recognise that it does not exist in 
isolation, but is part of a wider system of intra- and inter-personal beliefs, behaviours, 
contexts and cultures (Michie et al., 2014). Like many other theories of behaviour, the 
socioecological model recognises the influence of personal characteristics and 
immediate social influences, but also emphasises the role of wider physical, social and 
cultural factors. It has been used to increase understanding of a range of behaviours 
such as inter-partner violence (Smith Slep et al., 2014), food choices (Moore et al., 2013, 
Townsend and Foster, 2013), sedentary behaviour (O’donoghue et al., 2016) and alcohol 
consumption (Gruenewald et al., 2014). It is useful for understanding complex 
behaviours with many alternative explanations, drivers and influences. 
The socioecological model places individuals within complex physical and social systems. 
It suggests that health and behaviour are a consequence of interactions between these 
individuals and their immediate and distal environments and experiences (Stokols, 1992, 
Bronfenbrenner, 1986). This is important because to develop effective interventions 
researchers should consider both individuals and the complex systems and 
environments in which they operate, and the interactions that occur between them 
(Sniehotta et al., 2017). The socioecological framework suggests interventions need to 
address multiple levels in order to achieve sustained behaviour change (Sallis and Owen, 
2015). However, it appears that behavioural interventions have generally tended to 
focus solely on individual and intrapersonal factors and rarely sought to influence 
community, institutional and societal level factors (Golden and Earp, 2012).  The same 
can also be said with AAS interventions, which have tended to focus on changing 
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individuals’ knowledge, attitudes, perceptions and skills and been largely ineffective at 
influencing use (Bates et al., 2017a). These interventions have not typically targeted 
other levels in the socioecological framework, yet, as explored in this chapter, research 
has identified that AAS decision making is influenced by a range of social, environmental 
and societal factors. This is not to say that individual level factors are not important, but 
that they alone do not predict behaviours and decisions. For example, some individuals 
live in communities where masculine values, characterised by factors such as 
muscularity, physical strength or traditional male roles, are highly valued (Dolan, 2011). 
For these people such community level factors may be powerful motivators. If 
interventions target individual factors and ignore the wider contexts and environments 
that these individuals experience then it should not be surprising if they are not 
effective. Viewing AAS through a socioecological lens will help ensure that researchers 
consider all these important factors.  
Complex systems thinking and anabolic steroids 
A socioecological framework places individuals at the centre of a system where multiple 
levels of factors influence the behaviour. Researchers seeking to understand health 
behaviours are becoming increasing aware of the importance of exploring these wider 
systems in which individuals exist (Peters, 2014, Hawe et al., 2009). Systems represent 
a group of interrelating and interacting components that directly or indirectly influence 
each other under the assumption that a behaviour does not exist in isolation. Within 
complex systems various components exist that represent sub-systems with clearly 
defined boundaries. For example, if we are interested in understanding people in one 
city’s use of green space then we can explore the city as a complex system of green 
infrastructure with components such as major parks, streets, trees, wetland areas and 
buildings. Sub-systems exist within these components. For example, in one park there 
may be sports facilities, woodland, a pond, and so on.  
The complex systems approach is concerned with examining the relationships between 
components that make up a system to improve understanding on how these 
components influence each other and bring about changes. A key principle is the idea 
that everything within a system is connected with everything else, and therefore no part 
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of the system is completely independent (Lee et al., 2017). A change to one component 
will have an effect on others. This has clear implications for interventions that are 
looking to change one component, particularly as relationships in a system are 
characterised by non-linearity (De Savigny and Adam, 2009).  As explored in chapter 2, 
researchers have often assumed that by increasing knowledge about the risks of using 
AAS people will make ‘healthy’ choices not to use them. However, there may be other 
factors beyond the individual and their knowledge, skills and preferences that influence 
behaviour. It is important to recognise this bigger picture to understand and influence 
individuals. Further, by understanding how systems operate it is possible to anticipate 
how they will react to changes and to respond to and alleviate negative responses (De 
Savigny and Adam, 2009). 
Why is AAS appropriate for a systems approach? 
Systems thinking has often been applied to health care systems, but can also be applied 
to complex behaviours and outcomes where there are multiple relevant components 
and social networks. In the UK, the approach has been applied to support the response 
to increasing rates of obesity with the development of a complex obesity systems map 
illustrating the relationships between over 100 components that together determine 
obesity for individuals or groups of individuals (Vandenbroeck et al., 2007).  Similarly as 
to with eating behaviours, research has identified that drug use is a complex behaviour 
that can be effected by many variables across the socioecological domains, but has 
infrequently been considered in the context of systems thinking.  
Harold Holder proposed a systems approach to prevention of alcohol-related problems 
through restructuring communities and drinking environments (Holder, 2006, Holder, 
2001). The approach recognised the need to consider variables such as economic 
factors, the availability of alcohol, legal regulations and social and cultural norms as 
contributing to alcohol consumption and the development of alcohol problems, and as 
part of any prevention efforts.  A systems approach has been applied in the UK to drug 
use in the context of understanding factors that promote or inhibit recovery from 
problematic drug use (Daddow and Broome, 2010), but generally research to 
understand or change drug use behaviours has not been carried out in this way. In their 
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article exploring obesity, Lee and colleagues (Lee et al., 2017) identify several factors 
that establish obesity as a systems problem that requires a systems approach in 
response. These include: a global scope, heterogeneous patterns, wide-ranging impacts, 
lack of a single cause, and the failure of single solutions. While AAS use does of course 
not compare to obesity in terms of the numbers of people involved, the complex causes 
and consequences, and complex patterns of use characterised by variations between 
different subpopulations throughout the world, suggests that it meets these criteria.  
Study aims  
The aim of this study was to synthesise quantitative and qualitative research examining 
experiences and beliefs about AAS to present use through a socioecological framework. 
Frameworks of this nature have been successfully applied to understand and guide 
policy relating to a variety of behaviours such as violence (Smith Slep et al., 2014), 
physical activity (Elder et al., 2007) and smoking (Corbett, 2001) where, as with AAS, 
decisions may be effected by factors at different levels. Discussing the different 
influences on use, and how these influences interact to effect choices, will support the 
development and implementation of interventions such as those that aim to reduce use 
or to provide support to users.  
Methods and approach 
The aim of the literature search was not to identify every piece of relevant literature as 
in a systematic review, but to identify a substantial body of evidence through which to 
develop the framework. To ensure rigour however, the search was based upon three 
recently published systematic reviews that sought to identify literature relevant to the 
research question in this study (Brennan et al., 2016, Nicholls et al., 2017, Sagoe et al., 
2014a). Evidence from studies of all methodological designs were eligible to be included 
within the framework. This included studies predominantly based upon interviews and 
surveys that focused on any population or setting (such as, but not restricted to 
bodybuilders, gym members, elite or non-elite athletes, prisoners, young people) and 
considered use in any non-medical context. The reference lists of studies included within 
the three reviews were then examined to identify additional relevant studies. Citation 
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searching with these same references was carried out to identify recently published 
articles. Additionally, seven experts in the field who have undertaken research on AAS 
were contacted and asked for texts that they thought were particularly interesting or 
useful for understanding influences on choices. Through these methods, a substantial 
amount of literature was identified.  
The concept for the study was presented to behaviour change specialists and health 
psychologists on a behaviour change training course hosted by University College 
London in August 2017. The researcher was assigned a mentor throughout the week’s 
course with whom the study was discussed. Feedback from the mentor and other 
facilitators were used to help shape the study. A PhD student who had experience of 
working with, and undertaking research with, people who use AAS acted as a ‘critical 
friend’. In research, critical friends can contribute to understanding of study findings. 
They can offer alternative explanations to interpretations and conclusions from the 
perspective of somebody more distant to the data than the researcher and using their 
own experiences and understandings relating to the phenomenon of interest (Coghlan 
and Brydon-Miller, 2014). The critical friend reviewed study findings and provided 
feedback on these through two discussions, held after the initial analysis was complete 
and after findings were written up. Finally, an article based upon the study was 
published in the Journal of Drugs: Education, Prevention and Policy (Bates et al., 2018). 
Through the peer review process, feedback from reviewers regarding the presentation 
of findings in the graphic framework and clarity of the methods used were helpful in 
production of the article and this chapter. This chapter is based upon this article, and, 
as in chapter 2, in sections the text of the published article is reproduced here, but has 
not been put in quotations for reasons of readability. The text in the article was written 
by the researcher who wrote this thesis, with the other authors’ input coming through 
supporting study design  and/ or limited to commenting on drafts of the article. 
Confirmation of author input for the published article is provided in appendix 6. 
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Findings 
Identified articles were reviewed and where findings related to causes or influences on 
AAS use (including those relating to initiation, continuation and cessation) were 
identified, these were extracted. These factors were grouped together thematically and 
then organised using a socioecological framework. The framework, presented in figure 
4, presents use of AAS as the result of the interaction between factors in the different 
socioecological levels. This includes the users’ biological and demographic 
characteristics, beliefs and experiences; the norms, attitudes and pressures in their 
social networks and relationships; the institutions and environments where these social 
relationships occur; the characteristics of the communities they experience; and the 
norms and policies of the wider society these influences exist within. Relevant 
theoretical concepts and evidence from outside the AAS evidence base was brought into 
the discussion of the framework alongside the evidence identified in this study to 
provide context to findings within each layer of the framework. 
The factors identified as influencing use are presented here through the levels in the 
framework. The originator of the theory of ecological systems, Urie Bronfenbrenner, 
updated his model to include what he termed the ‘chronosystem’ to allow for the 
influences of time and environments that individuals experience at different points in 
their life (Bronfenbrenner, 1986). To understand use it must be accepted that individuals 
will move in and out of different leisure environments, workplaces, social networks and 
communities over their lifetime. At many important transition points in their life (e.g., 
starting a career, entering higher education), individuals will be exposed to new 
influences in new settings and these can all effect their choices. Therefore, within each 
level in the framework the impact of time and experiences is recognised. 
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Figure 4: A socioecological framework for understanding AAS use   
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Individual level 
Prevention interventions in this area have typically focused on changing individual level 
factors (Bates et al., 2017a) and evidence suggests that attitudes, beliefs and personal 
traits do contribute to AAS decisions. Recent work has sought to develop a typology of 
male users based around their individual characteristics (Christiansen et al., 2016). The 
typology includes four ideal types, but recognises that there is much further variation in 
characteristics and approaches to use. Beliefs about appearance and AAS (Bloodworth 
et al., 2012, Judge et al., 2012, Lucidi et al., 2008) and their use by others (Woolf et al., 
2014) have been identified as important and attitudes are likely to be reinforced or 
changed through personal experience over time. It is commonly identified that 
individuals may initiate use to overcome perceived genetic physical limitations (Van 
Hout and Kean, 2015, Kimergård, 2014, Grogan et al., 2006, Hanley Santos and Coomber, 
2017). This suggests that biological factors such as muscularity and body shape that can 
be achieved through natural and chemical means, as well as the body’s response to AAS, 
will influence decision-making.  
It has also been suggested that some individuals may be more susceptible to AAS 
dependence due to biological characteristics. For example, variations relating to the 
neuroendocrine system and neurotransmitter mechanisms may increase or reduce 
vulnerability to severe withdrawal symptoms following discontinuation (Kanayama et 
al., 2009a). Certain demographic factors have also been associated with use, which is 
more prominent amongst males, and while initiation occurs within a wide age range it 
is most likely between 20 and 30 (Sagoe et al., 2014a, Pope et al., 2014a).  Factors such 
as high drive for muscularity or muscle dysmorphia (Jampel et al., 2016, Zelli et al., 
2010a), holding masculine values (Keane, 2005), valuing traditional male roles 
(Kanayama et al., 2006) and low levels of self-esteem (Blank et al., 2016, Nicholls et al., 
2014) have been associated with increased likelihood of use. Other personal factors 
identified include a history of abuse or bullying (Petrocelli et al., 2008, Dennington et al., 
2008), the  tendency for risk taking behaviours (Pedersen and Wichstrøm, 2001, DuRant 
et al., 1995) and moral disengagement (Mallia et al., 2016, Judge et al., 2012). The 
socioecological framework recognises the significance of these individual level factors, 
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but suggests that they become more important in, and can be influenced by, certain 
environmental and social contexts. 
Social network level  
The evidence points towards the importance on use of relationships and social networks 
in many different environments. Mixing with other users can be influential through 
normalising and providing access to AAS (Boardley and Grix, 2014, Dennington et al., 
2008, Maycock and Howat, 2005), and facilitating the diffusion of information (Maycock 
and Howat, 2005, Kimergård, 2014, Grogan et al., 2006). Similarly, the increased 
acceptability of, and positive attitudes towards, AAS by significant others (Lucidi et al., 
2008, Zelli et al., 2010b), and, for athletes in their support team such as coaches, trainers 
and medical staff (Hoffman et al., 2008, Stilger and Yesalis, 1999, Nicholls et al., 2014, 
Madigan et al., 2016) are likely to impact on use. Pressure from peers (Midgley et al., 
1999, Wroble et al., 2002) as well as perceived pressure to use in order to compete with 
peers who are already doing so may also encourage uptake and continued use (Canadian 
Centre for Ethics in Sport, 1992, Olrich and Ewing, 1999, Grogan et al., 2006, Petrocelli 
et al., 2008).  
A substantial body of evidence points towards the importance of the social benefits from 
AAS use as contributing towards behaviour. The desire to fit in and gain approval is likely 
therefore to be important in initiation, while positive reinforcement and a sense of 
belonging may drive continued use. Work exploring the experiences of users has 
consistently identified social recognition and peer approval as important benefits from 
the physique gains achieved with the help of AAS (Dennington et al., 2008, Olrich and 
Ewing, 1999, Olrich, 1999, Petrocelli et al., 2008, Hanley Santos and Coomber, 2017, 
Kimergård, 2014, Ravn and Coffey, 2016). Researchers have documented the 
importance of socialisation associated with use amongst groups such as bodybuilders 
(Maycock and Howat, 2005, Maycock and Howat, 2007) and doormen (Monaghan, 
2003). The influence of others from networks of users extends beyond their substance 
use into lifestyle and behaviour (Maycock and Howat, 2007, Fussell, 1991). Additionally, 
a shared perception of safety regarding risky practices may support increased risk taking 
in these environments (Kimergård and McVeigh, 2014a). Comparisons can be made with 
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the ‘risk environments’ theorised for other groups who use drugs where belonging to a 
group with similar values and beliefs helps rationalise risk and make it acceptable 
(Rhodes, 2009, Rhodes, 1997).   
The association between use and enhanced social status and belonging has also been 
identified in online communities (Smith and Stewart, 2012). The growth of the internet 
has increased the amount of related information produced and access to this, which 
may enhance feelings of capability and safety amongst users (Kimergård, 2014) and 
make available information that previously would have been predominantly transferred 
within sub cultures. Online forums are popular amongst many users and facilitate the 
sharing of experiences and information (Smith and Stewart, 2012). Further, steroids are 
easily purchased online from a number of websites (McBride et al., 2016).  
Institutional level 
Social environments and organisations are settings where important information is 
disseminated, interactions occur and relationships develop that are particularly 
influential on use. Participation in competitive or non-competitive weight training and 
sports where strength and physique are important are risk factors (Nicholls et al., 2017) 
and gym and sporting environments are perhaps most frequently discussed in relation 
to AAS. Where use is common, the acceptability (Boardley and Grix, 2014, Dennington 
et al., 2008) and normalisation (Grogan et al., 2006, Hanley Santos and Coomber, 2017, 
Boardley and Grix, 2014, Dennington et al., 2008) of this appears to facilitate use in 
others and provides access to suppliers and information providers. Environments and 
institutions where use is seen as normal, acceptable (by both users and non-users) and 
beneficial may be conducive to initiating and continuing use. Individuals who otherwise 
would not have considered starting to use, for example a young person entering a gym 
or competitive sporting environment, may find peers having a significant impact upon 
their AAS choices.  
‘Normalisation’ effects have also been identified in the workplace (Hanley Santos and 
Coomber, 2017). Occupational use has been discussed relating to professions such as 
police officers (Hoberman, 2017, Hoberman, 2015, Turvey and Crowder, 2015), 
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doormen (Maycock, 1999, Maycock and Howat, 2007, Midgley et al., 2001, Monaghan, 
2003) and army personnel (Hoberman, 2017). This may help to achieve the strength and 
size perceived to be important for dealing with risky scenarios and to achieve the 
physique expected by employers and colleagues. Similarly, in prison environments 
prisoners may feel that projecting strength is important for reasons of safety, with this 
population identified as one of the most ‘at risk’ groups for using AAS (Sagoe et al., 
2014b). Within certain environments, the perceived benefits may outweigh any 
perceived risks in a way that might not occur outside of that context. 
Community level 
Individuals and institutions should be considered within the context of the communities 
they exist within. Cohen and colleagues (Cohen et al., 2000) identified four categories of 
structural factors within communities that influence health behaviours including i) the 
availability of consumer products, ii) physical structures, iii) social structures and iv) 
cultural messages. According to Cohen’s model, the enforcement of policies and laws, 
access to environments and institutions conducive to or accepting of AAS, community 
norms about and prevalence of use and access to healthcare services impact upon 
steroid choices of the local population.  
Access to and prevalence of environments such as those discussed in the institutional 
level will vary between communities. Examples may include the increased prevalence of 
‘hard-core’ bodybuilding gyms or manual occupations in more deprived or working class 
areas. Further, manual occupations have been linked with masculine and physical 
cultures and traditional male roles (Nixon, 2009, Dolan, 2011). These masculine values 
are evident at the community level and can be reinforced amongst boys from an early 
age (Evans et al., 2011) and in more working class communities may particularly be 
associated with toughness and success (Dolan, 2011). The relationship between use and 
socioeconomic status is not straightforward, however: Users are more likely to be 
employed than those who use other illicit drugs and rates of educational achievement, 
employment and income amongst users have been demonstrated to be comparable or 
better than average (Cohen et al., 2007, Westerman et al., 2016). Purchasing AAS along 
with nutritional supplements and other substances often used concurrently to further 
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enhance physique or manage side effects (Sagoe et al., 2015) for long periods of time, 
along with additional costs such as gym membership and equipment, indicates that a 
commitment to the bodybuilding lifestyle can be expensive.  
The availability of appropriate healthcare services and the level of engagement between 
health professionals and the local population of users will influence health seeking 
behaviours, information provision and treatment opportunities. In countries such as the 
UK and Australia NSPs are a common source of injecting equipment (Kimergård and 
McVeigh, 2014b, Dunn et al., 2016) and with use associated with a range of acute and 
chronic adverse effects (including those associated with needle sharing), healthcare 
access is clearly important. However many users may be reluctant to engage with 
healthcare services (Zahnow et al., 2017) and report concerns about stigma, knowledge 
and attitudes of health professionals that may reduce contact (Dunn et al., 2016). Men 
with strong masculine values may be reluctant to engage with the healthcare system 
(Courtenay, 2000, Springer and Mouzon, 2011). Further, where healthcare coverage is 
inadequate this can have adverse health effects for AAS users (Griffiths et al., 2017).  
Societal level 
At this final level factors are included that together generate the societies that users 
exist within, and promotes norms and expectations regarding body image, gender 
stereotypes and use. These concepts have been explored extensively by Harrison Pope 
and colleagues. They suggest that increases in body insecurity and desire to increase 
muscularity amongst males in many parts of the world over the past decades reflect 
Western societal expectations regarding the male physique and unrealistic body ideals 
that AAS may help to reach towards (Pope et al., 2000). Pope suggests this is reflected 
in portrayals of strong men, such as the increasingly muscular physiques of male action 
heroes and children’s toys. Research with users has suggested that some were 
influenced by images and portrayals of AAS and muscular physiques in media such as 
men’s and fitness magazines (Dennington et al., 2008) and social media (Van Hout and 
Kean, 2015), and prevalence is higher worldwide in regions where muscularity is 
associated with masculine values (Sagoe et al., 2014b). It is clear however that most men 
who are exposed to such images and ideals will not go on to use AAS and it is important 
66 
 
to consider why these portrayals resonate with some individuals but not with others. 
This may reflect the interacting influences of other factors explored in this framework 
such as values and beliefs regarding muscularity, masculinity and AAS inherent in 
communities and individuals.  
The role of media and cultural influences may be in promoting muscular and lean body 
ideals, rather than explicitly AAS, and different forms of media exposure have been 
associated with attitudes and expectations relating to muscularity and body 
dissatisfaction. For example, exposure to increasingly muscular and lean images of male 
characters in video games has been linked to body and muscle dissatisfaction and more 
muscular body ideals (Barlett et al., 2008, Harrison and Bond, 2007, Agliata and Tantleff-
Dunn, 2004). Similarly, depictions of men on television and film are typically more 
muscular and lean than the average man (Lin, 1998, Morrison and Halton, 2009, 
Dallesasse and Kluck, 2013) and time spent watching television has been associated with 
increased drive for muscularity (Cramblitt and Pritchard, 2013). When individuals feel 
unable to match these body standards reinforced through cultural representations of 
the male physique they may be more likely to consider AAS. Indeed, prevalence amongst 
western in comparison to Eastern cultures is indication of the importance of these 
cultural factors (Kanayama and Pope, 2011). A recent study identified a positive 
correlation between the level of news coverage regarding AAS use amongst athletes and 
celebrities and public interest in AAS in Peru, as measured through internet searches 
(Avilez et al., 2017). This raises the question of how the public responds to media 
coverage of high profile cases of AAS use and prevalence in the general population. It is 
possible that increased coverage establishes perceptions of normality and acceptability, 
and behavioural theories have long pointed to the influence that belief about the 
prevalence of a behaviour holds.  
Finally, there are many examples of policies that can influence AAS use. Most sporting 
organisations ban AAS alongside other IPEDs (WADA, 2017), with drug testing policies 
commonly implemented for elite athletes as part of efforts to reduce use. These are 
seen as a deterrent by some athletes but not others (Overbye, 2017) and some may seek 
alternative IPEDs not identified through testing procedures or exploit exemption policies 
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allowed for those with legitimate medical conditions (Harper and Donnor, 2017). The 
effectiveness of these policies may be influenced by factors within other levels in this 
framework such as attitudes of individuals and their significant others towards drug 
testing and consequences of being caught. Governments can influence the availability 
and acceptability of AAS through laws, which vary by country. For example, in the UK 
personal possession is legal while supplying to others is an offence and there are 
restrictions on importing AAS purchased outside of the UK or online. In comparison, in 
the USA possession is illegal, unless prescribed. The commissioning and funding of 
services or materials designed to educate or to reduce harm associated with AAS, such 
as clinics, NSPs, or information websites and hotlines are examples of public policies that 
may influence AAS use and related behaviour. 
Discussion 
This framework helps us understand the association between use and a range of factors 
that change over time as users experience new environments and develop new 
relationships and social networks. Further, this study provides a framework through 
which to view routes for interventions to influence behaviour and outcomes related to 
AAS use. As illustrated here however there are many other potential environments 
beyond schools (which interventions to date have typically been delivered in) worthy of 
attention, and other influencing factors to consider when planning such interventions. 
For example there may be merit in changing knowledge and beliefs about body norms 
and AAS, but efforts that fail to also recognise the importance of the role of individuals 
in the wider systems, for example social networks and the environments these networks 
are formed and interact in, are unlikely to achieve sustained benefits. Conversely, 
individual processes remain important to target and focusing on the wider systemic 
levels without considering individuals and their behaviours is also likely to lead to 
ineffective interventions (Sniehotta et al., 2017). For complex behaviours with 
competing or complimentary influences interventions should address multiple 
socioecological levels to be effective (Sallis and Owen, 2015) and this framework will be 
useful for identifying potential behaviours and factors to target.  
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Implications 
Throughout this chapter, examples are provided that demonstrate how levels in the 
framework interact and help to explain why some factors may influence some 
individuals more than others at different times. A key concept underpinning the 
framework is the influence of time and experiences. It is expected that as individuals age 
and experience critical life events and new environments the factors that influence their 
decision making explored within this ecological framework will change. The timing for 
interventions will be important and approaches delivered at important transition times, 
such as upon entering environments, such as a gym or place of work where AAS are 
perceived to be beneficial or normalised, or following injury or an adverse health 
outcome associated with AAS use, may be more likely to have a preventative or habit 
breaking impact.  
Certain factors appear particularly influential across multiple levels in the framework. 
Perceived normalisation and acceptability of AAS amongst social groups in different 
environments and communities appears to facilitate initiation and continued use and 
exposure to norms regarding related concepts such as masculinity and muscularity also 
appear important. Establishing healthy and desirable norms amongst groups and 
communities or correcting false descriptive norms about prevalence may therefore be 
beneficial. Related to this, the role of significant others (for example peers, competitors 
or colleagues) as information providers, motivators and in reinforcing behaviour and the 
desire to achieve recognition and social capital appears influential in a range of 
environments. The influence of other users is clear, and suggests that peers and 
influential others could have a positive role in delivering harm reducing and health 
promoting information to others in their networks and environments. More research on 
the dynamics of the social networks of users and their environments and investigating 
the diffusion of information within them may help understanding of how these 
relationships might be utilised. However, it remains important to consider these social 
networks in the context of the complex systems that users operate within. Decisions are 
not the result of any one level of the system alone (De Savigny and Adam, 2009) and 
using this framework to explore factors across the different socioecological levels, and 
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their interaction, will help ensure that those looking to understand use or develop 
interventions account for this complexity.    
According to the BCW, it is important to consider a wide range of potential behaviours 
that interventions could feasibly target in order to address a problem (Michie et al., 
2014). This socioecological framework supports this process by identifying exposures 
known to influence use. Additionally while this study does not an attempt to map a 
system of influences on AAS choices, it contributes towards increasing understanding of 
this system by identifying important relevant components. A number of environments 
are identified as influencing decisions relating to AAS such as gyms and sports clubs, 
workplaces, prisons, and healthcare services, which represent components in this 
broader system.  
Limitations  
While a broad range of factors influencing AAS use have been identified, the relative 
strength of these factors at different times and for different populations is unclear. 
Studies to date have tended to explore potential predictors and causes of use without 
seeking to compare these and future research could seek to quantify this to support 
interventions to focus on the most appropriate influencing factors for specific 
populations. Much of the evidence-base included here focussed on one socioecological 
level and in many cases the studies were looking to identify the association between use 
and a specific factor, for example exposure to media portrayals or social norms. It seems 
likely that in such studies, other potential important factors might have been 
overlooked.  
Although a substantial amount of evidence has been considered, it is likely that as the 
evidence base develops further the framework will require modification. People who 
use AAS represent a diverse population with different motivations, experiences and 
backgrounds. A recently developed typology of users (Christiansen et al., 2016) 
increases understanding of the types of individuals who use these substances and 
suggests that there is substantial variation in their characteristics, motives and approach 
to their AAS use. Therefore it is likely that the factors that influence decision making 
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within this diverse population will vary greatly also. Using the typology and this 
framework together to identify which factors are more influential for different groups 
may help to continue recent progress in increasing understanding of use and informing 
the responses of health professionals and policy makers.  
For example, the majority of research in this field focuses on factors relating to the 
initiation of AAS and there is less investigation of later decisions such as changes in use, 
transitioning from oral to injectable use and cessation. Much of the research has focused 
on athletes, bodybuilders and strength training environments and may not represent 
many of this diverse population. While the amount of research into users has increased 
greatly in recent years (McVeigh and Begley, 2016) it would appear that little evidence 
is available for many subgroups amongst this broad population. Therefore, the 
framework is perhaps quite generalised and subgroups for whom less research is 
available, for example gay men, older men and those in prison environments may not 
be represented in this framework. Females also take AAS, but it cannot be assumed that 
they do so for the same reasons as men.  
Conclusion 
Using an ecological approach, this framework suggests that use of AAS is the result of 
the interaction of many factors at the individual, social network, institutional, 
community and societal levels that are likely to change over time. Increasing 
understanding of use in this way will support the development of effective interventions 
designed to prevent or reduce use and provide support to users. The influences of peers, 
social networks and norms about AAS, muscularity and masculinity, particularly in the 
context of environments where AAS are associated with success or social rewards, 
appear worthy of attention for those designing interventions aiming to influence 
choices. The findings suggest that several environments may be important and 
influential for users and that research is needed to increase understanding of how these 
different environments and social networks can be used in the delivery of positive 
messages and support. 
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Chapter 4: Identifying priorities to improve health and manage risk 
amongst men who use AAS. Provision of information and support.  
Rationale and outline. 
The widespread use of AAS and the increasing availability of evidence pointing towards 
a range of related harms, risky behaviours and negative health outcomes for users 
justifies the need for interventions. In the UK, users are recognised as a priority group in 
the Government’s 2017 Drugs Strategy (HM Government, 2017) but there is insufficient 
formal guidance to inform the provision of services and interventions beyond the 
provision of injecting equipment (National Institute for Health and Care Excellence, 
2014). Further, there is a lack of empirical evidence internationally to inform the 
provision of support services to this group (Bates et al., 2014) or any other types of 
interventions. While a substantial amount of research has examined AAS use in terms 
of motivations and influences, research has rarely explored what interventions are 
needed for, or likely to be effective with, this group. In order to develop effective 
interventions it is first necessary to clearly define and specify the behaviours or 
outcomes that are to be targeted. According to the BCW (Michie et al., 2014), this 
requires clarity and precision about the problem that is to be addressed regarding the 
population, the behaviour itself and the intervention.  
This study therefore aimed to identify consensus on what the priorities are for 
interventions in response to widespread use and increasing evidence of risky behaviours 
and health harms amongst AAS using populations. Further, the study aimed to generate 
ideas for interventions in response to these priorities. The study was split across two 
stages. The main part of this study (part A) involved stakeholders with a range of 
expertise and experience relating to AAS. Following this stage, a second part of the study 
(part B) followed up some specific ideas coming out of the first stage with a smaller 
group of stakeholders with specialist knowledge and experience relating to these points. 
In total, 33 stakeholders with a wide range of experience relating to AAS were asked to 
take part through one focus group and largely unstructured interviews and encouraged 
to discuss their ideas based upon their experiences and expertise. The recruitment of 
participants through the study is summarised in figure 5. A range of priorities was 
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identified under three overarching themes: Opportunities to provide information and 
support, improving engagement, and choices and behaviours. The first two of these 
themes are discussed in this chapter. 
Figure 5: Summary of study 3 participants 
  
Focus group with participants (n=5) with expertise in AAS 
 One focus group held at an IPEDs conference in 
Liverpool, October 2017. Participants were recruited 
from the attendee list in October 2017. 
Interviews with participants (n=22) with expertise in AAS  
 Recruited November 2017-March 2018 
 Potential participants identified through attendance lists 
of 2 national IPED conferences and the contact lists of the 
researcher and his colleagues, and through a snowball 
approach whereby participants suggested other 
participants 
 Participants had experience working with AAS users in a 
range of roles including fitness environments, AAS 
support services, health and social care services and 
public health authorities 
Interview participants (n=6) who worked in health services 
identified as important in part A and study 2.  
 Recruited March-May 2018 
 Participants had no expertise or specific interest in AAS 
and had no or little experience working with users  
 Potential participants identified by stakeholders in part 
A of the study 
 
Part A:  
Identifying needs 
for interventions 
with 27 
stakeholders with 
expertise in AAS  
Part B:  
Following up on 
findings from Part 
A regarding health 
services with 6 
health service staff 
without expertise 
in AAS 
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Part A – the views of stakeholders with expertise in AAS 
Recruitment 
The inclusion criteria for participants were that that they had worked with users in any 
capacity. While users were eligible to take part, in this case their expertise was primarily 
sought in relation to their experiences of working with other users. The focus therefore 
was on recruiting individuals who were involved in planning or delivering health or 
leisure services or information provision for users. It was important to include 
participants from different environments and different perspectives to identify priorities 
that related to as much of the AAS using population as possible. Identification of 
participants was supported through the development of the socioecological framework 
to identify influences on users, which identified settings and services where users 
commonly access and seek advice or support. Participants were identified and recruited 
through (i) attendance lists of two conferences focussing on use of IPEDs in a public 
health context that the researcher had been involved with, (ii) a snowball approach 
where participants and colleagues were asked to recommend any individuals who they 
felt would be appropriate to take part, which continued throughout the study. Potential 
participants were contacted by email or telephone and the purpose of the study, and 
why they were being asked to take part, was explained.  
Data collection 
The researcher had undertaken a number of research projects relating to AAS use and 
health service provision as part of, and prior to, this PhD before starting this study, and 
therefore had a number of preconceptions and expectations relating to the study aims. 
To avoid superimposing these preconceptions onto participants, an inductive approach 
was undertaken, which has been commonly used in research relating to health and 
social sciences (Thomas, 2006). The idea that research can be purely inductive and that 
researchers collect and analyse data with no knowledge or expectations appears 
questionable (Kennedy and Thornberg, 2018) and it is recognised that the inductive 
approach in this study was unlikely to completely overcome the issue of prior knowledge 
impacting on findings. Indeed when discussing the inductive approach, Thomas 
(Thomas, 2006) states that “it is inevitable that findings are shaped by the assumptions 
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and experiences of the evaluators conducting the study and carrying out the data 
analyses” (p.240), but recognises the usefulness in this for making decisions about what 
data is important. Therefore while  this study was not intended to be an example of 
‘pure’ induction, adopting this approach to data collection and analysis aimed to 
minimise the impact of the researchers’ preconceptions and to allow the generation of 
new ideas in line with Strauss and Corbin’s (Strauss and Corbin, 1998)  definition: “The 
researcher begins with an area of study and allows the theory to emerge from the data” 
(p.12). Unstructured interviews are suitable for research where participants are to be 
asked open-ended questions to explore their perceptions relating to the research topic 
(Firmin, 2008). Through this inductive approach, the study aimed to understand the 
perceptions of stakeholders and the unstructured interview structure was chosen to 
support participants to bring up topics perceived to be relevant and important rather 
than topics the researcher presumed to be so. 
The first five participants were invited to take part in a focus group held at an IPED 
research event hosted by LJMU. The focus group format was utilised to stimulate 
discussion and establish any initial points of consensus. Subsequently, all remaining 
participants were invited to take part through an interview. Where practical, face-to-
face interviews were arranged, but because participants were based in a range of 
geographical locations interviews on skype or telephone were offered. Immediately 
prior to each interview, the aims of the study were reaffirmed and consent was gained 
to record the conversations. To help them prepare for the interview, participants were 
informed in advance that they would be asked about what they thought were key 
priorities to address in order to improve health and reduce risk amongst users. This 
broad question was used to initiate discussion at the start of each interview, after which 
the interviews followed an unstructured format and no pre-determined interview 
schedule was used.  
While this unstructured format was used throughout the study, where participants 
discussed topics that had been raised previously, they were encouraged to provide more 
information or to follow up on specific points. For example, participants commonly 
discussed that general practitioner (GP) knowledge and understanding of AAS is often 
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inadequate leading to unsatisfactory experiences when users visit their doctor. 
Therefore, if subsequent participants identified GPs as having an important role, they 
were asked to reflect on the perceptions of participants who had preceded them in the 
study and whether this matched their own experiences. Additionally, if the participant 
had a specialist interest or expertise that would give them particular insight into a topic 
raised by others then this was discussed. For example, some participants suggested that 
one setting to deliver interventions could be sexual health services so a participant 
whose role included commissioning such services was specifically asked for their 
reactions to this idea. To support this, interview transcription was completed shortly 
after each interview and transcripts read thoroughly, with notes made on potential 
themes and topics to follow up with other participants. 
This approach to data collection therefore allowed the research to initially identify a 
broad range of perceptions in response to the research question. By following up on 
themes with subsequent participants, while still allowing them to lead the discussions 
according to what they felt were the important areas to address, it was possible to get 
feedback on ideas and further develop these themes. This was important not only to act 
as a check upon the researcher’s interpretation of the data, but also to explore whether 
participants agreed with what others had suggested or if they had different perceptions 
and experiences. 
Analysis  
The inductive approach continued during analysis, with the emphasis on generating 
themes from the raw data collected rather than using any pre-determined coding or 
theoretical framework. Thematic analysis was a pragmatic choice as the analysis 
approach. Reflecting the aims of the study, it was chosen to support the identification 
of areas of consensus (and conflict) between participants regarding intervention needs 
through the development of themes based on the stakeholder responses. Additionally, 
it was hoped to collect a substantial amount of data to represent the views of a range 
of stakeholders, and thematic analysis is useful for identifying commonality in large 
datasets (King, 2004). It has frequently been used in health research and is particularly 
useful for applied research where study findings need to be conveyed to non-academic 
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audiences (Braun and Clarke, 2014). A key part of this research was following up findings 
with further participants and therefore it was important that findings could be easily 
communicated.  
Braun and Clarke’s six-step guidance for undertaking thematic analysis (Braun and 
Clarke, 2006) was followed to guide the analysis process in both qualitative studies. This 
guidance is used in the fields of psychology and health by researchers looking to 
undertake thematic analysis and has been cited over 40,000 times. The flexibility of the 
approach was a key advantage as the guidance could be adapted for the different parts 
of the study with the change from inductive to deductive collection and analysis of data. 
The authors highlight that their form of thematic guidance is suitable for both data and theory-
driven forms of analysis (Clarke and Braun, 2017). The steps in the thematic analysis are 
described here, with the corresponding phases in the guidance developed by Braun and 
Clark (2006) indicated. While the analysis is described in a linear format here, in reality 
this was an iterative process where phases overlapped and were returned to throughout 
the analysis.     
Familiarisation with data (Phase 1) 
All audio recordings were transcribed in full. Transcriptions were read following this 
process with notes made. These notes were primarily used to act as prompts for 
subsequent interviews as potential questions to follow up with and to reflect on what 
worked and what did not work during interviews. The transcriptions were returned to 
throughout the analysis as part of the process of checking codes and themes in the 
context of the wider data set they had been identified within.  
Generating initial codes and searching for themes (Phases 2 & 3) 
An inductive data-driven approach was applied during coding to enable identification of 
any priorities in response to the research question. As such, an open coding approach 
was utilised and no coding framework was developed. Data was systematically coded 
within each transcript with a code identified for all data. Therefore, any data that related 
to priorities to address amongst users and ideas for potential interventions, 
improvements or changes that could be implemented in response to these needs were 
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assigned a code. This initial long list of codes was reviewed and similar or overlapping 
codes were combined to give 113 codes, grouped together into 17 preliminary themes. 
These initial codes and themes are presented in appendix 7. Finally, all data for each 
code was extracted from transcriptions into an excel file, and collated by preliminary 
category and code. 
Theme development (Phases 4 & 5)  
Once codes from all interviews had been identified and grouped into initial themes, 
these were examined more closely and refined, and sub themes developed. A mind map 
was created to support the development of themes and their presentation. A full version 
of this, from which the themes presented here were developed, is presented in appendix 
85, with summaries presented as thematic maps in the results section. Themes and sub 
themes were developed and refined, which involved revisiting the transcripts to check 
extracts and coding in the context of the wider interviews.  
Study validity and credibility 
The two qualitative studies in this thesis were both informed and guided by Tracy’s Eight 
“Big Tent” universal criteria for excellent qualitative research criteria (Tracy, 2010). 
Denzin coined the term ‘big tent’ in response to the dismissal of qualitative research by 
some authorities and decision makers in favour of quantitative and experimental 
research designs (Denzin, 2008). Recognising that qualitative researchers would be 
better off coming together and recognising the value that all types of qualitative 
research offer than arguing with each other, Denzin called for a ‘bigger tent’ in which to 
include these different paradigms. Considering the range of methods and approaches as 
one however raises some issues when assessing the rigor of a study. Indeed, some 
researchers have argued against developing criteria to judge qualitative research. 
Rather than arguing against the idea of judging research quality, these researchers 
proposition that there is no one way to measure the quality of qualitative research 
(Bochner, 2000, Guba and Lincoln, 2005) due to the range and diversity of 
methodologies that exist. Therefore, they suggest that no predetermined criteria can be 
                                                          
5 The thematic map presented in appendix 8 includes all three themes presented here in chapter 4 and 
in chapter 5, and their subthemes.  
78 
 
appropriate to judge quality (Rolfe, 2006, Sandelowski and Barroso, 2002). Other 
researchers however recognise that while there is great diversity within them, all 
qualitative methods have common features and that robustness and rigour must be 
assessed if research studies are to be reviewed and used effectively (Dixon-Woods et 
al., 2004, Tracy, 2010, Tracy and Hinrichs, 2017).  
Numerous guidance exists through which to develop and assess quality in qualitative 
research. Rather than offer fixed criteria to firmly guide researchers conducting 
qualitative research, Eight “Big Tent” criteria for qualitative research (Tracy, 2010) offers 
flexible universal criteria for all qualitative research types to support high quality 
research. The ‘Big Tent’ criteria state that high quality research is characterised by i) 
worthy topic, ii) rich rigor, iii) sincerity, iv) credibility, v) resonance, vi) significant 
contribution, vii) ethics and viii) meaningful coherence. Tracy distinguishes between the 
methods that researchers use and the end goals of the research, which she describes as 
the universal hallmarks of good quality research. By doing this, it is possible to create 
criteria for these end goals that can be applied in studies using any of the wide range of 
paradigms and methods that exist within qualitative research (Tracy and Hinrichs, 2017). 
Therefore while Tracy’s work supports a criteriological approach whereby the rigour of 
any qualitative research can be assessed through universal and predetermined criteria 
(Sparkes and Smith, 2009, Garratt and Hodkinson, 1998), it recognises the 
methodological and epistemological variations within the complex qualitative research 
community. Further information on each of the eight ‘Big Tent’ criteria is provided in 
appendix 9, along with a description of how quality was ensured in the two qualitative 
studies in this thesis in response to these criteria. The criteria are cited over 2,500 times 
in a range of methodological books, qualitative studies and discussion articles. However, 
while it was used as a way to promote trustworthiness and rigor in these studies, it is 
recognised that this approach is not without critique. For example, while supporting the 
use of universal criteria, Gordon and Petterson (2013) expressed concern that ethical 
considerations should not be in its own discrete criteria, but should be reflected 
throughout and theoretical frameworks must be made explicit.  
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Other researchers may still question the usefulness of applying universal criteria in 
qualitative research. Smith and McGannon describe that universal criteria for qualitative 
research are “inherently problematic” (pg 14) due to their exclusionary nature and 
impact upon knowledge production and creativity, and raise issue with how the criteria 
are often applied (Smith and McGannon, 2017). They suggest that where the Eight ‘big 
tent’ criteria are used to guide work, researchers must follow all eight of the criteria, as 
failure to do so undermines the apparent universality of the approach. Smith and 
McGannon claim that researchers commonly do not demonstrate all eight criteria or 
take into account the range of approaches highlighted by Tracy to achieve these 
standards (Smith and McGannon, 2017). Considering these comments, all eight criteria 
were considered6. To ensure that this work was underpinned by rigour, participants 
reflected on findings from prior participants during their interviews and the ‘critical 
friend’ discussed in chapter 3 also performed the same role during the qualitative 
studies. Study progress was discussed at two times during data collection and analysis, 
and feedback was provided on the generation and structure of themes. 
The consolidated criteria for reporting qualitative research (COREQ) checklist (Tong et 
al., 2007) was used to guide the development and reporting of the study. The checklist 
aims to support transparency in the reporting of research undertaken through 
interviews and focus groups and to enhance the rigour and credibility of such studies. 
The COREQ checklist recognises many factors that may be associated with potential bias 
under three domains: Research team and reflexivity; study design; and analysis and 
findings. Considering and providing detail on these factors both helps the reader 
interpret the study findings and the author to plan and on reflect on their study. For 
both qualitative studies, COREQ was used to inform the development of study methods 
and reporting and the completed checklist is provided in appendix 10.  
Ethical considerations 
The primary ethical concerns with these interviews related to confidentiality and 
anonymity, as out of a relatively small pool of experts relating to AAS, it may have been 
                                                          
6 This applies to both the study currently under discussion and the second qualitative study in this thesis 
(study 4) 
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possible to identify participants by reference to their location or employment. It was 
recognised that participants might disclose sensitive information such as their 
experiences working with service users and their opinions on service users, colleagues, 
current practices and the law. Additionally, while users were not targeted in the study it 
was likely that some of the sample would be current or past steroid users given their 
interest and expertise in this. Although they would not be asked about their own use in 
this study unless they themselves brought it up, it was recognised this might be 
disclosed. Steps were undertaken therefore to ensure participants were anonymised. 
All reference to locations or specific services mentioned were removed and generic 
descriptions of job roles were used, as in some cases, it may have been possible to 
identify participants by their job titles. These measures may have limited the research 
slightly as it was consequently, for example, not possible to identify specific services that 
might serve as examples of good practice or identify whether any issues were prominent 
or otherwise in any geographical regions. Additionally, on the participant information 
sheet advice was included for any participants with concerns about their own steroid 
use. 
Ethical approval was obtained to undertake this study from the LJMU Ethics Committee 
in September 2017 (reference: 17PBH047).  
Results  
Description of the sample 
In total, 30 individuals were approached to take part in the work. One focus group with 
five participants and 22 individual interviews were carried out; one individual was 
unable to participate because of illness and two did not respond to the invitation. All 
participants had expertise relating to AAS and experience working or commissioning 
services for users. This included 11 participants who worked in substance use services 
or specialist IPED clinics; six participants within public health authorities who had been 
involved with commissioning and delivery of substance use, pharmacy and sexual health 
services; three participants who owned or managed a gym; three fitness trainers; two 
academics who undertake research in the field; one probation officer and one GP. Of 
the 27 participants, eight disclosed that they used, or had formerly used, AAS. As the 
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focus of the study was on exploring participants’ perceptions based upon their work and 
experiences with other users, participants are referred to in the discussion of findings in 
the context of their role rather than any personal use. 
Themes identified 
Three overarching themes were identified through the thematic analysis process, 
summarised in box 2. In this chapter, the findings and implications of themes 1 and 2 
are discussed while theme 3 is discussed in chapter 5. Themes 1 and 2 together 
represent priorities to address to improve the potential for effective interactions 
between intervention providers and users where support, information provision and 
other interventions can be provided. They are summarised in a thematic map, presented 
in figure 6.  Theme 3 is focussed on what these interactions should try to ultimately 
achieve in terms of influencing the choices and subsequent behaviours of users that are 
associated with poor health outcomes and increased risk.   
Box 2: Summary of themes identified in study 3 
 
  
Theme 1 Opportunities to provide information and support  
Opportunities for intervention providers to engage with, and provide 
information and support to, users. 
Theme 2 Improving engagement 
 Factors influencing engagement and communication between healthcare 
providers and users.  
Theme 3 Choices and behaviours 
 The choices and behaviours of users that interventions should try to 
influence, and potential approaches to achieve this. 
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Figure 6: Thematic map for themes 1 and 2 
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Theme 1: Opportunities to provide information and support 
Access to information and support  
A recurring topic throughout this study was that a key problem facing users is around 
the accessibility of information and support. Specifically it was commonly stated that 
they frequently lack access to reliable sources of information, and are open to influence 
by sources perceived as less reliable. One participant expressed this as: 
“People are coming to me to ask these questions because they have nowhere 
else to go. They don’t feel there is anyone that they can talk to and ask questions. 
And that’s a crying shame, a crying shame, and it can mean they end up listening 
to all sorts of bad advice from people who you don’t really want to be advising 
them”. Participant 13, gym owner. 
Consequently, many of the priorities identified were related to increasing and making 
the most of opportunities to provide information and support to users. Throughout this 
overarching theme the need to increase opportunities to engage with users was 
explored, but within this key groups were identified who were unlikely to currently 
receive any support or harm reduction messages from a health professional related to 
their substance use. This included people in the community who do not engage with 
substance use services, as well as specific settings where AAS use may be a particular 
concern due to a culture of AAS use and those that are hard to reach for service 
providers.  
Non-engagement with health professionals 
A key priority identified was reaching users who are not in contact with any health 
services. Concerns that this represented a large proportion of this population were 
discussed in the context of perceptions that individuals do not see the value in attending 
substance use services and that increasing numbers are purchasing injecting equipment 
online or from friends, negating their need to access services. Consequently, 
opportunities to interact and intervene with these individuals were expected to be very 
infrequent. The reasons for purchasing equipment online may vary, but the ease and 
anonymity of doing so are likely to be attractive to many. Indeed, as suggested by two 
participants, as well as equipment some individuals will purchase their drugs online and 
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seek information this way, further reducing their interaction with potential peer 
information providers as well as health services.  
“More and more people are buying their equipment online rather in services so 
they’re never going to be asked any questions, they’re never going to have these 
conversations that we’d hope they’d be having, no one is going to pick up if there 
is a problem”. Participant 12, outreach worker. 
“There is active avoidance amongst some of these guys of any contact 
whatsoever, so they can buy the drugs online meaning they don’t have to speak 
to a dealer so that’s one barrier gone. They can buy their needles online or get a 
mate to pick them up some. They can go online to find out everything they need 
to know, allegedly”. Participant 16, commissioner. 
“If they're not coming into any services or going to exchanges7 then how you 
going to intervene, or make sure they receive any support that they may need?” 
Participant 1, substance use worker. 
Within these discussions there was a general feeling therefore that users are likely to 
need advice and support from health professionals or other experts in the field. Some 
participants however pointed out that not everyone may need or benefit from contact 
with services and may not be causing themselves harm with their AAS use and related 
behaviours. Others however felt that while some users will not believe that they would 
benefit from engaging with service providers, the reality may be different and benefits 
might go beyond providing support with an immediate problem or advice on AAS. 
Holding a self-image of good health, low risk, being in control, and consequently not 
requiring any support recurred throughout the interviews. Expectations regarding the 
aims of support services, such as if users anticipate being expected to discontinue AAS 
use or that staff will have a negative attitude towards them, were also anticipated to 
reduce likelihood of attendance.  
“I do think it’s important to remember that not all these guys are going to need 
any help. I see it more as thinking how we can be there for those who want 
someone to talk with or have questions. I think if we start to make assumptions 
that everyone needs our help, it’s a problem, it’s almost arrogant”. Participant 
11, public health commissioner. 
                                                          
7Needle and syringe programmes are commonly referred to as needle ‘exchanges’. People who inject 
drugs can return used needles and ‘exchange’ these for new ones. 
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“They might not think that they need to speak to anybody or that they are doing 
anything that might be causing them harm, and maybe at that time they’re not, 
but that can change. There can be underlying issues maybe, or they might think 
they’re okay but actually, when you drill down, that’s not actually the case. 
Participant 2, substance use worker. 
Key environments for engagement 
A substantial barrier to providing information and support to users is that within this 
population exists hard to reach sub-groups who avoid, or are unaware of, relevant 
health services, and rarely interact with health professionals. Therefore, providing 
services may be insufficient to engage with many users and intervention providers can 
look at providing outreach or promoting services in settings where users are commonly 
located. Beyond this, the role of key individuals within social networks and important 
settings as information and intervention providers can be explored. Participants 
perceived that the attitudes and shared experiences of friends and other key individuals 
were important influences upon others in terms of their own attitudes towards engaging 
with support services. 
“It’s amazing how much credence they’ll give to what their mates say, what the 
other guys at the gym say. If they hear that you shouldn’t go to a service because 
they’ll judge you and they don’t know anything anyway then that sticks and it 
becomes accepted wisdom”. Participant 12, outreach worker. 
Gyms 
Gyms are strongly associated with AAS culture and participants commonly identified 
these environments as promoting and facilitating AAS use, and therefore as an ideal 
setting to promote services targeting this population and base outreach clinics. 
Supplying AAS in many gyms was perceived to be common and there was collective 
agreement that AAS was perceived as normal and acceptable in these environments. 
Approaches to tackle this were difficult and unclear, but discussed as desirable. 
Participants shared their experiences from the perspectives of owner, employee and 
gym users of how the gym can be a conducive setting for AAS where the prevailing 
messages may downplay risks and encourage use.   
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“I’ve used steroids and, you know, they’re more readily available in gyms than 
anything, it’s part of a culture. And when something is available and you know, 
the norm, it’s easy to do it”. Participant 2, substance use worker. 
“You join a gym, start training, then you start using and then you get big. That’s 
fine, that’s normal, everyone does it… that’s the message you get when you’re 
in there. I think that’s the attitude for lots of people. It’s become so open”. 
Participant 15, personal trainer. 
“When they join a gym they’re probably already thinking about doing it, some 
of them, and there is nothing there that will put them off – quite the opposite. 
And if they’re not thinking about it at that point then there’s a high chance they 
will be after being around the gym where it’s so common”. Participant 13, gym 
owner & outreach worker.  
Discussion of the gym frequently focussed on the potential for engagement between 
these settings and substance use services to increase access for gym users to good 
advice and health professionals. For example, reflecting on those users who do not 
engage with any health services one participant stated: 
“We know that, for one reason or another, lots of these guys who are taking 
steroids are never going to go to a needle exchange let alone have a 
conversation with a specialist about their use, but we know that almost all of 
them are going to be using a gym. If you want to reach these guys, if you identify 
a gym locally that might be open to you coming in, it’s a logical place to do that”. 
Participant 3, substance use worker. 
Gym owners were frequently identified as both barriers and facilitators for service 
engagement and desirable information provision. They, alongside established 
members of gyms and staff were portrayed as influencing decisions and behaviours 
amongst gym members and therefore were seen by some as potential providers of 
positive messages, or encouraging use of services. Recognising that information and 
advice is already being disseminated within gyms, or more widely the range of 
networks that users have, supports the potential for approaches that would look to use 
these networks to influence decision making in a positive way. Where key individuals 
within important networks or environments engage with health care, they can 
potentially be used to connect and pass information to others who are not themselves 
engaging.  
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“It’s trying to engage with these gym owners, educating them to say you know 
what, be mindful that these are young lads, they don’t really know what they’re 
doing... tell them that if there is someone who is thinking about it to come and 
see us if they have questions, don’t just sell them everything and tell them to get 
on with it. It might be hard, but your potential reach is massive compared to how 
many people you’ll get coming to you in your exchange off their own back”. 
Participant 8, substance use worker. 
“You can’t stop them from talking to each other in those kind of communities so 
maybe better than trying to stop it is to get involved with it and try and improve 
the sort of information that is being passed on. So not to stop the network, 
because the network is actually really useful, but having some sort of sense 
check to control the information a bit”. Participant 10, public health 
commissioner. 
The feasibility of gym owner engagement was debated and the response is likely to vary 
greatly between different owners, with some supportive of approaches to improve the 
health of their members and others reluctant to engage with services. The motivation 
for owners to engage with services and potentially provide positive messages may 
conflict with their role in some cases supplying AAS, and with the need to promote a 
positive image of their gym. Participants shared their experiences of discussions with 
gym owners and the complex relationship between owners, members and AAS. 
“If they recognise it is an issue for health and wellbeing, and they’re interested 
in that, they might support services. If they don’t really care, or they don’t think 
it is their place to be part of prevention then they probably won’t engage with 
it. They’re in the health and fitness industry but still, that doesn’t mean they 
actually have the best interests of the public or their customers at heart. 
Participant 7, public health practitioner. 
“The owners are often the suppliers. It’s not that they don’t care, it’s money in 
their pocket. One I know says he wishes they didn’t take so much because he 
wishes they wouldn’t get hurt, but at the same time, that is what is keeping the 
roof over his head”. Participant 13, gym owner & outreach worker. 
“Some of the dealers and the gym owners are really good, I’ve seen it where they 
won’t sell it to them if they think they don’t need them, the steroids, or if they 
think they’re not getting other parts right, like when they’ll tell the lads they 
need to train more and they need to eat right and stuff like that”. Participant 8, 
substance use worker. 
Those who worked in substance use services reported frustrating experiences of 
trying to engage with gyms, although examples of successes were also provided. 
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While AAS may be normalised within many gyms, that does not imply that owners, 
particularly in chain or local authority gyms, will openly recognise that or wish to draw 
attention to AAS as an issue in that setting. Issues relating to trust and unwillingness 
to be associated with substance use services amongst gym management were 
commonly reported. Relationships between services and influential people within a 
gym were perceived to be helpful for building trust with gym staff and members, but 
establishing understanding with gym owners about the purpose of any service and 
developing that relationship can be difficult. Where staff are not experienced with 
fitness training this may add further perceived or real barriers to engaging with gyms, 
and therefore identifying an individual who overlaps the service and gym 
environments and can support that relationship and clarify that the focus of services 
is on harm reduction and health can be helpful. Having too much reliance on an 
individual however can cause problems should that person no longer be available. 
“I tried to contact the owner and get him on board with us, talk to us about that, 
but he wouldn’t even speak to me. He thought I was from the newspapers, he 
was very suspicious of me”. Participant 23, pharmacy substance use service 
commissioner. 
“If you're not from that gym world or you don't know the owner or staff already 
it can be difficult. They're going to be suspicious of you. If there's someone who 
uses your service who also uses that gym, someone who is known at the gym, 
use them. That definitely would be helpful for convincing the gym about you”. 
Participant 13, gym owner & outreach worker. 
“Anyone with a bit of influence, they might be able to speak with the manager 
and promote your service for you. It seems to come better if there is a bit of an 
intermediator who can make it clear that you are about harm reduction and 
worth engaging with” Participant 24, substance use worker.  
Promoting services as broader men’s health services rather than AAS or IPEDs 
specifically was identified as beneficial with participants from both fitness and health 
settings supporting this approach. Offering health advice around issues such as sexual 
health, fitness and nutrition may be more appealing and socially acceptable for some 
men to attend than a clinic promoted as about AAS specifically. This may also be a more 
effective way of developing links with, or delivering outreach services in, gyms as owners 
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may find a men’s health clinic or similar more appealing to promote or allow onsite as 
opposed to a service that directly refers to AAS. 
“Don't go in saying you want to talk about steroids or needles, that's going to 
put the guy running the place and the guys in the gym off you.” Participant 18, 
gym owner. 
“That’s how we got in the door with all the gyms we work with. We said we 
wouldn’t advertise a needle exchange, we wouldn’t advertise anything to do 
with steroids or IPEDs but we’d go in with a sexual health focus only”. Participant 
26, substance use worker. 
“I frame it in terms of a health project rather than being explicitly about steroids 
– I think that could be very off putting both for an individual and for a gym 
owner. Some will just not want to know if you go in talking about steroids”. 
Participant 12, outreach worker. 
At risk groups 
Beyond fitness settings a smaller number of participants highlighted other settings 
where they felt it was important to improve access to support. Both prison and armed 
forces settings were discussed in the context of environments where increasing strength 
and muscularity are likely to be desirable, yet access to appropriate services may be very 
limited. There was concern about injecting and lack of access to NSPs and harm 
reduction advice, and participants emphasised the importance of ensuring access to 
injecting equipment and information. However, approaches to tackle or even quantify 
the extent of this problem may be difficult due to the hidden nature of substance use in 
these environments. 
“There is an anti-needle exchange culture in these prisons and if someone is 
going from using on the outside to inside then they may be going from low risk 
to high risk in terms of transmission”. Participant 4, General practitioner. 
“It’s like ‘put a bit of beef on, look a bit tougher’ while they’re inside. It’s about 
the short term not the long-term, so what if there’s a bit of a risk?” Participant 
1, substance use worker. 
“It’s the army too, that’s another one. Armed forces. But good luck getting 
anywhere with that… we know what’s happening, but it’s a closed shop. It’s not 
that different to that prison population in that it’s a high pressure setting, there’s 
a perception that you need to be tough, to be strong, can’t show weakness. And 
here’s something that can help you do that”. Participant 15, personal trainer. 
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Healthcare settings 
Services and clinics 
It is therefore important that services that are catering for users are meeting the needs 
of, and are accessible to, this population. The value of clinics designed specifically for 
AAS, or more broadly IPED, users was frequently raised. It was suggested that such 
services are likely to be more appealing and accessible to users in comparison to 
traditional substance use services or NSPs, and have staff with expertise in AAS who can 
discuss a wider range of issues and offer a wider range of interventions. Traditional 
substance use services were seen as less attractive to users in comparison due to 
perceptions about staff, stigma and other substance users. These findings resonate with 
previous studies that have examined the experiences of this population in such settings 
(Zahnow et al., 2017, Dunn et al., 2014, Kimergård and McVeigh, 2014b). 
“The ideal scenario is that every town with a high amount of IPED use has its 
own specialist service. I don't think anyone would disagree with that because 
you have the expertise, credibility, it's a more attractive service for steroid users, 
you have more time with them, you can do more interventions”. Participant 3, 
substance use worker. 
Specialist IPED support clinics were discussed by some service providers as settings to 
offer blood testing for health markers such as cholesterol, liver function and 
testosterone. This was portrayed as being attractive to users and increasing the 
likelihood of their attendance, and therefore increasing opportunities for engagement 
and harm reduction. Blood testing was portrayed as enabling provision of personalised 
feedback on health, which was commonly identified as a valuable tool to engage with 
clients about health harms. However, some participants recognised that offering these 
services is dependent on factors such as funding and the availability of staff with 
expertise in the field. It was recognised that restrictions on resources limited the 
possibility of such services in many areas where IPEDs are not necessarily seen as a 
priority area in comparison to other public health concerns. Additionally, while clinics 
were discussed in very positive terms, it should be recognised that there is a lack of any 
evidence supporting their effectiveness.  
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 “There is less and less money for services like ours. I don’t think they’re seen as 
a priority compared to other injecting drug users because they’re not as visual a 
problem” Participant 26, substance use worker. 
“I think any type of service where you are reliant on specialist knowledge that 
most people in that field don’t have, it won’t work everywhere. That’s not to say 
it isn’t worth thinking about, but getting funding is one thing, and actually 
setting up and running a good service is another. What happens when that 
person leaves?” Participant 16, commissioner. 
While services dedicated to IPEDs were perceived to be popular and a way to increase 
engagement, increasing opportunities to engage with this population in other health 
care settings was a widely discussed need. As one participant stated: 
“I fully support the idea of creating a steroid service, but I’m under no illusions 
that everyone will come to it. Some will, we can see that from other similar 
places that people will travel for a good service, it can be popular, but lots of 
potential clients won’t think to come, so even if you have a dedicated service 
then that won’t solve the problem”. Participant 24, substance use worker. 
Many participants raised the need to make the most of all opportunities that health 
professionals, in particular those working in substance use services and NSP settings, 
have to engage and deliver information. Key to this point was the suggestion that 
because interactions between health professionals and users can be infrequent, no 
opportunity should be wasted. Therefore when clients attend services in relation to their 
substance use it is important that this contact is built upon, but some participants 
expressed concern that these opportunities were at risk of being missed or interactions 
were not always positive.  
 “And when a young person does go to their doctor, or drugs service, or wherever 
they go, because they want to discuss these things we need to make sure that 
this leads to a beneficial outcome. It might be the only chance to discuss these 
issues with them and to intervene because if they feel ignored or that their issues 
were not listened to, or identified, then they might not go back again”. 
Participant 7, public health practitioner 
“I think rather than specific clinics we have to upskill people who are going to 
come into contact with steroid users as part of the jobs. It’s not going to solve 
the problem of reaching these hidden ones but… it’s a start. In pharmacies 
certainly, probably some drug treatment clinics where they have needle 
exchanges I don't think they always make the most of opportunities with steroid 
users”. Participant 16, commissioner.  
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In many pharmacy NSPs people who use steroids make up a significant proportion of the 
overall client group. Participants frequently pointed towards pharmacies as an 
opportunity to engage with this population, but felt that currently interactions in these 
settings were limited in the provision of information and support. Pharmacies were 
discussed as settings for quick interactions with typically minimal harm reduction work 
or engagement, which was seen as an approach that perhaps suited both service 
providers and customers. One explanation for the popularity of pharmacy NSPs may be 
that many users prefer this quick interaction and lack of engagement, however where 
there is little attempt at engagement this could be an opportunity missed to identify 
where support may be needed, deliver harm reduction messages or signpost to further 
support.  
“I get a bit frustrated when I hear that a steroid user has been into a pharmacy 
and they've not been asked any questions about their steroid use, injecting, if 
they're worried about anything. It seems like a clear opportunity missed to 
potentially do some good”. Participant 26, substance use worker. 
“I've used the pharmacy exchanges around here.  I always got the impression 
they wanted it to be as quick as possible, next customer. That suits me so I'm not 
complaining”. Participant 14, personal trainer.  
“It’s been quite evident to me that on one hand you have a client group that 
don’t really want to engage or feel comfortable having an open discussion and 
on the other hand you have the staff who also don’t really feel comfortable, or 
confident to do it either”. Participant 23, pharmacy commissioner. 
Some participants felt that opportunities needed to be capitalised on in health care 
settings where individuals are already well engaged with providers. Reflecting that 
opportunities to engage with this population are limited and that resources to deliver 
new or specialist services are also limited, where users are accessing health care such as 
young people’s, walk-in, or sexual health services these encounters could potentially be 
utilised to deliver important messages. However, some participants described potential 
barriers to this. For example, there are likely to be restrictions such as with staff 
capabilities and service resources that will limit the support that can be offered to users 
in these settings. The nature of interventions in these different settings would vary and 
need to take into account the expertise of the relevant health care providers. For any 
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approach to be feasible it would likely need to fit within existing models of service and 
require minimal additional training or time to implement.  
“My feeling is that you don’t have that many interactions with this client group. 
They don’t come into services that often and so your opportunities to engage 
are fairly limited. Where you have that chance to ask a couple of quick questions, 
gage if they perhaps need any further support, then ideally you don't want that 
wasted” Participant 24, substance use worker. 
“One of the things that I believe strongly is that there are wasted opportunities 
currently.  So I am thinking how can we make a bit more of the interactions that 
are already happening? Where there are steroid users coming in to services, 
whether that be a needle and syringe programme, a sexual health clinic, or 
somewhere else, are there some questions that can be asked routinely for 
example”. Participant 10, commissioner. 
“I wonder if they’re speaking with anyone else about this sort of thing, and if not 
then is it a case that people like me could do more, but it’s just a step too far for 
us at the moment. It begins to be a steroid advice thing and I don’t know 
whether we’re the right people to do that because we don’t really know about 
it”. Participant 21, sexual health commissioner. 
Signposting users to support services was identified as a fairly simple potential role for 
health care providers that would not be demanding upon them, but could have a 
positive impact by increasing access to services. Beyond this, asking some quick 
questions about clients’ AAS use and health could gage whether further support was 
needed at that time, raise issues to reflect on later and establish the provider as a source 
of help and support if required without being intrusive. This would not necessarily 
require great understanding and knowledge of AAS and therefore was seen as suitable 
for health professionals with a range of expertise.  
“I could see one or two standard screening questions when a young steroid user 
goes to see a sexual health nurse, or a needle and syringe programme, their GP. 
So nothing that will be a burden, but enough to get a sense of whether there is 
anything they should be doing more of or if they should refer them on 
somewhere for more help”. Participant 16, commissioner. 
General practitioners 
A frequently raised issue involved the response by GPs to AAS use and related harms 
amongst their patients. Similar barriers to engagement and provision of appropriate 
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care were identified with GPs as other health care providers. As with the response in 
pharmacies, the issue may be both GPs not having sufficient understanding or 
confidence to raise and treat issues related to AAS, and users not wanting to engage 
with their GP about their substance use. It was frequently suggested that gaps in 
knowledge and understanding about AAS and those who use these substances may lead 
to GPs not identifying AAS use in patients. For example while GPs have excellent 
knowledge about health factors such as liver function and mental wellbeing, they may 
not link this with AAS and therefore any advice or treatment for that issue may be 
lacking. Further, opportunities to ask appropriate follow up questions and to influence 
decision-making will be missed if AAS use is not identified or questioned.  
“I’d say that 95% of GPs would not know what to do with it if they came across 
steroid use. And they know that – both the users and the GPs, and neither has 
any confidence or any willingness to engage with each other as a result”. 
Participant 2, substance use worker. 
A common concern was that where GPs identify AAS or it is disclosed to them then 
the response to it and to any health problems is often unsuitable, with a focus 
typically on cessation rather than further support or treatment.  
“My GP told me that steroids don't work so don't bother with them. I just said 
"thank you" and walked out. I know that's literally false. How can you offer 
advice on something you know nothing about?” Participant 14, personal trainer. 
 “They know so much about the health problems themselves, but I think the 
problem is that they don’t pick up that anabolic steroids are involved a lot of the 
time. They are good at treating symptoms but not necessarily the root causes of 
these symptoms”. Participant 13, gym owner and outreach worker. 
Similarly to with staff in other healthcare services, there was not an expectation that 
GPs should have expertise in AAS, rather sufficient knowledge to identify possible use 
and ask appropriate questions and awareness of related harms. Specific health issues 
that were perceived to be commonly mistreated included mental health after cessation 
and concerns about fertility and libido, with a lack of involvement from endocrinologists 
with patients for whom issues related to testosterone were identified. Raising 
awareness and improving recognition of AAS and related harms amongst GPs may help 
to improve the response in primary care. 
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“I wouldn’t expect them to be an expert in steroids but you’d hope they’d know 
a little bit so they can provide the appropriate health care”. Participant 26, 
substance use worker. 
“There is a massive gap, a really massive gap involving endocrinologists in this 
process, when you’re working with somebody for a good period of time, they’re 
not using anything at all, and their testosterone and their hormones are shot to 
pot. There needs to be some sort of specialist engagement at that time and that 
doesn’t happen”. Participant 3, substance use worker. 
Participants drew on their own experiences and those disclosed to them in services by 
others to give examples of negative interactions with GPs and where they felt GP 
response had been insufficient. A common theme of these was a dismissive attitude 
regarding AAS from GPs that can be a barrier to engagement. A patient who asks their 
GP for advice about AAS but gets a very negative response that they perceive conveys a 
lack of understanding may be unlikely to listen to any advice or avoid returning if they 
require further support. A further complication appears to be the reluctance of some 
users to go to their GP or disclose information, limiting the possibility of useful 
interactions and increasing the likelihood of harms being untreated. They may feel 
uncomfortable discussing substance use with the GP, anticipate an unsatisfying 
interaction or it may conflict with their ideals about health and help seeking.  
“A lot of doctors will try to stop you in your tracks and advise you not to do it. 
They don’t advise you on how to do it correctly, or what to use safely. It’s just 
‘don’t do it’”. Participant 19, gym owner. 
“I think he was a bit worried, having second thoughts about it all and so went to 
his GP and said he was using steroids, he’s a bit worried about it, and he said 
she laughed at him… said that he didn’t look like he used steroids, said he was 
too skinny”. Participant 27, substance use worker. 
“I do say go and see your GP, but they’re all like, leave it I’ll be alright in a few 
weeks, it will go away. Typical blokes, like shrug it off”. Participant 18, gym 
owner. 
Alternatively, it was suggested that another barrier to treatment is that poor knowledge 
about AAS harms amongst users may lead to thinking that their AAS use is not relevant 
to any health conditions they see their GP about. 
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“They don’t mention steroid use to the GP, not because they’re hiding it but 
because they don’t understand that it might be relevant after 6 months off. So 
they’ll tell the GP ‘I’m feeling really low, I’m struggling to get myself out of bed 
in the morning, I’ve fallen out with my partner, I’m not interested in sex, I’m 
struggling to get an erection’ or whatever, and they’ll get a prescription for anti-
depressants, or for Viagra if needed”. Participant 2, substance use worker. 
Finally, participants who worked in substance use services commonly discussed 
difficulties engaging with GPs. This was discussed as part of efforts to respond to 
negative experiences reported by clients and to raise awareness of AAS and related 
issues amongst local GPs, and to encourage signposting to services. Some service 
providers had reached out to local practices and tried to build links, but had very little 
response. While there was commonly an appreciation that GPs were busy and had many 
priorities, the process was seen as time consuming, difficult and frustrating. 
“I spent time calling and writing to several local GP surgeries. Guess how many 
responses I had? One out of 16, and that didn't go anywhere because when I 
followed up again I never heard back”. Participant 25, substance use worker. 
Theme 2: Improving engagement and communication in services 
This theme was based upon the notion that as well as increasing opportunities to engage 
with users, the quality and nature of these interactions is important. The potential for 
messages to be delivered that will influence decisions and behaviour depends on many 
factors, and participants raised a range of considerations that they felt to be important 
contributors to effective interactions. Central to this was the concept that how 
information is delivered and the skills and credibility of the person delivering it will have 
a significant impact upon whether it is listened to, understood and ultimately makes any 
difference. Generally, findings here related to healthcare settings and interactions 
between service providers and service users, and participants who emphasised the 
importance of communication and relationships were those with experience in these 
settings.  
Several factors were felt to be important to increase potential engagement and to 
maximise the chances of influencing clients in health services through effective 
communication of messages. Recurrent messages underlying this theme was the 
recognition that users may be wary to engage with health professionals and reluctant to 
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discuss their substance use, and that communicating risks and ideas that may conflict 
with their preconceptions and behaviours can be very challenging. 
Provider characteristics 
Credibility and knowledge 
A frequent point raised concerned the importance of credibility in service providers in 
the eyes of users. Credibility is inextricably linked with the type of intervention or 
information being provided. For example, in a specialist IPED clinic offering expertise in 
AAS and the wider field, what makes that provider credible will be different from the 
credibility a member of staff in a sexual health service would require to discuss issues 
relating to injecting, sexual behaviour and testing for BBVs. Having a muscular physique 
and a strength training background were seen by some as useful for engagement, but 
less important than knowledge and understanding. Some participants working in 
substance use settings reported that in their experience their lack of gym and fitness 
background did not inhibit engagement. Further it’s possible that the association 
between AAS and traditional male roles and values may indeed prevent engagement on 
some topics where both provider and client are from that masculine environment.  
“If you don't know your stuff they probably won't take you seriously. I'm not 
from that background, I don't go to a gym, but I don't think that matters as much 
as knowing a bit about it. I think they'll talk to me about things they wouldn't 
speak with a big tough looking guy about”. Participant 9, substance use worker. 
“I've not had a sense that because I'm not a user and I don't go to the gym I'm 
not someone they would speak to… I don’t think it's a problem, but I think people 
sometimes presume it will be”. Participant 8, substance use worker. 
Knowledge about AAS was generally agreed to be an important factor in giving a 
provider credibility and the development of conversations. Concerns were frequently 
raised about the level of knowledge about AAS amongst service providers and their 
ability to communicate effectively with clients and identify where further support is 
required. Insufficient knowledge was seen as a barrier to engagement in substance use 
services as inappropriate questions or advice may lead to that client not opening up at 
that time or returning to that service.  
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“I don’t think there is a great deal of knowledge in services about anabolic 
steroids or any IPEDs really, not from what I’ve seen. It is just a bit outside what 
they have been trained in and what they probably really know about”. 
Participant 12, outreach worker. 
“For some people it’s going to be harder because if you don’t have that 
knowledge then how can you get through to people, how do you know what to 
talk about or how. I wouldn't listen to someone who didn't know the basics of 
what I was doing, I just wouldn't care what they thought”. Participant 17, 
personal trainer. 
Rather than having expertise of all aspects of AAS and associated factors, service 
providers need some understanding of the basics relating to this form of substance use 
to a point where they can converse confidently about the topic and ask appropriate 
questions. Participants indicated that clients would not expect all service providers in 
health care settings to be topic experts and would be responsive to questions for further 
explanation and seeking to understand their substance use. Further they would not 
need extensive knowledge of types of AAS, dosages, post-cycle therapies8 (PCT) or 
fitness topics to engage. More important perhaps would be knowing what questions to 
ask and communication skills. 
“It’s not about trying to show that you’re an expert because I don’t think that 
there are many experts in this field. I think you can have a lot of knowledge but 
it’s about asking “why are using that peptide alongside that one, is it for 
appetite? Or what is it?” and then they’ll start talking to you. If you show an 
interest then people quite like to talk with you”. Participant 24, substance use 
worker. 
“Outside of your IPED specific services I wouldn't expect people to know all the 
ins and outs and have real expertise, but if you want these guys to trust them 
and open up to them or whatever, then they need a sort of baseline knowledge. 
Just enough to ask the right questions”. Participant 2, substance use worker. 
Confidence 
There was a general sense that outside of specialist IPED workers confidence to engage 
with users was lacking in comparison to working with other substance users and this 
may relate to knowledge gaps. If a service provider does not feel they have the skills and 
                                                          
8 Post cycle therapy refers to the use of drugs during the ‘off cycle’ period to attempt to restore natural 
testosterone functioning, which is suppressed by the use of AAS. 
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knowledge to engage effectively then they may be less likely to try. In services where 
interactions with users are infrequent, staff will have little experience in working with 
this client group so opportunities to gain confidence are limited. Further an individual 
accessing a service in relation to their AAS use is more likely to be physically fit and 
healthy and see their substance use as a positive and health improving activity than 
other clients. This might impact on the relationship between provider and client, 
particularly when the client is more likely to be the expert of the two, and make it more 
difficult for the provider to feel they can lead the conversation and offer advice. 
“Most of the staff are very experienced with working with psychoactive drug 
injectors but they lack knowledge and experience working with the IPED 
population so therefore very little is engagement done. So even when someone 
visits the drop in, which they do occasionally, they wouldn’t engage with them 
because they don’t feel confident to do so”. Participant 23, pharmacy 
commissioner.  
“I think that some of them don’t find it very easy to have those discussions with 
these lads… they’re not their normal client and, let’s be honest here, they’re not 
all that easy to talk to. They can be very wary of talking about their substance 
use, particularly to people who they don’t know or don’t think will understand”. 
Participant 27, substance use worker. 
“There are a lot of staff here who see these big, muscular guys who are using 
steroids and have good diets and training, straight away they see themselves as 
not being the expert. Which doesn’t really make sense because they’re all really 
confident about speaking to people who are a heroin user, but there is 
something about steroids and the way that people portray their usage and not 
wanting to stop or get help”. Pharmacy 24, substance use worker. 
Health professionals are less likely to have experience with, or training to work with, 
users of AAS than other substances. If those without expertise in this area are to have a 
greater role in engaging with this population then they will require some support. 
Training requirements clearly vary according to the anticipated role, but some 
participants suggested that increasing basic knowledge about AAS and confidence to 
engage with users should be a priority and would not necessarily be complex or in depth. 
“I don’t think it requires any real complex or in depth training or anything to get 
an understanding of these things. Within drugs services and exchanges I think 
it's about having the confidence to apply what they're good at to a different 
client group as much as anything else”. Participant 5, academic. 
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“It shouldn't be a big ask to expect a bit of understanding and awareness. Any 
training could be quite straightforward, get the main points across. Job done”. 
Participant 13, gym owner and outreach worker. 
Communication skills 
Language and attitudes 
Language and terminology was important to several participants because it 
demonstrated familiarity with AAS culture. Where providers use terminology unfamiliar 
to service users or do not understand common terms this was seen to increase barriers 
to engagement.  For example, several participants recalled examples of users being 
asked questions such as ‘what drug do you use?’ leading to disengagement in services 
by someone who may not see themselves as a ‘drug user’.  
 “I think they need to be able to explain things as simply as possible as well, 
which I don’t think people are always very good at. The guys will just switch off 
if someone starts making things complicated, using scientific words, terms that 
aren’t used normally”. Participant 12, outreach worker. 
 “With these guys if you ask them ‘what drug?’ they look at you like you’re an 
idiot because they don’t see themselves as using a drug… so you have to frame 
it more about recognising that they’re probably using IPEDs so you can say, you 
know, ‘is it steroids you’re injecting… what ones?’ and see if they know”. 
Participant 20, substance use worker. 
Moralistic or judgemental language and attitudes about AAS use were seen as 
particularly counterproductive to engage with users who do not see their substance use 
as problematic or unhealthy. It was commonly suggested that if a service user feels that 
a provider has a clearly negative attitude then this will be a substantial barrier to 
generating discussion and communicating messages. Further, it may act as a barrier to 
future engagement or service attendance. 
“If you have this moralising approach you're not going to get anywhere. If you're 
coming across like "steroids are bad, you shouldn't take them" it's going to get 
people's backs up straight away and you're losing them straight away. They're 
not going to listen to you, and they probably won’t come back. Lots of them 
have experienced this and it kind of sums up what they think people in services 
are going be like”. Participant 1, substance use worker. 
“Show that you're interested, don't be moralistic about it. Don't be saying ‘oh 
but you shouldn't do that’, at least not until you've got their trust a bit. Listen to 
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them, active listening... and keep asking 'why' when they tell you something 
because a lot of the time that's what opens up a conversation”. Participant 9, 
substance use worker. 
Developing relationships 
Being aware of these factors and of appropriate questions and language to use are 
important for developing rapport with users. It was recognised that many users are 
reluctant to engage with service providers or have negative expectations regarding 
provider attitudes and ability to offer support. Participants talked about breaking down 
these barriers through conversation. Showing an interest and asking service users to 
expand on their beliefs and behaviours were seen as useful approaches to stimulate 
discussion and to identify risks. This was viewed as encouraging users to share their 
expertise and demonstrating interest in them and their substance use rather than 
openly challenging them and being confrontational.  
 “I find asking ‘why’ a lot is useful… so like ‘okay you’re using that three times a 
week… why?’ ‘Where did you buy that…Why? Do you think that’s safe?’ I try not 
to put my own opinions over too much or come across as too know it all, but 
show I’m interested, question them without getting their backs up”. Participant 
20, substance use worker. 
“When I ask some of them about why they're doing it and what they what to get 
out of it, and push them to be precise, it sometimes unravels a bit”. Participant 
13, gym owner and outreach worker. 
Participants sometimes linked these points with the issues relating to credibility and 
knowledge. In particular, by asking the right questions and using the right language 
providers can build trust and relationships with a service user that facilitates the 
delivery of information and support. Positive outcomes from interactions were seen as 
most likely when relationships are formed through open discussion. One participant 
summed this up by saying: 
“If you talk to them in the right way then they’ll listen to you. So not kind of just 
imposing your sort of attitudes or trying to ask them too many direct and 
personal questions, trying to keep them in an open conversation rather than 
specific questions. Once they realise that you know what you’re on about and 
you’ve engaged them in conversation then they can listen”. Participant 8, 
substance use worker. 
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Once the initial barriers have been overcome, it was felt that providers will then be in 
a better position to offer advice and influence service users through alternative 
perspectives or appropriate harm reduction or motivational messages. As many users 
may infrequently access services in relation to their AAS use and service settings may 
not be conducive to lengthy or private discussion, developing these provider-client 
relationships can be difficult. Several participants however shared their experiences of 
clients being willing to talk with and open up to them. For many users they may not 
commonly be asked questions about, for example, their worries or aspects of physical 
or mental health and they may welcome the chance to discuss these issues with 
someone who takes an interest in them and they feel that they can trust. 
“The amount of men you get, big guys like doormen, bouncers, security… you 
start asking them the right questions and they start out pouring with 
information, personal things. I think they’ve literally never had the chance to talk 
about it before, and when they feel like they have got that chance then 
sometimes it comes out”. Participant 9, substance use worker. 
Understanding individuals 
Being able to make information seem real to individuals may help to communicate risks 
and influence decisions. As discussed in theme 1, having resources to undertake blood 
tests and feedback findings to service users is not only attractive to users but provides 
opportunity for engagement. Where it is not possible to offer blood tests however some 
participants suggested trying to help service users to apply risk, health and social 
scenarios to their own lives and those with whom they have important relationships. To 
do this, providers need to understand service users and their motivations, which is likely 
to come only through engagement. Several participants discussed that it was unlikely 
that any one universal message would be effective in all cases, recognising the diversity 
amongst users. Seeking to understand what is motivating them and influencing their 
decisions is likely to help providers in developing meaningful messages.  
“It’s about recognising what matters to an individual, what are the switches that 
need to be flicked with this individual. No one approach will work with 
everyone”. Participant 6, academic. 
“They all have different motivations and causes. I try and understand if there are 
underlying causes or what is making them tick. I think you need to if you want 
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to give them advice, or change their minds on anything because it's not like one 
size fits all”. Participant 25, substance use worker. 
Part B – Follow up interviews  
Rationale and aim 
Participants in part A discussed their perceptions regarding many environments. The 
idea of increasing engagement and information provision in services that users attend, 
such as NSPs, substance use services and sexual health services, was commonly seen as 
important and participants identified what they thought were the potential barriers and 
facilitators for this. Much of the discussions focussed on the characteristics and 
approaches of service providers who do not have expertise in AAS or work in specialist 
services, and the practical issues of engaging with users in these settings. Therefore, to 
further understanding on these issues, follow up interviews with a small number of 
stakeholders who do not have expertise in AAS, but work in relevant healthcare services 
were carried out.  
The aim of this part of the study was to seek reflections on findings identified in part A 
from participants who do not have specific expertise in AAS. The potential benefits of 
this were i) acting as ‘member reflections’ (Smith and McGannon, 2017) on findings, ii) 
identifying any further barriers and facilitators to the ideas generated in part A, and iii) 
generating further ideas in response to the overall aims of this study.  
Methodology   
The inclusion criteria for this part of the study was health professionals who do not have 
expertise or a particular interest in AAS, but work in the environments identified in part 
A as being potentially important settings for the delivery of relevant interventions. 
Participants were identified using a snowball approach where participants in part A were 
asked to recommend potential participants for part B who they thought would be 
interested in taking part and able to follow up on the issues discussed in part A. In 
response to the findings from part A, health care providers operating in pharmacies 
offering NSPs, substance use or addiction services, young people’s services and sexual 
health services were targeted.  
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Semi-structured interviews were carried out over the telephone. Participants were 
informed that they would be asked for their perceptions on ideas and findings from the 
first part of the study, focussing mainly on providing support for users in the settings 
that participants had expertise in, and the barriers and facilitators for this. A semi-
structured interview schedule was drawn up that followed up on key relevant themes 
from part A of this study (presented in appendix 11). The schedule was adapted for the 
different roles that participants had. For example, where the participant worked in a 
sexual health setting the interview included questions that specifically followed up on 
ideas from part A relating to that setting. The interviews ranged in length from 20-45 
minutes. Analysis of study data followed generally the same procedures for the 
approach to thematic analysis (Braun and Clarke, 2006) as described in part A. However 
to reflect the more deductive approach in this stage of the study the analysis approach 
was adapted. Data were firstly coded under initial categories relating to the interview 
topics (Service role; Barriers and facilitators; Engagement; Increasing access; Other) and 
then sorted through the analysis into structured themes.  
Findings 
Six further participants were recruited in this part of the study, all of whom were staff 
within healthcare services. This included two pharmacy needle NSP workers; one youth 
and sexual health outreach worker, one sexual health consultant, and two practitioners 
based within substance use services. All six participants had experience working with 
users, but no particular interest or expertise in this and were more experienced working 
with people using other substances or with other health needs. Two additional potential 
participants were approached. One pharmacy NSP worker did not reply to the invitation 
and an alternative participant was identified in their place, and one substance use 
practitioner recommended their colleague participate in their place (who become one 
of the participants). 
Themes identified related closely to the categories used in the coding process. As the 
interviews followed a quite structured approach to ensure that the important points 
from part A were reflected upon, this was not surprising. Three overarching themes 
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were identified: i) Role in providing healthcare to users, ii) Staff characteristics, and iii) 
Engagement. 
Role in providing healthcare to users 
Service scope and staff roles 
A reoccurring point throughout these interviews was that while interventions and 
support should be provided to users in healthcare services, this would have to be within 
the topic and skill scope of the service. For example, the four participants based in 
pharmacy or substance use NSPs discussed that they saw their role primarily being 
providing harm reduction related to injecting and BBVs regardless of which type of 
substance the client injected. These participants discussed how they felt these topics 
were within their remit and that raising these issues with users ought to take place in 
any NSP setting. They provided examples of why injecting-related support was required 
from their experiences with clients showing naivety or poor knowledge in this area. 
 “You’ll get things like about what needles to use and you can tell them which 
ones and why, and they’ll still opt for the other ones because that’s what 
someone has told them”. Participant 30, substance use practitioner. 
“Some of them are clueless about what needles to use for different places, and 
they wonder why it hurts or they’re finding it difficult. You have to talk them 
through this stuff. I ask if they ever have pain and a lot of them say yes but that 
they think that means it is working, not that they’re doing something wrong”. 
Participant 32, pharmacy NSP worker. 
However, participants agreed that it is likely that staff may not always try and discuss 
these issues with users presenting in NSPs. In part one of the study, participants shared 
their perceptions that there were missed opportunities for engaging with users and 
identifying harm and risk in health services and the experiences of participants in this 
part of the study appear to corroborate this. They shared experiences of working in or 
visiting NSPs where interactions had been limited and there had been little or no attempt 
to engage with clients about their substance use. 
“Where I was working previously, it was much more minimal than where I am 
now. They’d come in, say what they wanted, you’d give it to them and they’d be 
on their way”. Participant 32, pharmacy NSP worker. 
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 “I’ve been into needle exchanges and asked them about injecting, injecting 
injuries, safer injecting for people who use all sorts of drugs, not just steroids, 
and they don’t do anything with them, you’d think they should be doing 
something or at least referring them, but often there is nothing”. Participant 28. 
Young persons and sexual health outreach worker. 
In terms of the types of support that should be offered, participants agreed that 
providing advice specific to AAS, such as relating to dosage or cycles, was generally 
beyond their remit and capabilities. For staff in sexual health services, this might extend 
to injecting advice as well. All participants emphasised that anything specific to AAS use 
or that fell outside of the normal scope of the service, for example sexual health or BBVs 
in sexual health services, was unlikely to be the focus of any intervention in that setting.  
“We know very little knowledge so we don’t do much beyond the basic injecting 
stuff, not through lack of willing but lack of the right knowledge if I’m honest 
with you”. Participant 30, substance use practitioner. 
If healthcare professionals do encounter users who they feel require some support that 
for reasons relating to expertise, capacity or setting they are unable to provide 
themselves then they can signpost that person to a more suitable service. Participants 
in the first part of the study identified that users may not be engaging with any relevant 
services and where they are identified in other settings, signposting could help to 
increase awareness and use of services. Participants in this part of the study agreed that 
this felt within their remit. Indeed, the primary role for healthcare professionals outside 
of services designed for substance users may be identifying users and then referring 
them on to relevant support where appropriate. 
I think from my point of view where I see sexual health playing a part is identifying 
steroid or IPED use and signposting to relevant services. Because if these people 
are not speaking to anyone about their steroid use when they would benefit from 
doing just that, then I think we can support that. Participant 31, sexual health 
consultant. 
“If they ask something that we don’t know then we tell them to go there (a local 
drug treatment service) and ask. We give them the address and the opening hours, 
it’s on the poster we have. Participant 33, pharmacy NSP worker. 
However, participants identified barriers to signposting. Steroid clinics are scarce and 
users are most likely to be signposted to drug treatment services for support beyond 
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provision of injecting equipment. However, there may be a possibility that staff in non-
substance related settings will be unaware of treatment services or their potential role 
in working with this population. Further, while the two participants from treatment 
settings shared their experiences of working with users, they expressed concerns that 
this was not always the case and that consequently signposting might not always be 
useful.  
“They might not think of us (a drug treatment service) as a place to send steroid 
users”. Participant 29, substance use practitioner. 
“I would do (signpost someone) if I had reason to, but I’m not sure what the 
appropriate place would be”. Participant 32, sexual health consultant. 
“We know though that in some treatment services they're not really prepared 
to do much with steroid users, so if that's where they are being referred to then 
I don't know how helpful that is really ever going to be”. Participant 30, 
substance use practitioner. 
An additional barrier to effective signposting or other intervention is if the individual is 
not recognised as requiring support. Participants expressed this in terms of lacking 
awareness that someone is using AAS in services where substance use may not be 
discussed, but also where engagement was not sufficient. If staff do not having sufficient 
expertise to recognise issues that might require support or engagement is limited, then 
it is unlikely that needs will be identified. 
“You don’t hear much about steroid use, it’s not a question we would ask as 
routine in sexual health.  I think it probably gets missed a bit, bit of a lack of 
recognising them… they’re not all big bodybuilding types are they, but that’s not 
that well known always, lots of staff will have that assumption”. Participant 28, 
Young persons and sexual health outreach worker. 
“I'm guessing I wouldn't pick up on a lot of potential issues because I don't know 
what they are. If they said something direct about a problem they were having 
or a question they needed help with then I would know they needed help in that 
case, but if not then it's possible I just wouldn't think of it at all”. Participant 33, 
pharmacy needle NSP worker. 
“The main area that we can do more with is identifying where there might be 
issues with IPED use and then making sure we respond to that in one way or 
another. I expect a lot of the time it gets overlooked because we don't know 
what we're looking for”. Participant 31, sexual health consultant.  
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Time constraints 
Staff may have the capability to deliver appropriate support to users, but in services 
outside of substance use settings time restrictions are likely to be a factor. Participants 
felt that staff in pharmacy and sexual health services have an increasing amount of 
responsibilities in response to a range of health conditions of which AAS is only one 
example. This has consequences for the amount of time they are able to spend learning 
about and delivering interventions related to any one topic with a client. Any potential 
role they would have with users would need to take the need for brief interactions and 
competing pressures into account. For example, signposting to relevant services as 
discussed previously was felt to be appropriate and realistic, while learning about all 
different types of AAS to advise on AAS regimens was not. While all participants raised 
these points relating to time limits and competing pressures, it was also perceived that 
in the majority of cases users will not require further support. If staff can quickly identify 
which clients may require more help and which do not then in most cases there will be 
no need for interactions to be time consuming. 
“It’s a capacity issue as well as obviously a knowledge issue. Even if I knew the 
answers to all these things, I can’t do much in a three minute transaction, they 
need to go somewhere where there is more time to do that”. Participant 33, 
pharmacy needle NSP worker. 
“There is a lot already being asked of sexual health because people have realised 
that certain groups such as young people, particularly young males, are simply 
more likely to go to see their sexual health clinic out of necessity than many 
other health services”. Participant 30, sexual health consultant. 
“I think there's a perception that it will be a huge time demand, but if it's only 
the ones that need help that you spend time with, it's only going to be the odd 
one probably”. Participant 29, substance use practitioner.  
Staff characteristics 
The issue of staff expertise was a common theme relating not just to signposting but 
more generally to the ability to potentially engage with and provide support and 
interventions to users. The findings broadly reflect the perceptions of participants in the 
first part of the study and related to credibility, knowledge, skills and motivation. 
Participants felt that while they did not have expertise in AAS and it was in some cases 
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unrealistic to expect this of healthcare staff likely to encounter users, they did not 
require great expertise specific to this form of substance use to fulfil the role that they 
perceived their services to have. In order to provide healthcare to users, participants 
suggested that staff needed credibility and confidence to hold discussions and develop 
rapport in a topic that they do not have great knowledge in. Issues relating to credibility 
were very similar to those raised by participants in part one of the study about staff 
without expertise. Participants here discussed concerns that due to their inexperience 
relating to AAS, users may not be interested in or respect any advice they had to give or 
want to discuss their AAS use with them. Having confidence to initiate discussions about 
AAS and related behaviours may be associated with concerns about knowledge or 
credibility and therefore increasing skills and knowledge as well as confidence is likely 
to be beneficial. 
“You don’t need to know exactly what steroids they’re injecting into whichever 
muscle, you just need to know about safer injecting practices into the muscle 
and about sexual health, things like that. In any needle exchange they should be 
confident doing that, so maybe it's reframing these things that is needed”. 
Participant 29, substance use practitioner.  
Participants in substance use services and NSPs shared their experiences of working with 
users who they perceived to be reluctant to attend services and engaging with staff. If 
staff do hold such perceptions or have presumptions about users, their choices and their 
health then they may be less motivated to provide suitable healthcare. For example, if 
perceived that users are not seen as a priority because they do not want support or AAS 
are not problematic then this can have a demotivating effect on staff.  
 “There’s sometimes the perception that there is nothing wrong with doing it so 
we can just let them get on with it, it’s fine, it’s legal and loads of people are 
doing it. But also there’s this idea that if you’re stupid enough to do it then again, 
fine, get on with it, on you go because it’s seen a bit differently to things like 
heroin and cocaine where everyone is aware of the potential for not just health 
problems for the person doing it but also problems for others so through crime, 
violence, everything like that”. Participant 30, substance use practitioner. 
“I think with pharmacies from the people there I've spoken about this with it's 
probably a mixture of confidence, not seeing that it's important and therefore a 
good use of their time, and just not having the time”. Participant 29, substance 
use practitioner. 
110 
 
“Sometimes it feels a bit like why are we bothering. They don’t want to be having 
that conversations, we don’t either really”. Participant 33, pharmacy needle NSP 
worker. 
Engagement 
Engaging with people who use AAS 
In part one of the study, participants commonly identified language and terminology as 
key factors in engaging with users. These were identified by four participants as both 
barriers to, and facilitators of, engagement in different settings. Staff’s inexperience and 
lack of knowledge relating to AAS may include terminology, which may have an impact 
on their ability to engage with clients. It was suggested that some staff may be aware of 
terms but not feel confident to use them or be concerned that incorrect use of 
terminology would lead to reduced credibility. 
“I wouldn’t necessarily know what to say, maybe performance enhancing or 
image enhancing, doping in a sports context. I don’t know, and that’s one of the 
first problems… I would have thought that was fairly typical amongst people 
working in sexual health services because it’s not what we have expertise in 
generally”. Participant 31, sexual health consultant. 
“There is a confidence issue I think with being comfortable using some of these 
terms that are unfamiliar but, also, it’s knowing what the right terms are”. 
Participant 32, pharmacy NSP worker. 
The importance of asking questions to encourage engagement and the development of 
positive relationships was identified in part one of the study. Participants here suggested 
that their lack of expertise about AAS and their use of terminology and language with 
clients may limit the ability to ask the right questions. Further, they recognised the 
importance of helping clients feel comfortable in the service to increase engagement 
and future use of services, but it was suggested that these issues relating to terminology 
and knowledge amongst some staff might limit this. Consequently, these were felt as 
important issues to address with staff to improve their ability to engage with users. 
“I think one thing we would like a bit of help with is about what things to say 
and what to avoid. It’s a bit of a minefield probably and there must be things I 
would imagine that we might be able to phrase better, to ask in a way that 
might be more conducive to making these men feel more at home, more 
comfortable talking with us”. Participant 33, pharmacy NSP worker. 
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“I think we would benefit greatly by learning about what’s the language of 
steroid users and what language can we then use in clinics to try and identify 
these things that we need to respond to. That would be part of any training that 
we would be interested in I would imagine”. Participant 31, sexual health 
consultant. 
Settings not conducive to engagement 
Participants in part one discussed that developing positive relationships and rapport 
with users was an important part of helping them to feel comfortable in the service 
and in leading to fruitful conversations. This was recognised as important by 
participants here, who felt that developing rapport can be difficult however in 
different types of services. This was discussed in the context of having limited time 
with clients and due to the anonymous and drop in nature of many services where 
appointments are not required, relationships will not be built up over time with 
repeat interactions between individual members of staff and clients. Further to this, 
the nature and set up of many NSP services may not be conducive to open 
conversations and relaxing clients. 
“I think a big challenge for any of us is how to develop that relationship with 
that person in a limited time and probably in an environment where they're not 
that comfortable being open and honest”. Participant 28, young people and 
sexual health outreach worker. 
 “I think sometimes that some of them want to ask more questions but hold back 
for some reason, probably because they don’t feel that comfortable talking to 
me in a pharmacy”. Participant 33, pharmacy NSP worker. 
“You’re stood up, it’s a fairly small room and there’s a glass barrier between you 
and them, you don’t have the time to build a huge rapport or anything. And you 
don’t have the opportunity for follow up because unless they enter any sort of 
treatment then the next time they come back, chances are they’ll see someone 
completely different, so you don’t have that sort of relationship that builds up 
over time where they start to trust you”. Participant 29, substance use 
practitioner. 
Approaches to improve engagement, help clients feel comfortable and increase trust 
were discussed and were very similar to those raised by participants relating to asking 
questions, making clients feel comfortable and developing positive relationships in the 
first part of the study. Here, participants frequently discussed these issues in the context 
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of limitations through staff expertise and service characteristics discussed above. 
Importantly, as participants suggested in part one of the study, there was agreement 
that staff did not need great expertise to ask some quick questions that would help to 
break down potential barriers and help clients feel comfortable and able to raise any 
issues or ask their own questions. Instead, as suggested in part one, asking general 
questions and showing an interest in clients and their lifestyles will be within the 
capabilities of all staff. Asking these quick questions may also help staff to identify AAS 
use in non-substance use settings. Other important points included having a positive, 
friendly and non-judgemental approach and avoiding coming across as negative or 
confrontational. 
“I ask a couple of questions, just things like have you done this before and do 
they need any information at all. Usually of course they say no, they just want 
to get out of there, but some of them, particularly the ones who haven’t been 
before or maybe I imagine are new to it they might ask a question. We do try 
and get them to feel like they can ask us questions”. Participant 33, pharmacy 
NSP worker. 
“Just be friendly, be interested in them. Treat them like you would anyone else. 
Some of them say things like “we thought you were going to lecture us” so that’s 
something to avoid obviously, we don’t do that but if they think you’re being 
negative or trying to get them to do something different then I don’t think they’d 
stick around or come back”. Participant 32, pharmacy NSP worker. 
Participants in substance use and pharmacy settings felt that one of their main roles with 
users was to help clients feel that the environment was one that they could return to 
and discuss any problems or concerns that they had at a future date. The amount of 
questions and discussion, and what that might lead to, is likely to vary by service type 
and the nature of any support identified as required. For example, in a substance use 
service staff are more likely to be able to continue a conversation about a persons’ AAS 
regimen than staff in a sexual health service who instead might identify the need to make 
a referral.  
“Throwing in things like what’s your eating like, how often are you in the gym, 
it just waylays those fears or perceptions that they’re doing something that’s on 
the sly and they don’t want to talk about it. You can make it easy for them to 
talk about it and make them feel more comfortable in there”. Participant 30, 
substance use practitioner. 
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“You could ask one or two questions and then within your own knowledge either 
give them some advice or trigger a referral to someone who can do more, like 
the drug treatment service”. Participant 28, young persons and sexual health 
outreach worker. 
Discussion 
The findings presented here represent stakeholder consensus on a range of priorities 
for providing healthcare, information and support through which to influence behaviour 
and improve health outcomes in users. Ideas for addressing these primarily involved 
increasing information and support for users to support a range of decisions relating to 
AAS use, as well as improving healthcare provision to this population.  
It appears likely from this and previous work that many users do not currently engage, 
or engage effectively, with substance use practitioners or any health professionals in 
relation to their substance use and related health needs (Zahnow et al., 2017). Further, 
they may not have access to reliable information or support. If many users do not 
encounter intervention providers, or providers are not able to engage or communicate 
effectively then messages to reduce harms and change AAS use will not reach them. If 
we recognise that users represent a diverse population, there is unlikely to be one 
approach that will reach everyone. It may be helpful to start thinking about some of the 
different groups of users relating to their approach to information and support. For 
example participants here discussed that there are men who already attend services, 
amongst whom some who may or may not want and need better engagement and 
support in these settings. There are also those who use some or a combination of other 
sources such as friends, forums, websites, dealers and other users (Pope et al., 2004, 
Hanley Santos and Coomber, 2017, Kimergård and McVeigh, 2014a, Maycock and 
Howat, 2005). It is likely that not everyone who uses AAS will want, need or benefit from 
any support or improved information provision. However, clear targets identified in this 
study were to increase access to information and support in order to convey important 
messages and influence decision-making to those that either seek or do not have access 
to reliable information, and those who would benefit from it.  
It may be likely that for many individuals they will never engage with substance use 
services regardless of their availability and opportunities to engage with and deliver 
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interventions to users are likely to be limited. This has some clear implications. Firstly, 
where users present in any health service it provides an opportunity to deliver 
appropriate messages to them relating to their substance use. Within the healthcare 
system, where users encounter health professionals in settings such as pharmacies, 
sexual health services and young people’s services it may be possible to deliver 
interventions at these points or signpost effectively to support services. Further, 
identifying other opportunities outside of healthcare to either encourage use of support 
services or deliver important messages will help potentially to reach more people.  
Environments identified by participants in this study as being important included gyms, 
prisons and the armed forces where concerns were raised about the acceptability, 
normalisation and perceived benefits of AAS and the prevalence and diffusion of 
unreliable information and advice. Gyms and prisons are recognised by Public Health 
England (Public Health England, 2014) as settings where healthcare for users is required, 
but there is little evidence to support the implementation of interventions or 
information provision within these settings. Important influences within these settings 
identified here appear similar to in other environments, for example normalisation 
relating to AAS (Grogan et al., 2006, Hanley Santos and Coomber, 2017), exposure to 
information and opportunities to learn about and purchase AAS (Maycock and Howat, 
2005, Dennington et al., 2008) and the reinforcing and motivating characteristics of 
social networks (Olrich, 1999, Olrich and Ewing, 1999, Ravn and Coffey, 2016). The role 
of key individuals within these settings and social groups, such as other users, gym 
owners and trainers, requires further exploration but potentially they could act as 
providers of reliable and useful information and support to people who they influence. 
There are many potential routes through which to achieve this to explore. Some of them 
will likely be more realistic, practical and effective than others, but it is only by 
broadening thinking on possible intervention routes that new ways to reach more 
people who may benefit from increased support will be identified. 
Conclusion 
Within the two themes explored in this chapter, a range of needs have been identified 
that, if addressed, will reduce risk and risk of poor health amongst users. Much of this 
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chapter reflected stakeholder perceptions that many users lack access to reliable 
information and support and that improving this will lead ultimately lead to uptake of 
desirable behaviours that reduce risk of poor health. The reasons why information 
provision and support in general (including identification of AAS use and potential health 
issues, advice and intervention provision) may be lacking at present were attributed to 
a range of factors. This included the motivation and attitude towards engagement 
amongst both users and healthcare providers; the nature and characteristics of services; 
and the communication skills, knowledge and credibility of service providers. Improving 
engagement in services is likely to lead to improved information provision and delivery 
of support in such settings, but it remains important to recognise that many users do 
not engage with services or healthcare providers. Broadening thinking on the potential 
settings and providers of interventions may help potentially broaden their reach.  
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Chapter 5: Choices and behaviours of men who use AAS  
Rationale and outline. 
Chapter 4 discussed interviews with 27 stakeholders with a wide range of expertise and 
experience relating to AAS and people who use them. Two overarching themes were 
presented including opportunities to engage with, and meaningful interactions with, 
users in order to provide important information and messages. A third overarching 
theme discussed was what the information and messages provided in these interactions 
should be to help users manage their risk. This third theme ‘choices, harm and risk’ is 
discussed here. All 27 participants who took part in the study contributed.  
 
Results   
Stakeholders identified common behaviours and choices amongst users they perceived 
to be linked with increased risk and harm. In addition, participants discussed influences 
on these choices such as attitudes towards risk and health, knowledge about steroids 
and information sources. Further, opportunities and approaches for intervention 
providers to change these behaviours through influencing decision-making and 
motivating change at different time points were identified. Key to this was that 
intervention goals should differ between individuals depending on motivation and 
experience relating to AAS. The findings are presented in a thematic map in figure 7.   
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Figure 7: Thematic map for theme 3 
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Risky and harmful choices 
Some users were identified as being more at risk than others are because of their AAS 
choices and related health choices. These were identified as the factors that information 
and interventions should seek to influence. 
AAS regimes 
A frequently raised priority was to reduce the amounts of AAS that individuals are using. 
This was related to concerns about high doses over multiple AAS and other substances 
used over long periods of time without suitable breaks or ‘off cycle’ periods. Participants 
associated these ‘risky’ patterns of use with increased risks of a range of health harms. 
Using high amounts for long periods of time was linked to receiving bad advice, poor 
understanding about quantities, mirroring what others are doing and the desire to put 
on size quickly without prioritising or understanding long-term health risks. For many, a 
range of substances will be used as part of their regime and in some cases, it was 
described that some individuals are never off cycle, only reducing their use for short 
periods of time. This was linked by some with post-cycle concerns of experiencing side 
effects and loss of gains. 
“Steroids are an enhancement and taking the right amount can help your 
workout, but at the same time they are taking it and then over dosing, as in 
taking too much. They seem to always think that more is always better”. 
Participant 14, fitness trainer. 
 “It’s like non-stop cycles for some of them… so blast and cruising, never stopping 
in case they lose it. I know 100% that some of them think that if they off cycle, if 
they stop for a bit, that all that muscle will just fall off them and it’s like a sign 
of weakness”. Participant 17, fitness trainer. 
Health problems were frequently perceived to be occurring earlier in life than what 
might have previously been expected amongst people using AAS and participants 
associated these with using AAS from earlier ages, and particularly using high quantities. 
Participants commonly shared examples of concerning health problems amongst those 
they encountered that they associated with using AAS, although it should be noted that 
these conclusions were not seemingly based upon any clinical evidence. Lowering the 
amounts that individuals are taking therefore was seen as an important harm reduction 
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message, but several participants identified difficulties in communicating these 
messages.  
“I've noticed that when we're seeing some of these things, heart problems, liver 
function, they're getting younger and younger. It must be because they're 
starting earlier and the amount they're taking”. Participant 3, substance use 
practitioner. 
Participants raised the difficulty in conveying risks, for example reducing the amounts 
used may be unacceptable where it is perceived to reduce gains and this may override 
any concerns for potential health impacts.  Fear of losing gains was associated with long-
term use, high doses of multiple substances and discussed in the context of dependence, 
with some practitioners sharing accounts of clients they had encountered for whom AAS 
and training activities were prioritised over relationships with family and friends and 
work life.   
“Like with other substances where steroids become the main focus in someone's 
life, other parts of that life are going to suffer. We need to identify those people 
who haven't got that balance right”. Participant 11, public health commissioner. 
 “I think the problem may be that what we think is a big concern to them is often 
nothing compared to the gains they want to get. It can be quite tough getting 
that message through to someone who doesn't think about risks the same as 
what you do”. Participant 24, substance use practitioner. 
Post cycle period 
In addition to potentially losing gains, where men stop using AAS they may experience 
a number of changes such as to mood and libido. For many users, it may only be when 
they stop taking these substances that they experience negative effects. Indeed, one 
participant noted: 
“For the vast majority of people for the time they are taking steroids, they’re 
feeling pretty good. Everything that they don’t like, it happens post-cycle”. 
Participant 3, substance use practitioner.  
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Avoidance of these symptoms was frequently associated with regimes characterised by 
brief off-cycle periods or following a blast and cruise approach9. Symptoms of poor 
health were identified as a common cause of relapse amongst those who do try and 
stop, or of regimes characterised by brief off-cycle periods. In particular, concerns 
about mental health and mood at this time were raised in the context of a population 
for whom such issues may not always be well accepted or understood.  
“The last two guys I saw with real problems was when they’d come off and they 
were feeling so low, so awful, they really were. One said he did not want to live. 
There must be loads of people feeling like that. People like them just don't have 
problems like that, it's not something that gets discussed.” Participant 2, 
substance use practitioner. 
“More often than not because the person is feeling so bad and so down for that 
long period of time, what happens is they’ll jump back on. Because jumping back 
on will feel like a remedy to them”. Participant 4, General practitioner. 
Promoting off cycle recovery periods and raising awareness about post-cycle health 
was discussed as important advice to be providing. Understanding and attitudes 
amongst users about PCT to reduce these negative effects after stopping AAS were 
perceived to be varied, but attitudes amongst participants regarding PCT varied too. 
Raising awareness of, and increasing access to, PCT was identified by some participants 
as important to support recovery and reduce health harms. However, others discussed 
concerns about the amount of substances that some men use and that the availability 
of PCT was seen as a way of mitigating the negative effects of AAS use, and therefore 
as a safety net to justify taking large amounts.  
“When someone is coming off it would be really great if they were told about 
what they might experience, about post cycle therapy as an option and how to 
go about doing that. I think that would reduce a lot of worry potentially and a 
lot of problems”. Participant 9, substance use practitioner. 
“It’s like another barrier is gone. Some of them think that you don’t have to 
worry about long-term problems because PCT will sort you out, which is stupid 
obviously”. Participant 7, Substance use practitioner. 
                                                          
9 A common cycle for some users where a smaller dose is administrated for a period of weeks (the 
‘Cruise’), alternated with larger doses as adopted in a normal cycle (the ‘Blast’). 
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AAS source and quality 
Some participants identified that it was important to reduce risks associated with 
purchasing substances of unknown quality. Service providers had little confidence in 
clients’ knowledge about the actual substances they were using and how they might 
vary in strength, or about risk of contaminated products where substances are prepared 
outside of laboratory settings. The risk of using a contaminated or low quality product 
was particularly associated with purchasing AAS online. For some it may be seen as the 
easier option to order substances online without having to identify a source and 
approach them, and this may be a greater motivator than reducing risks. As discussed 
by some participants, where a product is believed to result in the desired gains it can be 
difficult to make risks seem important. Further, some participants suggested that 
amongst individuals who recognised the prevalence of poor quality AAS, they invariably 
believed that what they themselves were using was of good quality. 
“It’s amazing about how people will say they are aware of all the risks and that 
there is a lot of rubbish out there, but they are completely confident that what 
they have is good stuff. They won’t doubt their own source at all”. Participant 
25, substance use practitioner. 
 “It's probably a bit intimidating to have to go to someone and ask them if you 
can buy steroids from them for some of them… much simpler to click a button”. 
Participant 23, public health commissioner. 
Risky behaviours 
Many participants were aware that HIV had been identified amongst this group of 
substance users, which was a clear priority to tackle for commissioners. Some service 
providers recounted examples of clients for whom hepatitis B and C had been identified 
and of poor awareness amongst users, who were perceived to generally associate BBVs 
with people who use psychoactive drugs rather than AAS. Sharing of needles amongst 
injectors was indeed perceived to be rare, although several participants suggested they 
had come across cases where this happened and provision of injecting equipment and 
advice regarding sharing was still seen as important. Sexual health behaviours of users 
were mentioned by a small number of participants in the context of BBVs. High levels of 
sexual activity and low rates of condom use were linked to concepts of masculinity and 
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poor awareness and concern of risks, suggesting that condom provision alone in services 
may be insufficient.  
“How many gyms do you go in where they’ve got no idea about any harms at all 
to do with their substance use? Like you mention HIV and they look at you 
blankly like ‘what, how can I possibly have that’”. Participant 1, substance use 
practitioner. 
 “They’re not maybe that bothered. We give out condoms and talk to them about 
it, but I don’t know if it’s seen as cool or the manly thing to do to use them”. 
Participant 26, substance use practitioner. 
Several participants suggested that BBVs were an infrequent problem in comparison 
with other health conditions associated with long-term use and high doses amongst 
clients who they encounter. Providing advice relating to sexual health and injecting 
practice and identifying where BBV testing was required were discussed as standard 
harm reduction practice, but some suggested that focussing on BBVs should not lead to 
other more common health harms being overlooked. Additionally, some participants 
discussed a sub group of individuals who engaged in a range of risky behaviours 
including binge drinking, psychoactive drug use and unsafe sex. It was suggested that in 
addition to their AAS needs their attendance in substance use services provided an 
opportunity to explore these other behaviours and provide relevant support.  
 “In the grand scheme of things, blood borne viruses… they’re way down in terms 
of how likely you come across them... a couple of cases compared to the things 
like liver damage, testosterone levels being down”. Participant 3, substance use 
practitioner. 
“Some of them, particularly the younger guys, there is a whole package of things 
going on that ring the alarm bells. It’s your typical group of lads who are going 
out and drinking a lot, cocaine, amphetamines, getting into fights, picking up 
girls. For lots of them the gear is just one thing that they do”. Participant 22, 
probation officer. 
Tackling influences on risky AAS decision making 
Changing knowledge and attitudes 
Amongst participants who worked directly with users there was common concern about 
the attitudes that younger men in particular have towards their bodies and health, and 
the influence of this upon their AAS decisions. This was frequently framed as the seeking 
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of a ‘quick fix’ in response to a common desire to increase muscularity promoting short-
term thinking and decisions that prioritise immediate benefits over potential risks. For 
many new users their focus is on making substantial gains quickly and an individual 
highly motivated to achieve a muscular physique may perceive AAS as a short cut to 
achieving that goal.  
You talk to these guys in their late teens and early twenties and they’re looking 
at something like that, what the older guys do, that as a first cycle… They can’t 
wait, there is no tomorrow and they want to do it all now”. Participant 13, gym 
owner. 
“They don’t have a clue what it’s doing to them because they don’t look it up, 
they don’t ask questions… they don’t really care, they only care about getting 
massive”. Participant 18, gym owner. 
 “They go for a sort of shotgun approach where they take loads of something, 
see if it works, then up the dose because they want it to work more quickly or to 
see more effect”. Participant 12, substance use practitioner. 
This short-term attitude towards rewards versus risk was associated with a lack of 
consideration for health and wellbeing, and not taking AAS seriously. This was 
highlighted particularly for adolescents or young men and associated with not 
undertaking research or seeking advice. Participants discussed the importance of 
supporting individuals to think about the potential long-term impacts that their choices 
now might have, but frequently recognised the difficulty in doing this as short-term 
benefits were perceived to be powerful motivators, particularly in the context of social 
pressures and expectations. 
 “No one really cares about risks because they’re young and they don’t see that 
as real to them.  It's all about the here and now, you need to get through to them 
about what it might mean in a few years’ time… but to them, that's not as real 
as doing what your mates are doing and what you feel compelled to do now”. 
Participant 1, substance use practitioner. 
Similar to attitudes, participants discussed the importance of changing knowledge to 
influence decisions about AAS, in particular, but not exclusively, amongst younger 
people and newer users. Those who had worked directly with users frequently described 
poor knowledge regarding the impact of AAS on the body, common harms and side 
effects, and substance doses and strength. Many shared experiences of working with 
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individuals who demonstrated a lack of understanding or awareness about their 
substance use, which was sometimes described as surprising and concerning. Some 
described examples of poor injecting practices amongst those who did not engage with 
health services and reiterated the need to provide support around injecting. 
“I have asked them about whether they know about how testosterone levels can 
be affected over time and what that means and you just get blank faces. They’re 
putting testosterone in to their bodies, you’d think they’d have some idea what 
that means”. Participant 21, sexual health practitioner. 
“We thought they’d know a bit about health risks but no, not a hope in hell. We 
were quite surprised to be honest because we had a sense that they knew loads 
about it and were all experts but, particularly the younger guys, they had no idea 
about what it was doing to their bodies or what the risks were”. Participant 10, 
public health commissioner. 
 “A lot of them inject with the wrong needles in the wrong places. Most of the 
guys who come in know about injecting because they’ve been in before, so it’s 
easy to be blasé about it, but then someone comes in for the first time because 
they’re in pain or something and it’s because they’re doing it wrong, sometimes 
for a long time”. Participant 25, substance use practitioner. 
There was recognition that knowledge could also be very good, but this was generally 
portrayed as being the minority of individuals. Amongst older and more experienced 
users there was perceived to be generally better knowledge, but some participants did 
highlight that misinformation and misconceptions could be ingrained amongst these 
men leading to risky practices. A smaller number discussed how some users expressed 
disbelief that AAS could have serious impacts upon health and perceived that risks were 
fabricated in order to scare them. Where users believe that health risks do not exist, or 
can be easily avoided or managed, it may be easier for them to justify risky behaviours 
and more difficult to deliver convincing harm reduction messages.  
“The more you dig beneath the surface the more you realise just how little some 
of them know. Sometimes they’re just very naïve and inexperienced, others are 
very experienced but despite what they think and having that experience, they’re 
actually very misinformed and putting themselves at great risk” Participant 5, 
academic. 
“They think it's all made up that there were these problems. They’ve been told 
it’s something that was made up to scare them off using, or that it’s made up 
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because the government want to ban it and things like that. We have to try and 
address that”. Participant 22, probation officer. 
Information sources 
Both knowledge and attitudes were linked by participants to the amount of research 
that users, particularly younger people, were undertaking and where they were getting 
information. A common need identified was to promote reliable sources, information 
critique and questioning of source motives and biases. Different common sources 
including websites, peers, dealers and experienced users were discussed as often 
problematic, particularly when individuals do not have the skills or inclination to critique 
or question the source or the information, or are looking to confirm preconceptions and 
justify decisions. It was acknowledged that all these sources can be excellent providers 
of useful advice, but that they can also provide inaccurate and biased information, or 
messages not relevant for an individual or their circumstances. For example, participants 
discussed how experienced users sometimes provide advice that reflects their own 
experience and may not be appropriate to others. They suspected that many people can 
be naïve or find it difficult to question recommendations from experienced users or 
dealers, who may be respected and seen as an authority on the topic.  
“If you speak to a gym owner who uses steroids, or the big guys in the gym, 
they’re going to give you information that reflects their own experiences, their 
own biases”. Participant 7, substance use practitioner. 
“In an ideal world they’d ask themselves about what they were being told and 
think about things like: one, who is telling me this and are they reliable? Two, 
why are they telling me this? You know, do they have my best interests at heart, 
really? I don’t think they do that. I didn’t, I just thought ‘this guy is bigger than 
me and has been juicing10 for longer, I best do what he says’”. Participant 17, 
fitness trainer. 
The mixed quality of advice on social media and websites that many individuals access 
was highlighted and it was noted how easily ‘bad’ information is passed around online 
and in social groups. Within social networks information, including that which is false or 
potentially harmful, may be repeated and reinforced by dominant members of the 
group so that it becomes the norm. Social pressures to conform to what others are doing 
                                                          
10 A common slang term for using AAS. Some users will refer to steroids as ‘juice’. 
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and not use smaller amounts than someone else, even amongst someone just starting 
out with AAS, could lead to patterns of use perceived as increasing risk, particularly 
where peers are poorly informed themselves.  
“They just cherry pick these websites, they cherry pick the articles and the studies 
that they like, that say that there is no risks or that you can do away with the 
risks if you’re clever”. Participant 6, academic. 
“I think most of them get a lot of it from each other though. They do it in groups 
or they form groups when they start and a lot of the information just bounces 
around the group. And you tell me how good you think that information is likely 
to be, when it’s second hand information that one of them has got from God 
knows where?” Participant 19, gym owner. 
Changing intentions and reducing use 
As well as addressing specific risk factors and harms, participants commonly raised the 
need to address the overall decision to use AAS. It was recognised that individuals will 
vary in their motivations, decisions and readiness to change their behaviours, but that 
generally the most positive outcome, and the best way to reduce risk and improve 
health, would be that an individual decides not to use AAS. Some may be motivated or 
open to stopping their substance use, while others may be satisfied with their current 
position and not motivated to make any change. Additionally, some may be open to 
consider adapting or changing their practices with the intention of reducing harm, or 
risk of harm occurring. Consequently, the aims and goals of any interventions and 
interactions was seen as dependent on the individual and their circumstances. This was 
summarised by one participant as: 
“Without wanting to over simplify it, at the end of the day we want people to be 
using less. If they are going to do it then that’s their choice and that’s fine, and 
in that case we want them to do it as sensibly as possible and take care of 
themselves, but ultimately, we would want them to make that choice not to use 
steroids”. Participant 15, substance use practitioner. 
Awareness raising and motivating to make a change 
Many users visit services to acquire injecting equipment rather than for any help or 
advice and may not be open to making any changes at that time. In addition to providing 
harm reduction messages, participants used terms such as ‘planting a seed’ frequently 
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to convey the potential for every interaction to have an impact upon future decision-
making. Participants felt that where any conversation was held about AAS it was 
important to get individuals thinking about key issues and that in some cases this could 
start the processes that may eventually lead to cessation, or less risky use.  
“If they're doing something that could be harmful then you need to take that 
chance you have with them and plant that seed in their mind that it might not 
necessarily be a good idea. They might not listen to you or accept it then, but 
later on, whether that's weeks or months, you've started that conversation”. 
Participant 26, substance use practitioner. 
In some cases, clients in services may ask for support to stop using AAS, or suggest 
that this is something they are considering. Several participants who worked in 
substance use services discussed their experiences of this, including being 
approached by clients who want to stop or appear open to the idea, particularly when 
they have experienced a change in their life or are less motivated than previously to 
use AAS. Where there is an opportunity to intervene at this point and support an 
individual towards ending their substance use, this was seen as important. 
“If you get the feeling from them that they might think about calling it a day 
then surely supporting them to do that is the best harm reduction you can do”. 
Participant 27, substance use practitioner. 
“I think it’s human nature to think about your choices and lifestyle at times like 
when they’re settling down so you’re probably more open to advice. Having kids 
definitely, or a new girlfriend. You get them chatting about that and then push 
a bit around how steroids might affect these plans.” Participant 20, substance 
use practitioner. 
A range of physiological and psychological side effects is associated with AAS use and 
when individuals experience harms this may influence their beliefs and perceptions of 
risk relating to their substance use. Service providers suggested that when an individual 
is seeking support about a side effect or is concerned about health or appearance, this 
may be an opportunity for engagement and intervention. Two participants who had 
experienced side effects themselves when using AAS commented that this effected their 
thinking. Both agreed that this would not be a deciding factor for everyone, but some 
would be more inclined to consider changing their habits and to listen to advice at such 
a time.  
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“I think the most productive conversations where you can see them listening to 
you are when they've come to you with a problem, or you've identified a problem 
with them and they're thinking about whether it's all worth it. You have to make 
the most of that chance, build on it, you can get through to them when I guess 
they are feeling unsure or vulnerable”. Participant 9, substance use practitioner. 
“The one time I thought seriously about stopping was when I had 
gynaecomastia. I was doing all these things to be the big man, and instead I was 
getting bitch tits, you know? I was panicking, and I wanted to stop, but I wanted 
more to keep going. I think people who are less committed, something like that 
would really affect them and make them think”. Participant 14, fitness trainer. 
Early intervention 
It was commonly expressed that intervening early when an individual is considering 
starting, or has recently started, using AAS can be effective for engagement, conveying 
risks and influencing decisions. An individual who has recently made that decision may 
be more interested in harm reduction information and advice. Further, at this stage 
individuals are more likely to make changes than after they have been using for a period 
of time when they may have formed habits and perceptions that are difficult to change, 
particularly when they start to see desired effects upon the body. 
 “Someone newer to it, they’re not as embedded in that lifestyle and behaviour, 
they’re not as committed to it and so it’s easier for them to change their minds. 
And have their minds changed”. Participant 6, academic. 
“They can see the effects in a positive way and that kind of reduces the impacts 
of the negative effects. But if they haven’t already seen the benefits then that 
gives you a chance to talk about all these other things like diet, harms, side 
effects”. Participant 24, substance use practitioner. 
Participants who worked in gym settings applied the idea of early intervention 
specifically to new starters in the gym. In that environment with the potential influences, 
opportunities and pressures related to AAS, initiation may be particularly likely. 
Therefore, this may be an opportune time to engage with these individuals before other 
influences are experienced and habits established.  
 “Often they’re interested in juicing sometimes as soon as they start in the gym 
I think. They're keen to listen to what I have to say at that stage, much more 
than if you catch them once they're a couple of cycles in when they already think 
they've got it all sussed.” Participant 17, fitness trainer. 
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Participants, particularly those with expertise in fitness training, commonly highlighted 
the possibility of delaying initiation through promoting natural methods for enhancing 
muscularity. For individuals who are beginning in their efforts to increase muscularity, 
there may be no need to use AAS in order to achieve gains that can be achieved through 
changes in strength training and diet. Some participants associated this with lacking 
understanding about the body and training, particularly amongst younger people. Many 
may not progress to a point where they are considering using AAS following an initial 
delay and it was perceived that some of the attitudes and choices identified as 
problematic and contributing to riskier use might be negated to some extent by this 
delay. 
 “They need to understand their body and they need to understand that there’s 
probably reasons why they’re not putting on size and if that is what is they are 
looking for then they’ve probably got the whole training regime and diet wrong. 
So trying to educate them on how to eat right, train right, rest right and then 
maybe some of them won't want to use steroids if they don't need to”. 
Participant 8, substance use practitioner. 
“Lots of them will only use for a cycle or two anyway, and then lose interest or 
get other priorities. So if you can get in there and put them off starting for a bit, 
they might never get round to doing it again anyway”. Participant 2, substance 
use practitioner. 
Primary prevention 
While most of the discussion focussed on men who had already started using AAS or 
were considering it, several participants also raised the importance of prevention at an 
earlier stage. Participants who discussed this topic did so generally in the context of 
adolescents and often school-based programmes, but there was a lack of consensus on 
what any potential prevention interventions should be with many different possibilities 
mentioned. Some recognised that prevention was a complex topic, particularly as AAS 
and broader issues of appearance and body image related problems are likely to have 
many potential predictors and risk factors, and therefore while intervening before 
someone is considering using AAS would be very beneficial, it is not straightforward. 
“Ideally you'd catch them before then, before they're even at that stage where 
they're thinking about it but I think that is more complicated. There's just so 
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many reasons why people want to get bigger or want to use steroids”. 
Participant 14, personal trainer. 
“I think prevention is very difficult compared to something like harm reduction 
which seems a bit more clear cut about what actually needs to be delivered and 
what will actually help people, whereas prevention is a bit more woolly I think if 
that makes sense? There seem to be a lot more factors to consider about when, 
what, how”. Participant 10, Public health commissioner. 
The points raised in these discussions often moved away from AAS specifically into a 
broader spectrum of issues facing young people such as body image, mental health and 
peer pressure. In particular, participants felt that improving young people’s skills in using 
social media and critiquing media images, improving understanding about the body, 
supporting positive norms and expectations about appearance, and supporting abilities 
to cope with pressure from peers and society would have benefits. Inherent in these 
discussions was a presumption that by intervening to change these factors, this would 
have a positive impact upon later decisions to use AAS.  
“It would be good to do something earlier on in their lives about the media and 
body image I think. Like which bodies are attainable are which are not, and how 
Photoshop and things effect what you say, and what is a realistic ideal. How to 
cope with the pressures that so many young people must be under to look a 
certain way”. Participant 25, Substance use practitioner. 
“I think we need to provide information about these technologies and how 
images can be manipulated, and to inform young people that many of these 
bodies are not naturally achieved and therefore are not something that should 
be seen as the norm”. Participant 7, Substance use practitioner. 
While these may be important factors for interventions to focus on with young people, 
other participants pointed out that the variety of factors influencing AAS initiation, and 
the complex nature of some of these, may be difficult to overcome. They emphasised 
the complexity of issues that might cause AAS use and questioned whether these could 
be overcome without being individualised. Influences such as body dysmorphia and 
emotional factors might require different types of interventions. Others pointed out that 
drug prevention programmes have generally not been that successful in reducing use of 
different substances, and they were not confident that a steroid prevention programme 
would be any more effective. However, it was recognised that these potential 
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programmes could still have an impact upon the wider issues facing young people, 
regardless of any potential impacts upon later use of AAS. 
“There are a lot of reasons people start using steroids… what about bullying, 
abuse, things like that. It's not just about body image… it can be more mental 
disorders, body dysmorphia, confidence to go against your mates and what 
they're doing. I think it's very complicated and that makes these early 
approaches more complicated. It can be many different things and can be deep 
rooted and complicated psychological issues that we don’t want to 
oversimplify”.  Participant 4, General practitioner. 
 “It’s about having an idea of what we’re trying to prevent. Are we actually 
trying to prevent drug use, in this case steroid use… in which case I would 
suggest that looking at the history of drug prevention, we pretty quickly run out 
of interest and hope that it will work really”. Participant 11, Public health 
commissioner.  
“Generally, drug prevention as in stopping any use of a drug has not been 
successful. But that doesn't mean it's not important and beneficial to work on 
things such as body image and peer pressure with these kids. It's about changing 
a culture of wanting to be something you're not, and the pressure to look a 
certain way. And that could have loads of benefits and for some then maybe 
that would include making them think again later about steroids”. Participant 
16, Public health commissioner. 
Finally, there was discussion amongst a small number of participants only around 
prevention relating to people who play sports at an amateur level. Prevention of AAS 
has historically been in the context of professional sport as part of efforts to reduce 
‘doping’ for performance enhancing purposes. It was discussed that authorities need 
to hold a similar stance on AAS and other IPEDs at the amateur level as they do for 
elite athletes to avoid mixed and inconsistent messages. While the participants in this 
study were unanimous in their support for accessible harm reduction for men who 
use AAS, there was recognition that in a sporting context that was likely to be less 
acceptable and practical, and the goal of interventions for athletes should be to 
prevent uptake and identify those who do take these substances. 
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Discussion 
The findings presented in this chapter establish harm reduction and other behaviour 
change needs that interventions are required to address. These are summarised in box 
3.  
Box 3: Priorities for interventions to address identified in theme 3 
There was general agreement regarding harm reduction needs for this population. 
Consensus was that the riskier AAS regimes adopted, characterised by taking high 
amounts over long periods of time without allowing the body time to recover, 
particularly by new users or younger people, may be harmful and relate to dependence 
and health conditions such as cardiac and fertility issues at a young age. Previous 
research has identified ‘risky’ practices amongst some users including polypharmacy 
(Sagoe et al., 2015), high dosages (Pope et al., 2014b, Chandler and McVeigh, 2014) and 
long or continuous ‘on’ cycles (Kanayama et al., 2009a). For those who are highly 
motivated to use AAS, participants in this study identified a need to therefore minimise 
risk through promoting use in moderation, cycles that allow the body to recover and 
access to good quality information sources. In reference to evidence of BBVs and 
injecting-relating injuries in this population, promoting good practice relating to 
injecting, sharing of injecting equipment and condom use were also common points of 
consensus. Additionally, participants identified the need to reduce AAS use, particularly 
amongst individuals who are adopting risky practices, and encourage cessation in 
Harm reduction  
 Increase use of reliable sources of information and encourage critique of 
information 
 Encourage and support AAS use in moderation characterised by moderate doses 
and cycles including periods of no use 
 Support users to practice safe injecting and avoid sharing needles and other 
injecting equipment 
 
Reducing AAS prevalence 
 Reduce prevalence amongst young people and new starters 
 Support cessation amongst those who want to stop 
 Motivate long-term changes in use and attitudes and beliefs about AAS 
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response to health harms. It is interesting to acknowledge at this stage the similarities 
between many of the priorities identified here and the findings of research carried out 
in the 1990s examining the views of gym owners on AAS users (McVeigh, 1996) and their 
harm reduction needs (Morrison, 1994). Certainly, concern over choices regarding 
dosages, cycle length, AAS sources and information sources are not new. Similarly, some 
of the findings in the previous chapter resonate with other studies of the same era that 
investigated the support that users require and what IPED services should look like 
(Lenehan, 1995, Morrison, 1995, Pates and Barry, 1996). Therefore while AAS use 
appears to have increased outside of athlete populations over the past 20 years, the 
issues and challenges in addressing the health harms and risks of people who use them 
remain in some ways similar. This could suggest that approaches to date to tackle these 
issues have been limited in their success if similar priorities and concerns remain 
prominent two decades on. This reinforces the need to develop evidence- and theory-
based interventions to respond to harmful and risky AAS use in an effective way.  
Moderation and risky use 
Many of the findings can be summarised as the need to support people who are 
motivated to continue to use AAS to manage their risk. Developing guidance on 
promoting use in moderation is complicated by a number of issues however. A key 
influence for using AAS and against adopting risk- and harm-reducing AAS regimes was 
perceived in this study to be the prioritisation of quick gains in, or maintenance of, 
muscularity over potential health risks. This suggests that these individuals will choose 
options perceived to maximise rapid benefits with little regard for, or understanding of, 
long-term risk and this may be a barrier to adopting harm reducing strategies. They 
appear similar to the ‘YOLO type’ (‘you only live once’) in the typology of AAS users 
developed by Christiansen and colleagues, defined by impatience, poor knowledge 
about AAS, a lack of concern for health and risk taking (Christiansen et al., 2016, Zahnow 
et al., 2018). Models of health behaviour such as protection motivation theory (Prentice-
Dunn and Rogers, 1986) suggest that an individuals’ intention to protect themselves is 
partially dependent on their appraisal of both the severity and likelihood of a threat. 
Research suggests that motivation to take risks reflects the perceived balance of risks 
and rewards (Weber & Johnson, 2008; Weber, 2010), and for many users there are 
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powerful social and personal benefits influencing decision-making. Intervention 
providers will therefore need to change perceptions of risks and benefits with this group 
regarding their approach to AAS use.  
The ‘Expert’ and ‘Wellbeing’ groups in the same typology include subgroups of users 
who consider themselves highly knowledgeable and attempt to manage and reduce 
risks or use in moderation. While some manage use with periods of ‘off cycle’ recovery 
and lower dosages (Brennan et al., 2016), the long-term risks to health from any AAS 
use outside medical settings are largely unknown. The extent to which AAS use in 
moderation will protect individuals is at present unclear, as the risks of harms 
associated with AAS use are not well quantified in terms of different dosages, 
substances or cycles. Additionally, the nature of the illicit manufacturing of most AAS 
means strength may vary (McVeigh and Begley, 2016), which complicates any attempts 
at managing risk or controlling what one is taking. Therefore, while encouraging 
moderation is likely to be a sensible and positive harm reduction approach, research to 
determine how best to define this is required. 
Users are susceptible directly and indirectly to information and pressures from a range 
of environments and sources that together influence their AAS decisions and practices 
(Bates et al., 2018). Information online and from peers, dealers and other users 
combined with the unpredictable quality of this information, preconceptions, and skills 
in critiquing information all contribute to decision making and were perceived here to 
contribute to poor knowledge and risky AAS use. Further, exposure to information that 
promotes risk taking or reduces concern for harms potentially contradicts or 
undermines messages from healthcare providers. For example concern was identified 
here of naivety amongst experienced and ‘Expert’ types who despite their experience 
may be unaware of, or disbelieving of, the potential harms from their substance use. 
Researchers have long identified that long-term exposure to risks leads to reduced 
perceptions of severity and increased feelings of control, particularly where few 
negative consequences are experienced (Johnson and Tversky, 1983, Brown, 2005). 
These beliefs can be passed on to others through social networks and within 
environments such as gyms and can be a powerful influence on risk taking (Kimergård 
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and McVeigh, 2014a). As discussed in the previous chapter, a priority identified in this 
study was to increase the amount of reliable and appropriate information to users. 
Further, healthcare providers should promote to users a critical and questioning 
attitude to messages and information sources, and encourage them to critique their 
own behaviours and choices. They should therefore ensure users are aware of the 
potential for harm while continuing to support them to use their AAS as safely as 
possible. Further, they should try to motivate users to develop exit strategies and 
encourage reassessment of regimes and practices.   
Motivating change 
Much of the discussion regarding changing use was similar to recommended approaches 
within UK guidelines for managing drug misuse and dependence, which includes 
discussion of behaviour change approaches (Independent Expert Working Group, 2017). 
Health professionals who work in drug and alcohol services therefore should be 
confident to work with this population and there are likely to be transferable messages. 
Motivation to use AAS, maintain a particular regime or adopt harm reducing strategies 
is likely to be dependent on many factors and different individuals at different times will 
be more open to making a change. Key opportunities to intervene and motivate change 
were identified in this study as early intervention before habits are formed, following 
experience of poor health or other adverse effects, and when the individual is already 
considering a change. In this study participants framed this in terms of ‘planting a seed’ 
or ‘chipping away’, with the intention of slowly changing intentions and attitudes to 
motivate change. Decision-making however is not necessarily rational or reflective and 
may be dominated by automatic processes (Marteau et al., 2012). Therefore while 
beliefs about risks and benefits are undoubtedly important, they will only predict a 
behavioural response where motivation is strong enough to overcome other drives, 
habits, impulses, cues and emotions (West, 2006). Motivational interventions will need 
to consider these factors and identify what is important to individuals if they are to be 
effective. For example, an individual who experiences positive social reinforcement by 
peers and has a strong identity as an AAS user as part of a subgroup may be resistant to 
change.  
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Users are increasingly recognised as a diverse group whose AAS use can be motivated 
and influenced by a wide range of potential factors (Bates et al., 2018). For example, the 
importance of approval and positive reinforcement from peers for users have commonly 
been identified by researchers (Hanley Santos and Coomber, 2017, Kimergård and 
McVeigh, 2014a, Olrich, 1999) and the process of socialisation and self-identification as 
part of a group of individuals with similar motivations and lifestyles is well documented 
(Maycock and Howat, 2005, Maycock and Howat, 2007, Monaghan, 2003). Feelings of 
group belonging have long been linked with social identity and positive self-concept 
(Tajfel and Turner, 1979) and are likely to be powerful motivators to overcome for those 
attempting to stop using AAS. In this example, increasing awareness and understanding 
of risks and harms might be part of motiving change, but changing identity is likely to be 
an important part of driving and sustaining any changes to AAS use. For others, factors 
such as low self-esteem (Blank et al., 2016) or experiences of abuse (Petrocelli et al., 
2008), or community or institutional norms, may be important predictors driving 
choices. Therefore, identifying which factors are significant and influential for 
individuals will be important when looking to motivate any change and to address 
through interventions. The priorities identified in this study relating to improving 
accessibility and availability of relevant services and improving engagement between 
providers and clients will be important to consider if interventions seeking to motivate 
change are to be implemented and effective. 
Limitations 
The intervention priorities discussed here and in chapter 5 reflect the perspectives and 
experiences of stakeholders with a range of expertise relating to AAS and those who use 
them. While this included a number of current and former AAS users, further research 
with individuals who use AAS to explore whether these findings match their own 
perceptions and experiences, and how to communicate and implement the messages 
and interventions discussed, will provide valuable insight. This was the aim of study 4, 
which followed on from this study. Additionally, findings relate in the main to those 
people who are already attending services relating to their AAS use. It must be 
recognised that many users do not attend any services of this nature and may have 
different profiles and needs, and be exposed to different influences and messages. 
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Consideration is therefore required on how to increase engagement and deliver 
important harm reduction messages and interventions in response to the AAS and 
health needs of this population both in and outside of healthcare settings. A strength of 
the study was that the participants represented stakeholders with a range of 
experiences and areas of expertise and the inductive approach to data collection and 
analysis supported participants to express their beliefs and perceptions regarding what 
they felt the greatest needs that should be addressed with this population are. However, 
the nature of this approach meant that while 27 participants were included and a 
substantial and rich dataset was generated, the overall numbers taking part were 
relatively low. It is unclear whether the priorities identified here are representative of 
the perceptions of the large number of stakeholders with interests and experiences in 
this area. One important subtheme related to GPs and their response to AAS and men 
who use them, but no GPs were included in the study so it was not possible to gain 
insight into their perspectives on these issues. As described in the study methodology, 
efforts were made to ensure that participants represented important viewpoints on this 
topic, but it is unclear whether any other key perspectives were overlooked11.  
Conclusion  
This study identifies consensus from stakeholders on priorities regarding support and 
interventions targeting users. The priorities include harm reduction messages and 
adoption of adapted practices for those who use AAS and provide a platform for the 
development of guidance for practitioners who work with users to deliver harm 
reduction messages and the development of interventions to influence AAS decision 
making. However, more thought and research is required into the precise nature of 
harm reduction messages, particularly regarding AAS use in moderation and PCT, and 
into the potential influences on decision making that are specific to AAS and those who 
use them. Further, there was consensus identified on priority areas in terms of reducing 
AAS use, which focussed on prevention and delaying onset of use particularly amongst 
younger people and supporting cessation amongst those who wish to stop. Potential 
                                                          
11 Further discussion of the limitations of this study and the implications of these is included in the 
broader discussion of limitations in chapter 7 
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approaches to bring about the desired choices were identified and will be explored 
further, supported by the reflections and perceptions relating to these findings by users. 
It is clear from the evidence base that the priorities identified in this study are not all 
new ones, but are in fact similar to concerns raised over 20 years ago. This suggests that 
approaches to date to respond to these concerns, primarily through the provision of 
clinics targeting AAS users, NSPs and drug treatment services have not been that 
successful at influencing choices amongst this broad group of substance users. This 
reinforces the need to broaden thinking and consider other ways to influence and 
provide information to this population. 
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Chapter 6: User perspectives on priorities and provision of support 
and healthcare 
Rationale and outline 
The aim of this study was to continue to identify priorities and opportunities for 
interventions from the perspective of users. In particular, it was proposed to enable 
users to reflect on the perceptions of other stakeholders. Semi-structured interviews 
were carried out with 12 users, who were asked questions exploring key themes from 
the previous study. Through a deductive thematic analysis, four themes were identified: 
i) health and risk, ii) information provision and support; iii) support services; and iv) GPs. 
Generally, findings supported those from the previous studies relating to priorities for 
improving provision of information and support and reducing risky patterns of AAS use. 
There was a greater emphasis on the need to improve the response to AAS amongst 
GPs, but less of an emphasis on the importance of support services, although similar 
barriers to accessing and engagement in such settings were identified.  
Methods 
Participants and recruitment 
Participants in this study were all AAS users in the UK. Recruitment took place through 
two methods: firstly, users who had participated in a national IPED survey and 
consented to be contacted regarding future research studies were emailed and asked if 
they would like to participate. This included a total of 31 individuals. Secondly, a 
snowball approach was utilised where stakeholders from study 3 and participants in this 
study were asked to identify potential participants. Where these individuals provided 
consent, their contact details were passed to the researcher and they were 
subsequently invited to participate. To include a wide range of perspectives and needs 
again, men with different amounts of experience with AAS were sought. The focus of 
much research with users previously has been on bodybuilders and more experienced 
users, so stakeholders were particularly encouraged to identify any younger and less 
experienced users.   
140 
 
Data collection 
The progression to a more structured interview format throughout study 3 continued in 
study 4 with semi-structured interviews used. This reflected the change in emphasis 
from identifying ideas to following up on them. Therefore, interview schedules were 
prepared to ensure that important topics were covered and key findings from study 3 
were followed up on. Questions related to users’ beliefs towards undertaking research 
and knowledge about steroids; information sources; experiences of and attitudes 
towards support services and health professionals; experiences of and perceptions 
about the influences of gym environments, other users and significant others; and 
perceptions about risk and risky use in themselves and others.  To support these 
interviews, 12 statements summarising the views of participants in the previous study 
were drawn up, which were identified during the initial analysis of this data. The 
interview schedule and the supporting statements are presented in appendix 12. All 
participants were read the first statement and asked for their thoughts on this to 
stimulate conversation at the start of the interview. The remaining 11 statements were 
used alongside the relevant question where the interview covered that topic. Some 
participants talked extensively on some topics and some interviews covered topics not 
on the interview schedule. While all interviews covered all topics therefore, not all 
participants were asked all of the questions.  
Data analysis 
Analysis was carried out following the same processes as described for study 3, and 
again followed the thematic approach outlined by Braun and Clarke (Braun and Clarke, 
2006). However, the thematic analysis followed a more theoretical and deductive 
approach (Braun and Clarke, 2006), similar to in part B of study 3 following the shift from 
unstructured to semi-structured interviews. Therefore, only data that was relevant to 
the research aims was fully coded with other data given the code ‘off topic’.  Initially, 
data was coded under categories corresponding to the interview questions and then 
arranged into a thematic map following closer scrutiny.  
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Ethical considerations 
While the interviews focussed on specific topics coming out of the previous study rather 
than topics likely to be particularly sensitive or upsetting, participants were asked to 
reflect on their experiences and generally around their steroid use. Therefore, it was 
inevitable that conversations at times would include discussion of their personal history, 
health and concerns and reflections on their choices. It was not anticipated that this 
would lead to any upset, but at the start of each interview participants were told that 
they could take a break from, or end, the conversation at any time and that they did not 
need to discuss any issues that they did not want to. The participant information sheet 
given to all participants included advice if they had any concerns about their substance 
use. Steps were undertaken to ensure the anonymity and confidentiality of participants, 
similar to as with stakeholders. Where specific services, individuals and places were 
identified by name, all identifiable information was removed in transcripts. This was also 
important to assure the anonymity of services, health professionals and other users who 
were discussed. Job roles were reported using general terms and locations and names 
of work and study places and sports teams were removed. While participants did not 
generally appear concerned about these issues of confidentiality, several did seek 
reassurances as to the purpose of the work before they would agree to interview. In 
particular they were concerned that their data would be misinterpreted and 
misreported and that the researcher was seeking to generate sensationalist publications 
that would increase the scrutiny on AAS and those that use them. Common questions 
received were clarifying study aims, whether the researcher was a journalist, and what 
his opinions were on the legal status of steroids. In all these cases, conversations over 
email were held and where the researcher clarified these points and provided examples 
of his previous work in this area. The majority of participants who expressed these 
concerns subsequently completed an interview. 
Ethical approval to undertake this study was granted by the LJMU Ethics Committee in 
February 2018 (reference: 18/PHI/002). 
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Results 
Semi-structured interviews were carried out with 12 individuals, lasting 33-70 minutes. 
Five of these participants responded to the recruitment email and a further seven were 
identified through the snowball approach via participants from this study and study 3. 
An additional five users expressed interest in participating following the recruitment 
email and six users were identified by others as being interested. However, these 11 
individuals did not take part for reasons including being users of other IPEDs but not AAS 
(n=3) deciding they did not want to participate in a research study (n=2), not having the 
time (n=1), and communication ending without a reason being given (n=5).  
Participants were asked their age and how long they had used steroids. The sample 
ranged in age from 20 to 48 years (mean, 29.5, median 26.5). Experience was defined as 
length of time since first using steroids, which ranged from five months to 27 years 
(mean 6, median 3.5). Over half (7/12) of the sample had used over a period of between 
three and six years, mostly without a substantial break in that period. Two participants 
were very experienced, having first used steroids 19 and 27 years ago, both including 
periods of non-use, while three participants were new users, being within their first 
year. The study did not aim to explore motivations for use, but to give context to findings 
and stimulate conversation participants were asked to describe their reasons for training 
(and using steroids) and what they did for a living. Three of the sample were students 
and the rest were in full time employment including roles as a personal trainer (n=2), 
manual labourer (n=2) and prison officer (n=1).  The remaining four participants 
described other professional roles. Three participants discussed their participation in 
amateur sports and two more described their intentions to compete as bodybuilders in 
the future. For the remainder, their use and training was discussed in the context of 
health, fitness and appearance with the exception of two participants who had concerns 
about low testosterone. The sample therefore included a range of ages, experience and 
motivations.  
Through the thematic analysis, data was organised into four themes: i) health and risk, 
ii) information provision and support; iii) support services; and iv) General practitioners.  
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Figure 8: Thematic map for study 4 
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A thematic map providing an overview of these themes and subthemes is presented in 
figure 8.  
Health and risk 
While this study did not aim to explore participants’ AAS regimens or determine their 
own level of risk, through the discussions it was apparent that the sample represented 
different AAS attitudes and practices. There were examples of practice that might be 
described as  
increasing risk, such as those who described long cycles and use of many different 
substances, but generally participants own patterns of use were described as being 
relatively low risk. The attitudes towards risk amongst themselves and others was 
summed up by participant 6, who stated:  
“I wouldn’t say I’m at risk. I’d like to think that I’m doing good for my health by 
doing this, that’s what it’s all about. I know what I’m doing and I know how to 
do it well. It's the ignorance about it all that is risky, lads who don't know what 
they're doing and then doing stupid things”. Participant 6. 
Several emphasised that they believed their own use was beneficial for them and 
enabled them to be healthy.  
 “Using steroids doesn't make you healthy but if you're eating well and training 
well, and using steroids wisely, then it can be a good thing. If you don't do it 
wisely then that's when you have a problem”. Participant 2. 
Regardless of their personal patterns of use, many participants agreed with concerns 
about patterns of use amongst many men using AAS. Examples given suggested that 
some, particularly younger ones, are frequently making choices relating to AAS that 
increase risk with the amounts that others were using and cycle lengths particular points 
of concern. Generally however there was little indication that participants had concern 
about their own use. There were exceptions to this amongst some more experienced 
participants who reflected on their experiences and suggested that they regretted their 
decision to start using AAS and pointed at choices they had made previously that they 
now felt were naïve and risky. This was reflected in the advice that they gave to others 
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whom they had somewhat negative attitudes about and criticised for not practicing 
‘sensible’ or moderate use. Despite their regrets, they continued to use however. 
“When I tell them how much I’m using, they’re surprised because they’ve been 
told to do a lot more than that so that’s what they’re doing. I think they see it 
as the more they do the bigger they’ll be, like it’s magic”. Participant 9. 
“My advice is always the same and that is just not to start you know, because 
for me it was “I’ll just do one cycle” and there never is just one cycle. Some of 
them, it's one never ending cycle for years and years. I don't think they think it 
through before they start, not at all”. Participant 4. 
For these more experienced users they appeared to empathise with those who they 
were critical of, and recognised that they had a similar attitude when younger and had 
engaged in riskier practices. For example, participant 2 compared their own attitudes to 
users younger than them and described their approach to information and attitude 
about risk: 
“When I started, I was 18, I buried my head in the sand about it all. I didn’t want 
to know about anything apart from was it going to help me bigger and stronger? 
I know that some people tried to tell me not to do it, to wait or just not do it at 
all and they gave me reasons but I did not want to know, not interested. If there 
were reasons not to do it then I didn’t want to hear them because it was so 
important to me and I had already decided what to do”. Participant 2. 
A typical description of attitudes prominent amongst men using AAS was given by 
participant 9, and was similar to those described by stakeholders in the previous study:  
 “They want to hear that going on juice is going to be safe and it’s going to get 
them where they want to be and it’s going to be a bed of roses. They want the 
body and they want it easy, and they want it now. I know that because it’s what 
they tell me. They want something to just sort them out, no hassle. They want it 
easy”. Participant 9. 
Similarly to previous findings, a range of examples were given to demonstrate the ways 
that knowledge and attitudes amongst other users was undesirable. This included a lack 
of understanding around how AAS work, optimal practices and injecting, and health in 
the post-cycle period; the desire for quick changes in muscularity; seeking easy options 
to achieving body goals; using products of unknown or dubious quality; and not taking 
the time to research and understand what they are doing. These factors were again 
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linked with risky patterns of AAS use and not fully engaging in other parts of the lifestyle 
such as with diet and training to the extent that participants felt was required to justify 
using AAS and to achieve the desired benefits.  
Support and information provision 
Similarly to the previous study, knowledge gaps and risky choices were often discussed 
in the context of undertaking research and of the accessibility and reliability of 
information and support. There were mixed attitudes towards the need to do research, 
although typically participants appeared to value information seeking and emphasised 
its importance particularly when first starting out. Developing understanding and 
expertise were commonly seen as important for achieving goals and reducing the 
likelihood of negative outcomes such as making unwise choices, being susceptible to 
bad advice, causing harm to health and being ripped off by dealers.   
“You should do your research and if you don’t then you shouldn’t be surprised if 
it doesn’t work out for you I think or if you do yourself more damage than good”. 
Participant 5. 
Perhaps unsurprisingly therefore some participants emphasised how seriously they took 
research and took pride in their own level of understanding, and this could be used as a 
measure to criticise others for. In particular, research was valued as part of the decision 
making process when starting to use AAS, but also beyond that point with more 
experienced users indicating that they still value new information. This was tied in with 
the idea of understanding what one is doing, which was portrayed as a key difference 
between those who were using sensibly and those who were potentially more at risk.  
“I read all the information when I started off and about how everything should 
be used and in what way.... That’s the really concerning thing as far as I’m 
concerned for lots of them, there just isn’t any attempt to do the research and 
understand what it is they’re doing”. Participant 4. 
“I’m still learning, everyone can learn something, and the guys on there (online 
forums) some of them have a lot of knowledge and experience that they share 
and you can pick up little tips and bits and pieces from them about how to 
improve what you’re doing. If you’re putting things into your body then you 
should take the time to learn about it and understand it yourself, I don’t get why 
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you wouldn’t do that, you can’t just sail through life waiting for others to tell 
you what’s what”. Participant 10. 
However, not all participants were so interested in seeking information and improving 
their own knowledge and understanding. For some developing understanding may be 
less important and they are content with a level of knowledge that enables them to 
achieve their goals. There may be a reliance on others to provide essential information 
and a lack of motivation to undertake research as demonstrated through the following 
discussions, firstly:  
Participant 7: “I know that some people want to know everything but I’m happy 
doing what I’m doing. Someone will tell me if there’s anything I need to know I 
suppose”. 
Interviewer: “So you’re not that interested in reading up about it, improving 
your own knowledge?” 
Participant 7: “It’s interesting but there’s only so much I want to know, you 
know? I always say to him (a friend) he does the reading so I don’t have to. It’s 
not that I’m not interested but, I think, what I want to know is what should I take 
and how often. Other than that, no, I don’t need to know every detail like some 
do, no problem with that if that’s what you want to do with your time, but I’m 
not a details man”.  
Secondly: 
Participant 12: “I think it's different for different people. Some want to know 
everything about it and they'll do loads of reading because they want to 
understand it. And then you have the opposite where they just want to be told 
what to do and they're the ones that are I suppose you could say vulnerable to 
some of the bad advice that floats around, particularly from the lads who are 
shifting it”.  
Interviewer: “So you mean some of the dealers are giving bad advice, and some 
people are maybe just taking that at face value?” 
Participant 12: “Yeah some of them, the shiftier ones, they'll take advantage of 
what they see as being ignorant. I think some of them find it funny or like they 
deserve it cos they don't know any better. It's sort of like teaching them a lesson 
and it helps them to make a bit more money”.  
Dealers were amongst a range of key individuals identified as being influential on the 
attitudes and choices of people who use AAS. Discussions here were very similar to those 
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with stakeholders and reflected how information and advice, both perceived as being 
‘good’ and ‘bad’, reaches users via other users including dealers, friends and other 
people known to the individual. Perhaps unsurprisingly the gym was again identified as 
a key environment where individuals can be influenced by other users including those 
they see regularly in that setting who may or may not have the knowledge and skills to 
provide useful and reliable support. Within social groups clearly a lot of information 
sharing goes on which some participants discussed in a positive way.  
“Lots of guys have their stacks and they’re doing different combinations, so 
they’ll tell you about what works and what doesn’t, how to counter sides, how 
to get lean as well as big. I always listen because you never know what might 
be useful later on down the road”. Participant 12, discussing a group of peers at 
his gym. 
“He (knows it all because he’s been around it for a long time so he’ll sit with you 
and work out what you need and when you need to do it. To someone like me 
who doesn’t know a lot about these things really that’s been great”. Participant 
8, discussing his dealer. 
If one of the needs of people who use AAS is to have access to information and advice 
then clearly there are potential advantages of this peer-to-peer support. However, 
participants shared many examples of how this knowledge sharing and advice can be 
problematic due to the information being provided and the susceptibility of some users 
to misinformation or advice that may not lead to desirable choices. Generally, this 
resonated with stakeholder perspectives and the evidence presented in the 
socioecological framework. For example, participants discussed how the stereotypical 
‘big guy in the gym’ might have attitudes that lead to advice that does not support the 
idea of using in moderation, yet they often have a receptive audience for their advice 
and may, whether they intend to or otherwise, be influential information providers.  
“I’d say about 90% of the time, their advice is awful. Definitely, it’s that high. It’s 
usually they have an old school mentality of just sitting in the gym for hours on 
end doing pointless exercises. They’re just there all the time, so everyone knows 
them and they will talk to people about it because they’ve got nothing else to 
talk about because they live in the gym. They believe you should do as much 
gear as possible when that’s not necessary”. Participant 5. 
“The big guys will just attract other people who want to look like them, or at 
least want to get a lot bigger and they think they must know best because 
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they’re the biggest ones. Some people will just presume these big guys know 
best, and often they really don't, and they'll listen to them”. Participant 9. 
Similarly, within friendship groups this may also occur with more experienced users 
being seen as sources of advice and information being passed around the group that 
may influence others. This extract from the interview with participant 11 reflecting on 
their friendship group illustrates how this can advice can be influential in potentially 
positive ways: 
“We do keep each other grounded I think because if someone is talking about 
doing something like running lots of different ones at the same time or really 
hammering it then we’ll chat about that usually and they’ll come around. That’s 
why it’s good having a group when there’s one or two of us with heads screwed 
on who won’t let everyone get carried away and start abusing it like you see 
other people do”. Participant 11. 
On a similar theme the same participant described how information was shared in their 
group of friends, where one person did a lot of research and then passed it on to others 
who were less motivated to increase their knowledge. Several examples were given in 
this study that indicated the trust that individuals have for their friends and in the 
information they provide and the reliance on the information provider having good 
understanding themselves. 
 “I’ve got one mate who knows a lot about everything, if you want to know 
something he’s a good bet to know the answer. We call him the encyclopaedia 
because he’s got all the facts. He reads a lot of stuff, like scientific stuff and 
books. He says that he does the research so that we don’t all have to, but really 
without him I don’t think we’d really be that bothered. I don’t really bother 
looking at it”. Participant 11. 
Other examples however were given indicating that undesirable habits and 
misinformation can be passed around peer groups and that frequent discussion can 
reinforce motivation to use and perceptions of normalisation. While the advice provided 
may not necessarily be appropriate or ultimately beneficial for the recipient, this is not 
to say that these individuals aim to cause harm or give out ‘bad’ advice to peers or other 
users they encounter (although as highlighted above, it was suggested that some dealers 
may be motivated to mislead naïve users). It is perhaps more likely that they base their 
advice upon their own perceptions and experiences and may not necessarily have the 
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understanding or motivation to modify this to reflect the needs of different individuals. 
The complex sub cultures and social structures within environments such as gyms and 
peer groups may have an impact upon the nature of advice and opinions shared and how 
this is used.  
“He’s (another user at the gym) kind of the go to man about all this stuff, he 
asked me about what I’m doing, about my cycle. So I told him and straight away 
he’s like “only four weeks D-bol? Are you a man or not?”, that sort of stuff. It’s 
macho shit, kind of I take more than you so I’m better than you… stupid”. 
Participant 8. 
“There are people out there who do have good intentions but they’re only 
talking from what they know, based on either what’s happened to them, what 
they’ve experienced, or what someone else has told them and they don’t know 
anything about you. It’s hard to put yourself in someone else’s shoes, I think it’s 
quite hard to, you know, give objective advice. That’s not just on websites, that’s 
people in gyms, dealers, your pals, anyone really”. Participant 3. 
“It’s not like anyone really says to people go and use it, it’s great, do it, so it’s 
not like they’re promoting it in that way, but they definitely give off, they put a 
positive spin on it for sure. It’s all about justifying it and justifying yourself as 
working hard in the gym, putting the time in, being in control of everything”. 
Participant 2. 
Where there is undesirable advice and information being given out to people who are 
perhaps naïve and open to influence, there is the potential for harm. An extract from 
one participant illustrated this where he described an interaction he had with another 
user: 
Participant 4: “He had a piece of paper with everything written down about how 
much to do and when he should be taking it. He didn’t know what some of it 
meant, because obviously somebody else had written it all down for him so you 
have this situation where here is a lad, 18 years old or so, and he’s got all these 
vials and pins and a big list of what to be taking, but he doesn’t understand any 
of it. And some of the amounts were really, really high. 
Interviewer: “And he would just have followed this, because someone else had 
told him that was what he should do?” 
Participant 4: Yeah. Some of these lads starting out, I expect they are quite 
vulnerable and open to influence… I was, and so were some of the others I knew. 
It’s only later when you look back on it that you realise it, at the time you just 
want to be like them, you don’t really question it”. 
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Beyond the motivation to do research and interest in improving knowledge there may 
be issues with accessing and understanding reliable information. Similarly to 
stakeholders in study 3, participants here discussed how it can be difficult to determine 
what advice is good and what is unreliable, biased or not appropriate to the individual 
and their circumstances. Seeking information may increase the likelihood of someone 
receiving advice and modifying their choices as a result, but their abilities to understand 
that advice, to critique it and apply it to their own situation will all have an impact on 
how it is used. The sheer amount of advice available through a range of sources was 
highlighted as being both useful and problematic as while it increases the accessibility of 
information for people who may benefit from it, it also makes it more difficult to find 
the ‘right’, and increases the likelihood of finding the ‘wrong’, information. The 
individual’s motivation to understand the issue is likely to be important. Some discussed 
this in the context of websites and chat forums:  
“The thing is though that yeah there is some useful information out there but 
it’s not that easy to find. It’s not accessible really”. Participant 5. 
“You can always find information that you wanna read. If you’re buying a new 
phone you’ll only read the reviews that say the ones you like are good, you won’t 
read the ones that slag it off. It’s the same with steroids, people will believe all 
sorts of nonsense if it’s what they want to hear. When I speak to people and say 
things like about have they looked up about what they’re doing, they’ll quite 
often say yes and that it’s right, it’s what they’ve been recommended. They 
don’t know any better so they don’t question that”. Participant 9. 
Several examples were provided of times that participants had sought or been given 
advice through online forums and websites, and opinions on these as reliable sources 
were mixed. Some participants suggested that they valued academic literature, which 
they perceived to be reliable and trustworthy. However, it was also noted that this 
literature could be difficult to understand due to scientific language and frequent use of 
unfamiliar terminology and it seems possible that this evidence may be misinterpreted 
or ‘lost in translation’ in some cases. Participant 5 indicated in this extract that he valued 
the academic literature, but that while they personally felt able to interpret it, this was 
not the case for everyone: 
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Participant 5: “I’m fortunate in that I did a degree and I guess I’m used to 
reading academic stuff but it can be quite complicated and lots of guys won’t 
want to read that and they won’t really understand it” 
Interviewer: “So there’s good information there, but it’s not that accessible?” 
Participant 5: “What they do is they’ll quote you studies that they think show 
something, but actually when you look at it it’s not what they think. And that’s 
because they’ve looked at it and not understood it or someone else has told 
them about it or they’ve read it online and that person hasn’t understood it, or 
they’ve taken it out of context”.  
In all of these examples therefore, the issues relating to information and advice provision 
were quite complex and indicated a range of important factors to address. Accessibility 
to information and support, both reliable and otherwise, in a range of formats and 
settings appears important and is complicated by the motivations, skills and knowledge 
of the person providing it and the person seeking or receiving it. Additionally the nature 
of, and social and cultural influences within, the setting or group where information is 
provided is likely to be important and influence the content and interpretation of the 
messages. 
Support services 
In the UK, healthcare targeting people who use AAS is mainly delivered through 
substance use services and pharmacy-based NSPs that provide a variety of interventions 
and support for people who use a range of drugs. Further, a small number of clinics 
specifically target people who use AAS or other IPEDs that are attached to more generic 
substance use services or delivered or promoted in outreach settings, typically gyms.  
There was less consensus here about the value of support services. It appeared that 
experiences of visiting services differed greatly and the level of support and information 
provision, staff attitudes and knowledge, and engagement between staff and client 
varied in different locations. As might be expected, clinics specifically targeting people 
who use AAS were discussed most favourably amongst those who had accessed one. 
Positive experiences were discussed in the context of feeling accepted by knowledgeable 
staff, receiving useful information and advice, having the opportunity to openly discuss 
matters relating to their AAS use, and being offered blood tests. NSPs or other substance 
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use services outside of specific IPED clinics were typically discussed similarly to one 
another and in often directly contrasting terms to these clinics. Generally these were 
thought of as places to acquire injecting equipment rather than to access any other 
support, which matched with what some users wanted and needed. Some participants 
indicated though that because they were able and happy to buy their own equipment, 
there was no need for them to go to services. Experiences when accessing these services 
typically resonated with stakeholder perceptions and concerns and reinforced the needs 
identified previously in this research to improve engagement and delivery of support in 
these settings. For example, participant 9 compared his experiences at a drug treatment 
service when he had first started using AAS with later experiences in a clinic setting: 
“I didn’t have a great experience there, it was the opposite of the clinic here 
where it’s completely open and accepting of you, there it was quite negative and 
more about them telling you why you shouldn’t be doing it, that sort of thing”. 
Participant 9. 
This was fairly typical of participants in this study. Amongst those who had negative 
perceptions of such services, the attitudes of staff were often perceived to be quite 
negative and judgemental regarding people who use AAS. A reason why this group do 
not use healthcare services has been suggested to be concerns about stigma and this 
was tied in with implications from staff in services that using AAS is a ‘bad’ choice or 
where the individual is implied to not know or care about the health implications. Where 
they anticipated that they would be criticised for their choices or treated as though they 
have done something wrong this was poorly received. 
“They’re (staff) not going to be like ‘it’s great that you’re using’ are they? It’s 
boring to be honest, I’ve heard it before. Why should I go somewhere to be told 
that stuff? Literally no one gets anything out of that”. Participant 1. 
For some, feeling judged in services was part of generally not feeling comfortable 
accessing them. These participants expressed that they did not feel that they belonged 
or were welcome there and examples were given of how people who use steroids are 
perhaps not seen as an important client or customer compared with people who use 
other substances. 
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“He (member of staff) did say I'd been a bit of a silly boy and that I wouldn't be 
doing it again would I. As if it was all one silly mistake. I didn't think much of 
that, I found it quite patronising and like the sort of thing they might say to, I 
don't know, someone who had done something really stupid not something that 
loads of other people do, and are fine with”. Participant 8. 
“You just don't get the feeling that they don’t actually want you to be there, they 
don't want to have to deal with us”. Participant 11. 
Not feeling comfortable accessing these services was not solely attributed to staff 
however. People who use AAS may have concerns about their place in services 
traditionally associated with injecting drug users and other forms of substance use. 
Some of the discussions in this study reflected this and continued narratives established 
in previous research regarding attitudes towards people who use other drugs and having 
to associate with them and concern about stigma and being seen in services.  
 “No one said anything but it’s not people I really want to be seen with, it’s not 
exactly hidden away so people can see you go in and out”. Participant 12. 
“People are there doing their shopping and I’m walking past them with a pack 
of needles, it wasn’t ideal, everyone knows what is going on there. Even the 
pharmacy, loads of my friends won’t go to a local one because they don’t want 
anyone to see them walking out of there with their needles, they’d rather go to 
one a bit further away”. Participant 2. 
However not all participants had negative experiences and a small number emphasised 
that they found staff pleasant, interested in them and useful and that services had been 
worth attending when they had felt respected and valued. For others, the experience 
was somewhat neutral and neither better nor worse than expected. Staff knowledge 
about AAS contributed to expectations and attitudes towards services and it is clear that 
for some, expectations of poor understanding is a barrier to attendance. Several 
participants expressed frustration at what they saw as basic gaps in knowledge amongst 
staff they had encountered in services. This extract where one participant recounted 
their experiences of receiving misinformation from staff in a pharmacy NSP illustrates 
that poor knowledge can lead to advice that could lead someone towards potentially 
unhealthy choices or disengagement from using services in the future: 
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Participant 4: “The worker proceeded to tell me ‘well you need spoons because 
your steroids get mixed up in a spoon’. And I was like ‘what are you talking 
about’? I’m the most mild mannered person but that staggered me”. 
Interviewer: “Oh, wow, I haven’t heard that one before”.  
Participant 4: “I thought it was unbelievable. If they want us to use these sort of 
places then they need to have the simple stuff down. It’s like day 1 levels of 
knowledge, surely”.  
Interviewer: “I guess you don’t want someone trying to give out advice if they 
don’t know anything about it”. 
Participant 4: “If you don’t know about it then don’t try and give advice because 
there’s a good chance you’re giving out bad advice. I’ve had some really terrible, 
bad advice in these sorts of services. I’ve had workers telling me that steroids 
don’t work, which is ridiculous. I’ve been told that using steroids means I’m 
going to be violent towards others. What else… just ignorant comments and 
advice, I was advised by a young man when I went to pick up my pins that orals 
are safer and better for you than injecting, I have been told outright to stop 
doing it because it’s bad for me”. 
The frequency of bad advice being given out is unclear however and in many cases 
participants who had attended services reported that they were not given any advice 
or information while they were there. This resonates with concerns expressed in the 
previous chapters that opportunities for health professionals to provide information 
and support may often be missed. However, it is likely that some users will not see 
the benefits of accessing services or from interacting with staff. Indeed, for some 
participants service attendance was portrayed simply as a means to acquire injecting 
equipment rather than to seek or be given any information or discuss their health or 
AAS use. Anything beyond this equipment transaction was seen as unnecessary and 
unwanted by some users. Therefore while they were often critical of service 
providers, this did not necessarily lead to calls to improve engagement in services. 
This extract from the interview with one participant highlights this disinterest in 
support services: 
Participant 7: “I don’t really know what they could tell me or help me with, I 
don't need any help and if I did then why would I go to someone who probably 
doesn't know the first thing about steroids or have any interest in doing anything 
apart from getting me to stop?” 
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Interviewer: “What do you mean that you don’t need help?”  
Participant 7: “I mean I’m okay, me personally, my fitness is important and I’m 
not doing anything that means that I need someone to help me get my shit 
together. Some people do, I get that, but I don’t, I’m not doing anything bad for 
me”. 
These ideas tie in with other discussions of health and risk throughout the interviews. 
Here they are linked with not attending services because if one does not feel that 
their behaviours are putting them at any risk then motivation to seek contact with a 
health professional may be low. Where this is combined with negative feelings 
regarding what to expect from services, it seems unlikely that they will access 
services.    
“A lot of the guys think, they think that they’ll have a go at them. That’s their 
concern, they want to carry on doing what they’re doing but they think that if 
they go to a service, or a doctor, they’re going to have a go at them and tell 
them not to do it. Add to that the fact they don't think there's anything that they 
would actually gain from going along then why would they?” Participant 9. 
Beyond not seeing the benefits of attending a service, a small minority of participants 
alluded to potential negative outcomes from users accessing services and suggested 
avoiding services as a way to avoid drawing Government attention to AAS as a problem.  
“It’s like a way of justifying demonising steroids if they can show that it’s, like, a 
massive problem. So I always say to people don’t go to the exchanges, don’t give 
them any data that they can use to make it illegal, it’s class C at the moment so 
it’s not illegal to have it only to supply it, we want to keep it that way and that 
means staying under the radar”. Participant 10. 
General practitioners 
User experiences with general practitioners 
Participants were asked about their perceptions and experiences with GPs relating to 
any support, information or treatment they had sought relating to their AAS use or any 
related health concerns. A range of experiences were described that in some cases, but 
not all, followed a similar narrative to previous findings in this research. The most 
frequent comments were that a common GP response to someone who uses AAS is that 
they should just stop using, which was seen as an indication of lacking understanding 
157 
 
about AAS and those who use them. Participants reported their own experiences of this 
and hearing about it from others and it was always discussed in a negative context. 
Particularly prominent was the perception that ‘stopping’ was seen by GPs as the 
solution to a range of concerns and medical issues when it was identified that the 
individual used AAS, rather than treating any symptoms or further investigation of the 
problem.  
“I’ve spoken to two GPs and both of them just told me to stop taking steroids. 
That was it really. The first one was after I’d first started and I’d taken some 
dianabol for about six weeks and I was getting some pain in my liver and my 
kidneys which I am quite confident was nothing to do with the dianabol but was 
actually all the protein I was taking. But they just said stop taking them. And 
when I went back and saw a different GP when I had the pain from injecting that 
was it again, just stop taking them”. Participant 5. 
“It was really frustrating, all they could see were the steroids as the cause and 
like the solution too, as in stop taking them and that will solve everything”. 
Participant 2. 
However, some participants described interactions that are more positive. These 
experiences are important to note as they demonstrate that not only do GPs in some 
cases provide positive support for men who use AAS, but the consultations can lead to 
benefits for the patient. For example, GP signposting a participant that led to repeated 
engagement with a steroids clinic and information provision that led to a participant 
undertaking further research about the impact of long-term AAS use on testosterone 
levels.  
“I could have no complaints whatsoever. I had been told that a doctor doesn’t 
listen to you and isn’t interested in finding out what your reasons are and if 
they’re any good basically, but that wasn’t my experience. And when I went 
back, he recommended that I come see the fellas at the clinic, so whether 
someone had told him or he’d looked it up himself I don’t know, but I’m forever 
grateful for him for doing that for me”. Participant 2. 
For these participants, it appeared important that their GP listened to them and tried to 
understand their perspective regardless of whether they approved of or supported the 
decision to use AAS. It was acceptable that the GP question this decision and offer an 
alternative perspective in a non-judgemental manner that didn’t come across as overly 
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negative or patronising. They did not expect their GP to approve, but to ultimately 
accept their decision and provide appropriate healthcare as they would to any patient. 
“I’ve got a really good GP now and they’ve always been really good to me. They 
obviously say you shouldn’t be doing this, but they also understand that I’ve 
made that decision so they’re not judgemental or really critical, they listen”. 
Participant 2. 
“She was ok, nice about it. She basically said 'have you really thought about this, 
have you looked into the, you know, side effects and stuff?' and I think she could 
see that I hadn't just decided to do it on a whim and I was serious about it so 
she didn't give me a hard time”. Participant 8. 
This was in direct contrast with those who had negative experiences with GPs whose 
responses had largely focussed on the need to stop using AAS and who were described 
as coming across as judgemental and unwilling to listen or consider looking beyond AAS 
as the cause of any health problems. For example, one participant stated: 
“She didn’t want to know about it. It wound me up if I’m honest with you cos I 
was there trying to say I’ve got this problem but as soon as she heard steroids it 
was like, nope, can’t help you, you just need to get off it and you'll be ok”. 
Participant 1. 
As this quote suggests, such experiences can have negative impacts upon patients and 
many expressed similar frustration at how they perceived their GP to respond to them 
and not understand their use of AAS. In particular, those who felt this way expressed 
that going to the GP in relation to AAS was a ‘waste of time’ and it was clear this might 
affect their decisions to visit a GP in the future. These perceptions were acquired not 
just through personal experiences but through the accounts and advice of others. Some 
participants indicated that they had advised, and been advised by others, about the 
value of visiting their GP in relation to AAS where these negative experiences were 
passed on.  
“I’m not going to stop so if that’s all you have to say then… yeah, what’s the 
point in listening to you?” Participant 1. 
“Everyone who says anything about going to a doctor about something to do 
with juicing has only bad things to say about it, and don’t bother”. Participant 
9. 
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“They ask you stupid questions and they don’t understand you. My mate was 
going to speak to his GP when he was starting it and I told him not to bother… 
they don’t get it. He can do his own research and find out everything without 
the hassle, without the stupid questions”. Participant 6. 
Participants generally attributed these experiences to a lack of knowledge and 
understanding about AAS amongst GPs and a negative attitude towards them. For 
example, not understanding their own perceptions that AAS use was not harmful and 
expecting that people like themselves would be willing to just discontinue. This was 
suggested not only to be unnecessary advice that could be harmful, but as symptomatic 
of an ignorance about the role that AAS play in their efforts to be healthy. Examples of 
perceived misinformation and bad advice were provided that were felt to demonstrate 
this lack of a basic understanding. Although these participants suggested they largely 
ignored this advice, they expressed concern that others might follow bad advice with 
adverse consequences. 
“I can tell you one thing he did say, which was that steroids don’t work… he 
actually said ‘they don’t work anyway so you don’t need to do that’. I was like ‘I 
can think of a few people who would say otherwise and if you’re telling me that 
they’ve got that way naturally then I’m not having that!’”. Participant 8. 
“Sometimes you just feel like maybe if they had a little bit of better knowledge 
about these things then it might stop some of the harmful advice. Like telling 
someone to stop, well that’s not always that easy. You could have told me to 
stop and I might have wanted to, but I know how I’m going to feel if I do”. 
Participant 5. 
“Some people are listening to their doctor and if they’re told to come off them 
and they have no knowledge about what that’s going to be like or what they 
can do to help with that then it’s obvious what’s going to happen, they'll crash”. 
Participant 2. 
Discussion 
In general, findings were similar to the perspectives of stakeholders. This chapter adds 
to the evidence supporting priorities to address, including: 
 Provision of reliable and relevant information and support. 
 Engagement between users and GPs, and the response of GPs to users and their 
health needs. 
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 Strategies to support users to manage risk in response to risky patterns of AAS 
use as displayed by some users.  
User perspectives were similar to other stakeholders in this research regarding sources 
of advice and information from other users in a range of settings and health 
professionals that can be problematic. Again, poor advice and a lack of concern for 
undertaking research or critiquing information was linked with decisions that increase 
risk of harm. While there was a perceived gap in the provision of reliable and relevant 
support for many users, a notable difference compared to other stakeholders included 
that users put less emphasis on the need to increase user access to support services in 
response to this. While there were examples of positive and negative experiences of 
service use and criticism of the attitudes and knowledge of some service providers, there 
was little discussion about improving communication and engagement as being 
important. Whether improving engagement within services might help to change these 
negative attitudes towards services that many users had is not possible to say, but if 
these attitudes are the consequence of negative experiences then it seems feasible. The 
different experiences and attitudes expressed by users in this research supports the 
need to recognise that this is a heterogeneous population. Different attitudes identified 
towards undertaking research and seeking support and regarding one’s risk and health 
appear consistent with the constructs in Christiansen’s typology (Christiansen et al., 
2016). To be successful, the response to the needs identified is unlikely therefore to be 
a ‘one size fits all’ approach. Instead, it needs to recognise that different users will be 
influenced by and seek different forms of information and support in different 
environments. The variation in experiences, particularly relating to support services, 
also indicates that there may be much variation between different locations and specific 
services.  
Barriers and enablers to accessing services 
The findings relating to support services discussed here were considered alongside those 
within previous chapters to identify enablers and barriers to service attendance. These 
factors were mapped to constructs in the COM-B model (Michie et al., 2011) and 
presented in table 4. According to the model, all behaviours are the result of having 
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capability (C), opportunity (O) and motivation (M) to undertake that behaviour. Where 
one component is missing, the behaviour will is less likely to occur. Using this model is 
helpful therefore when looking to develop an intervention because, through what the 
authors term the ‘behavioural analysis’, what needs to change and be addressed in order 
to bring about a change in the behaviour of interest (in this case uptake of support 
services) is identified. The model is designed to support the design of interventions in a 
systematic process based upon this behavioural analysis (Michie et al., 2014). 
Table 4: Enablers and barriers to attending services, mapped to COM-B constructs 
COM-B component  Factor influencing service attendance 
Capability 
(Psychological and 
physical capacity to 
attend services) 
Psychological  Awareness that the service exists 
 Knowledge of opening hours, location 
 Understanding of the aims of the service 
 Understanding of what the service offers 
Opportunity 
(Physical and social 
factors external to 
the individual 
relevant to service 
attendance) 
Physical  Service availability locally 
 Service opening hours, waiting times, location 
Social  Peer norms relating to support seeking and engaging 
with health professionals  
 Peer norms regarding risk and health 
 Perceptions about stigma from attending services 
 Peer experiences of services 
Motivation 
(Automatic and 
reflective 
processes that 
direct decisions to 
attend services)  
Reflective  Expectation of benefits from attending 
 Expectation of staff knowledge and attitude 
 Beliefs about risks and consequences of AAS use 
 Beliefs about own health 
Automatic  Help seeking as a sign of weakness  
A range of factors was identified as being relevant to uptake of support services. While 
availability and awareness about services are clearly important, these findings indicate 
that increasing these factors alone will be insufficient in many cases. In other words, 
funding a service and telling people about it is only part of what is needed. Social 
opportunity and reflective motivation appear the most important components to 
address. Beliefs and expectations about the purpose of a service and the attitude of staff 
appear particularly influential, for example anticipating that choices will be criticised and 
that the focus will be on discontinuing use. Further, users may not understand the 
162 
 
benefits of attendance or consider potential benefits as meaningful or important, 
particularly where the individual considers themselves healthy and their AAS use low-
risk. Therefore, attempts to increase uptake will need to address this through clarifying 
service purpose and staff attitudes, as well as what to expect such as the types of 
support or interventions on offer. Social factors such as norms within social networks 
towards engaging with health professionals about AAS and group attitudes towards AAS 
in terms of risk and health are perhaps more complex. Providing clarification around 
what will take place in services may help to address these issues and change norms, as 
well as through using influential members within networks as role models.  
Improving engagement between users and healthcare professionals 
Once the individual engages with a service for the first time it is up to staff there to 
ensure that the experience is positive and to motivate continued engagement. There is 
evidence from providers here and previous work that people who use AAS access NSPs 
in the UK and in increasing numbers over the past two decades (Kimergård and McVeigh, 
2014b, ACMD, 2010b, McVeigh and Begley, 2016) (although the proportion who do so 
is unknown). For those who do engage a related priority to increasing use of support 
studies is to improve the quality of their experience and the interactions between users 
and service providers. In particular, concerns about users having negative experiences 
in services and the lack of positive relationships with staff were expressed by 
participants of all perspectives in this research and expected to inhibit effective 
provision of information and support. Recommendations from Public Health England 
suggest that provision of NSPs to this population should be based on NICE guidance 
(Public Health England, 2014). The guidance resonates with the findings of this research. 
It suggests for example providing supportive and non-judgemental environments, 
accurate information sources, services such as health checks and dietary advice, harm 
reduction and injecting advice; offering vaccination for hepatitis B; discussing other 
forms of drug and alcohol use and establishing links with local gyms and providing 
outreach services through these (Public Health England, 2014). There are also prompts 
for staff knowledge and skills relating to information and support provision, intervention 
delivery and signposting. The evidence in this study suggests that in many cases, there 
are gaps in service delivery relating to these issues. There was recognition in particular 
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of the importance of improving credibility of information providers and improving 
communication and developing positive relationships between providers and users.  
General practitioners 
Much of the discussion with users around health professionals was dominated by 
experiences with and perceptions about GPs. These closely matched those given by 
stakeholders, although users gave perhaps a greater importance to this area and clearly 
felt strongly about what they perceived to be a significant gap in health care provision. 
Identifying that users have negative experiences with GPs is nothing new. Monaghan’s 
ethnographic work in the 1990s with bodybuilders explored this theme in detail with 
findings relating to doctors’ perceived lack of knowledge and understanding in 
comparison to that of users and negative attitudes towards users and AAS (Monaghan, 
1999). More recent work has identified similar experiences amongst users (Zahnow et 
al., 2017).  
The findings from this research regarding health services including NSPs, substance use 
services and GPs are similar to other studies within the limited evidence-base that have 
explored this area. Previous research has consistently identified that many people who 
use AAS appear reluctant to engage with health professionals despite the association 
between use and experiencing adverse health effects (Zahnow et al., 2017, Pope et al., 
2004, Bates and McVeigh, 2016, Hope et al., 2014). People who use AAS may be 
reluctant to access healthcare services due to perceptions of poor knowledge or 
negative attitudes amongst staff (Zahnow et al., 2017, Dunn et al., 2014) and feelings of 
stigma and the association with being identified as a drug user (Brennan et al., 2016, 
Kimergård and McVeigh, 2014b, Zahnow et al., 2017, Maycock and Howat, 2005). 
Relating to going to a GP specifically, a substantial barrier to discussing or disclosing AAS 
use was the expectation that any health problems would be overlooked and the focus 
of the GP’s response would be on their substance use itself. This matched the 
experiences of many participants in the studies who felt strongly about being advised to 
‘stop using’ by someone who they perceived did not understand them or their AAS use. 
While a small amount of evidence as highlighted above is available from the user 
perspective, there is very little research into the perspective of the GP. One study with 
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a small sample identified that GPs and other health specialists may exhibit stigma 
towards users and view them negatively in comparison to other substance users or non-
substance users (Yu et al., 2015), but further research is needed into the perceptions 
and experiences of GPs relating to AAS and users. Increasing understanding about AAS 
and those who use them within primary care and raising awareness of associated health 
risks, particularly relating to post-cycle health, is needed. Although GPs will not routinely 
receive training relating to AAS, there is recognition that support is required with 
examples of guidance, advice and training available that target GPs and other health 
professionals (Brooks et al., 2016, Human Enhancement Drugs Network, 2017, Public 
Health Wales, 2018). However, ways to increase the number of health professionals 
exposed to such support need further investigation, as well as specifying the nature of 
this support.  
Reducing harm and risk 
While there was general agreement with stakeholders’ perceptions that some users are 
putting themselves at risk of harm through their choices, such as high doses and long 
cycles, and short-term approach to increasing muscularity, it was notable that 
participants consistently distanced their own current use from this. Similarly to in 
previous research, users frequently indicated that their steroid use was risk free 
(Kimergård, 2014) and instead, it was other users, and in particular younger users, who 
were frequently identified as being more likely to make risky choices and viewed 
critically. The suggestion that one’s own use is controlled and healthy and it is others 
who should change was common. Indeed, some experienced users stated that their 
main response to others who asked for their advice was simply not to start using, but 
did not indicate that they were intending to stop using themselves. That individuals 
sometimes underestimate their own risk of harm in comparison to others is well 
established and has been identified relating to health behaviours such as smoking 
(Weinstein et al., 2005), diet (Raats and Sparks, 1995) and alcohol consumption (Dillard 
et al., 2009). This phenomenon of unrealistic optimism may at least partially explain why 
some users see their own use as less problematic than others do and why they are 
unconcerned about potential harms. Having control through knowledge and experience 
is clearly important to many users and a common perception here was that therefore 
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those who do not have this (i.e. who do not do research, are misinformed or new to 
using) are at risk and should make a change.  
It is interesting to explore that, as noted in the previous study, some more experienced 
users stated that they had made similar choices when younger or starting using AAS to 
those whom they were now critical. It was only through their own experiences that they 
had changed their attitudes and practices through a trial and error approach informed 
by what was effective against their aims and any side effects or negative impacts. 
Concerns about knowledge and attitudes amongst young users are not new (McVeigh, 
1996) and it seems feasible that new users are simply more likely to be naïve and adopt 
risky AAS regimes than more experienced users. Therefore rather than younger or new 
users increasing their risk in comparison to previous generations, this may simply be a 
continuation of the same problem, but potentially on a greater scale if prevalence has 
increased. Greater use of support services to acquire injecting equipment (McVeigh and 
Begley, 2016, McVeigh et al., 2003) and increased research into and interest in AAS use 
and male body image (McVeigh and Begley, 2016, Kanayama and Pope, 2017)  are likely 
to have contributed to greater awareness of users in the 21st century. Therefore, 
awareness of risky patterns of use will also have increased amongst health professionals. 
If true, the implication shifts from identifying why a perceived change has happened to 
why approaches to date have not been able to adequately address this.  
Brief and motivational interventions 
A theme throughout this research related to responding to a perceived increased in 
prevalence through efforts to prevent initiation, early intervention, and encouraging 
and supporting cessation amongst longer-term users. Early intervention with new users 
was the area where the clearest picture emerged in terms of what this might look like 
through brief and opportunistic interventions. Brief interventions are recommended in 
the UK as an approach to engage with young substance users who are not in contact 
with any drugs services (National Institute for Health and Care Excellence, 2007). 
Typically, they are delivered opportunistically to prevent initiation of, or promote 
changes relating to, a range of substances and are delivered in settings including schools, 
universities, work places, primary care and health services (Stockings et al., 2016). While 
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there is evidence supporting their use to prevent alcohol consumption (Hennessy and 
Tanner-Smith, 2015), brief interventions for young people however have generally not 
been associated with preventative effects for other substances (Stockings et al., 2016, 
Bates et al., 2017b). However this evidence is generally based on school- or healthcare-
based interventions and there is a lack of research examining the impact of brief 
interventions delivered in key environments, such as for AAS the gym. The processes 
described previously relating to gym staff delivering key messages to users could be 
adapted with prevention in mind. For example, targeted brief motivational interventions 
delivered during gym inductions where the individual appears at risk of starting AAS. 
Findings from this research indicate that young people may be susceptible to prevention 
and harm reduction messages at this stage, but the nature and details of any such 
motivational intervention needs further research and clarification.  
Ideas expressed here mainly related to promoting alternative methods of enhancing 
muscle and changing perceptions of risk and harm. Some interventions have at least in 
part based upon the idea of promoting ‘healthy’ alternatives to using steroids to modify 
appearance (e.g. (Sagoe et al., 2016, Goldberg et al., 1996a). It is possible that the 
inclusion of elements such as skills in weights training and knowledge about 
supplements in prevention interventions will possibly, and unwittingly, contribute to a 
desire to change appearance and normalise enhancement of muscularity in young 
people who had not previously thought to do so. However, amongst boys and young 
men who are already showing an interest in using steroids, such as those joining gyms 
discussed by gym managers and trainers in this research, supporting them to delay this 
and to enhance their physique through their training and diet first appear sensible as 
part of more targeted prevention efforts. 
Service providers highlighted that, for them, a key reason to engage with established 
users was to get them thinking about their long-term use and eventually stopping. That 
treatments for AAS use disorders are required has been established (Pope and 
Kanayama, 2015), but there is a lack of evidence however on intervention approaches 
to support cessation and withdrawal from AAS use. Additionally there remains little 
guidance to support health professionals despite the increasing evidence available on a 
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range of physiological and psychological health harms associated with AAS use (Pope et 
al., 2014b). It is beyond the scope of this research to recommend interventions of this 
nature, but services providers felt that ‘planting a seed’ and slowly changing attitudes 
of users over time was an important approach.  
Health and wellbeing following cessation 
In the past decade, researchers have discussed AAS dependence and withdrawal 
(Kanayama et al., 2009a, Kanayama et al., 2009b, Kanayama et al., 2008), which needs 
to be a significant factor when considering options for cessation interventions. Those 
who stop using AAS may require support regarding post-cycle health issues and this was 
a large part of the discussions around priorities to address in this research and will need 
to be addressed as part of cessation efforts. Participants highlighted this an important 
time and, for many, the first time that adverse effects will be experienced. Following 
cessation some men will suffer symptoms such as low mood and loss of libido associated 
with hypogonadism (Gen et al., 2015, Rasmussen et al., 2016). Experiencing these 
symptoms, or concern about them, may be a cause of AAS re-initiation or continued use 
to mitigate their impacts (Kanayama et al., 2009a). Where symptoms are experienced, 
they may require treatment. A further motivation for long-term use for some users was 
to prevent loss of benefits attributed to AAS, similar to identified in previous research 
(Dennington et al., 2008, Olrich, 1999, Hanley Santos and Coomber, 2017). In addition 
to providing information and support about potential health problems, interventions to 
encourage longer breaks between cycles and cessation could therefore include the 
formation of plans to minimise anticipated losses through natural means. Similarly, for 
those who are initiating AAS use promote suitable natural approaches as an alternative 
to using AAS, particularly with younger men. Further exploration of this issue, including 
input from those with expertise in the fitness industry and nutrition, is required. For 
some users, PCT to minimise anticipated losses or to mitigate adverse symptoms is an 
important part of their IPED cycle and providing access to PCT has been suggested to be 
a harm reduction approach (Griffiths et al., 2017), as well as by some participants in this 
study. However, the ethics and practicalities for healthcare providers of promoting the 
use of a range of additional substances that may have to be purchased through the illicit 
market and present similar issues regarding unknown quality, strength and potential 
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harms as those discussed here already requires further consideration and debate. 
Additionally there were some inconsistencies between participants’ views on when and 
if PCT should be recommended and used. However, improving knowledge and 
awareness about post cycle health is tied in with priorities here relating to encouraging 
use in moderation and reducing AAS use.  
Conclusion 
The results of this study further support the identification of priorities to address to 
improve health and reduce risk amongst users and the responses to these. When 
considered alongside conclusions from the other studies in this research, some 
consensus and clear areas to focus on are apparent. While there is great variation in the 
attitudes and practices of users, the overwhelming impression is that many users would 
benefit from access to reliable and relevant information and support. While AAS support 
services are valued by some users, findings across the research indicates that other 
approaches are needed to reach others, possibly the majority. Common sources of 
information appear mixed in quality and relevance and if users are most commonly 
getting support from their peers and other users, and if this is linked with risky choices, 
then it should be explored whether this support can be improved.  
This study highlighted again the potential for health harms associated with use and that 
current healthcare provision is not always meeting the needs of users. Where users have 
concerns about their health or substance use then they should be accessing and 
receiving appropriate healthcare. Developing interventions to increase access to health 
professionals will be an important step and should be based upon an understanding of 
why they do or do not use support services. Interventions will in particular need to 
address concerns about the aims of services and attitudes of staff. It needs to be 
recognised however that these concerns are often based upon experiences and 
information from others, and may not always be unrealistic. Therefore, improvements 
in engagement between users and health professionals including staff in support 
services and GPs are needed if risks to health are to be identified and challenged and, 
where necessary, harms are to be treated.  
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Chapter 7: Discussion 
Four overarching priority areas have been identified through this research that if 
addressed will improve health outcomes amongst men who use AAS and help them to 
manage the risks associated with their use (presented in box 4). The priorities reflect 
points of consensus from the two qualitative studies with stakeholders and men who 
use AAS. A number of potential intervention approaches in response to these needs 
were identified in the two qualitative and two literature-based studies. A range of harm 
reduction needs for users were identified as well as ways to reduce overall prevalence 
(priorities 3 and 4). To address these needs, increasing provision of, and access to, 
relevant and reliable information and support is required (priorities 1 and 2). To have 
the desired impact, these messages need to be disseminated in a way that can reach 
those that need it and by individuals who are credible, trusted and influential.  
This is not an exhaustive list of priorities and other needs and potential responses were 
identified. However, there was less consensus on these or they represented specific 
subgroups. For example, within prison environments issues relating to the provision of 
injecting equipment, opportunities to intervene and conduct BBV testing appear 
concerning. Interventions in such a setting are likely to involve overcoming different 
challenges to those addressing these same priorities in the general population. A further 
example is in a sporting context where there is a greater emphasis on prevention, as the 
ideas relating to supporting users to manage risk are not compatible with the zero 
tolerance approach to AAS. 
Looking beyond support services to respond to the identified priorities 
The discussion around increasing access to relevant and reliable support was frequently 
held in the context of AAS support services. It is perhaps not surprising that many 
stakeholders identified increasing engagement with support services as key to providing 
harm reduction and behaviour change efforts. A key element of the harm reduction 
model adopted in the UK since the 1980s in response to drug use has been on increasing 
and maintaining engagement between those at risk and health professionals so as to 
influence their behaviours (Ashton and Seymour, 2010, Stimson, 2007). 
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Box 4: Summary of priorities identified 
1. Increase access to relevant and reliable information and support 
 Improve dissemination of relevant and reliable information to users 
 Support users to improve critique of information sources and access to 
reliable sources  
 Increase user uptake of support services 
 
2. Improve engagement between users and health professionals 
 Increase recognition of AAS use and related health harms amongst health 
professionals 
 Improve engagement between users and staff in support services 
 Improve engagement between GPs and users; support GPs to identify and 
respond to AAS harm   
 
3. Support users to manage their risk 
 Discourage risky AAS use characterised by high doses, long periods of 
continuous use with no or only short ‘off cycle’ periods, and use of products 
of unknown quality. 
 Support users to practice safe injecting; provide injecting equipment and 
support safe sex. 
 
4. Reduce prevalence of AAS  
 Support cessation amongst those who want to stop and support post-cycle 
health. 
 Motivate long-term changes in AAS use amongst users who are not planning 
to stop. 
 Reduce motivation and desire to use AAS, particularly amongst young people; 
delay initiation of use and encourage alternative approaches to changing 
physique. 
Throughout the UK, support available to AAS users is likely to be through NSP and 
treatment facilities in pharmacies and substance use services and there is clear evidence 
of use of such services by users (McVeigh and Begley, 2016). However many other users 
do not access them. For example, evidence of common practices of secondary 
distribution of injecting equipment amongst users indicates that large proportions of 
this group may have no contact with services (Glass et al., 2019). For many participants 
in the current study, providing clinics specifically for steroid users was perceived to be 
the optimal way to provide support. Such clinics have long been suggested as ways to 
reach this population with harm reduction messages and health care (Morrison, 1994, 
O'Connor, 1995, Korkia and Stimson, 1994). These clinics are relatively rare and are 
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typically driven by individuals with a particular interest in, or experience with, AAS and 
related health and fitness issues. They vary greatly in terms of what is offered (Kimergård 
and McVeigh, 2014b) and this may reflect the attitudes and skills of the provider. Where 
such services exist, promoting and signposting to them appears an attractive option, but 
it must be recognised that such locations are the exception rather than the norm and 
many users may not be interested in or see the value in accessing support services. 
Additionally, the lack of funding and resources available for local authorities to tackle 
use and harms limits the potential to provide specialist services and there is no 
indication that funding for such services will increase in the future.   
Further to this, the needs identified here resonate strongly with those identified in 
research over two decades previous (McVeigh, 1996, Pates and Barry, 1996, Korkia and 
Stimson, 1994), despite the establishment of many specialist clinics in the UK and 
substantial growth in the number of users accessing NSPs in that time (McVeigh and 
Begley, 2016). In this same time, concerns about AAS prevalence and risk increasing 
practices linked with health harms have grown too. There is no evidence that prevalence 
is declining while risky practices are continuing and many (and possibly the majority of) 
users are not accessing support services. This suggests that the service-based response 
is insufficient and a different additional response is therefore required to react to the 
priorities identified in box 4.  
There is indication in the studies here that some services have the potential to positively 
influence choices, but experiences of and attitudes towards services varies greatly. The 
extent to which interactions with health professionals can influence users is unclear, for 
example there was no indication that users in this research had considered stopping 
using AAS following discussions with providers. As far back as 1995 it was identified that 
steroid clinics need to demonstrate that through the services they provide they can 
bring about changes in behaviour (Morrison, 1995). There remains however no evidence 
to date beyond anecdotal accounts to demonstrate that services (including pharmacy 
NSPs, substance use services or AAS clinics) are effective in influencing AAS choices or 
changing behaviours. Targeting steroid users in support services alone is unlikely to be 
enough to respond to the priorities identified here. It appears unlikely that interventions 
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to encourage steroid cessation, reduce amounts being taken or increase information 
provision will consistently be delivered in such settings, or have the desired impact, due 
to the limitations of this environment and engagement that takes place between users 
and staff. Further, as a high proportion of users may never visit services they will not be 
exposed to these interventions. Even regarding the intention to reduce BBV 
transmission through NSPs, it is difficult to assert whether such services have helped to 
avert an epidemic of BBVs amongst the steroid using population (and beyond), or have 
failed to stop transmission or behaviour changes. Either way, there is a need for critical 
examination of these services to understand their impact and inform their development.  
Interventions therefore need to go beyond provision of support services if they are to 
reach the majority of users and respond effectively to the risks and harms associated 
with AAS use. We need to recognise therefore that support services are only one aspect 
of a potential system of support, information and influence for users and therefore if we 
want to bring about changes in their choices then we need to look beyond these services 
alone. If we accept that users are not a homogenous group, but in reality include a range 
of different experiences, motivations, influences and perspectives on health and risk 
(Zahnow et al., 2018, Christiansen et al., 2016) then it should not be surprising that there 
is no single approach that will reach or be suitable for everyone. Concerns identified in 
this research commonly related to the dissemination of information and advice of 
varying reliability and relevance to those receiving it outside of services and the 
influence this may have upon subsequent choices and norms relating to AAS, body 
image and risk that exist within peer groups and social settings. In addition to provision 
of support services, providing interventions that improve the effective dissemination of 
reliable and relevant information and support within users’ social networks and 
influential environments may therefore be an important approach. 
A map of information and support 
To support identification of a response to these priorities, a map relating to AAS 
information and support has been developed (figures 9-11). Based upon a ‘complex 
systems’ approach and the socioecological framework, and informed by the four studies 
presented here, the map is designed to support identification of opportunities to bring 
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change in AAS use and routes through which to deliver interventions. This represents, 
to the researcher’s knowledge, the first attempt to map the support available to users 
and the first attempt to apply a systems approach in the context of AAS use. Six major 
components that individuals interact within are identified (figure 9). These contain 
within them sources of information and support available to men in the UK general 
population who use AAS.  
While recognising that there is great variation amongst this population, the map is 
intended to represent a hypothetical typical user. Therefore, the system mapped here 
is restricted to components that such an individual is able to interact with and have some 
control over. Further, components represent the environments and individuals through 
which interventions are currently, or can potentially be, delivered in response to the 
priorities identified. Each component therefore represents a separate subsystem in this 
larger system and contains a number of potential change agents, who are the individuals 
responsible for the dissemination of information and provision of support and advice. 
While the components represent distinct entities, they are connected to and interact 
with other components. Information and support delivered within one component can 
therefore influence other areas. This is significant because while an intervention might 
focus on bringing about change within a network for example, any local health and AAS 
support services can still influence this change and benefit from it. This therefore not 
only demonstrates the complexity involved in AAS choices with competing influences 
from multiple sources, but also the potential for a range of routes through which to 
increase and improve provision of information and support.  
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Figure 9: A map of AAS information and support to users in the community 
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  Figure 10: Key actors who disseminate information 
and provide support 
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Figure 11: Interactions between different components 
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Influences from outside this system 
As identified in the socioecological framework, a range of societal factors may influence 
AAS choices. These largely sit outside the boundaries of this proposed system, but their 
impact upon it, and consequently the individuals within it, should not be overlooked. 
For example, background influences such as government and sporting authority policies 
and laws, representations of muscularity in magazines and films, and discussion about 
steroids in the media all support the development and maintenance of cultural and 
social norms within the components included in the map. Additionally, there are specific 
‘risk environments’ outlined in the socioecological framework such as prisons, the 
armed forces and employment in roles such as security officer or doorman that some 
users will experience. As these represent components that most users will not have the 
opportunity to interact in, or will do so at specific points in time only, they are not 
included within the map. For those that do experience them however they may be 
important, and they are connected with the components in the map through the 
individuals that move from one component to another. For example, someone who exits 
prison may introduce ideas into their social networks in the community, and vice versa.  
A system of agents across different components with individuals at the centre  
Within each component, a number of key agents are identified (figure 10). People who 
use AAS are the primary agents in the system and make decisions about their own use. 
Research however suggests that these choices are influenced by (to varying degrees) the 
behaviours of a range of other agents who users interact with in different environments 
and times. Together, these agents therefore compete with and complement each other 
as they influence choices and ultimately behaviours through their interactions with one 
another, which combine to produce effects that are different from the effect of any 
individual component in isolation (Luke and Stamatakis, 2012). The relationships and 
interactions in and between different important settings in any system are therefore 
important to examine (Hawe et al., 2009). These agents can be divided into two broad 
groups: professionals and peers. Professionals include health educators and providers 
and their roles may be well defined through their job. Peers include friends and a variety 
of other users including those who may be perceived as role models and experts, 
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amongst whom motivations and intentions vary greatly and whose role is less 
predictable. Their experiences and advice may be more likely to be respected and valued 
by users so their influence is therefore greater. However, their support is less likely to 
be motivated by a desire to reduce risk and public health harms than professionals, and 
more likely influenced by personal bias and past experiences. Identifying individuals who 
can sit within both groups (i.e. who have a role as peer and professional) and support 
interventions from both perspectives is therefore likely to be particularly beneficial.  
Interactions are dependent upon many factors including an individual’s motivation to 
seek and share information and support, the extent and nature of their social networks 
and their access to, and motivation to engage with, influential environments and health 
services. Additionally their personal characteristics such as age, past experiences, beliefs 
and occupation and the community they live in will influence their interactions with the 
agents in other components and consequently their AAS choices. Importantly these 
interactions are not constant or static. Individuals and their choices change over time 
and so do the influencing factors that drive them. Because of this complexity therefore, 
a specific intervention targeting one influence at one time is unlikely to address the 
identified needs.  
Components interact with one another and change over time 
Underpinning the concept of complex systems thinking is the idea that different agents, 
environments and influences relevant to any behaviour are interconnected as part of 
larger structures and that agents may have multiple relationships at the same time 
(Atun, 2012, Rosas, 2017). The ways that the components in this map interact with one 
another is presented in figure 11. This helps us to understand how messages can be 
disseminated and the subsequent effects of interventions based within one component 
on other components in this map. These consequences can be positive or negative in 
their impact and intended or unintended. For example, a user who accesses a pharmacy 
NSP may be given information that is intended to reduce the amounts that they are 
using. Theoretically, they may pass this information on to other users in their social 
networks, who may in turn modify their own doses or pass the information on to others 
in the gym that they use. This would be a positive if perhaps unintended consequence 
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of information provision in the pharmacy. Alternatively, if the interaction in the NSP is 
not a positive or successful one then this individual may inform other users in their 
networks of this and advise them not to go there, which could lead to reduced 
attendance.  
Thinking about these consequences can be helpful for deciding which interventions to 
prioritise and what to address within them. Resources and opportunities for 
implementing interventions of any type are likely to be limited and this encourages 
intervention developers to look beyond just how effective any one potential 
intervention is likely to be. The authors of the BCW method suggest assessing potential 
interventions against four criteria: i) the likely impact, ii) ease of implementation, iii) 
likely spill over, iv) ease of measurement (Michie et al., 2014). For example if an 
intervention is likely to be difficult to implement then, regardless of the potential 
benefits it has, it is unlikely to be an optimal approach to pursue. Interventions that have 
impacts beyond the settings or individuals they initially focus on can have broader 
positive or negative impacts. 
Components and the strength of supporting evidence 
The map is based upon evidence gained through the studies presented here and in 
previous research. However, it is clear that there are many gaps in our understanding 
currently. To understand the limitations and to guide future research efforts, the 
strength of the evidence relevant to each subsystem including the delivery of 
interventions and influence of agents within them must be considered. The strength of 
available evidence on interventions delivered within the components is highlighted in 
the map and overall again reiterates the paucity of intervention evaluations in this area. 
A more substantial evidence base exists on the characteristics of users and the nature 
of their AAS use, but overall, and even in components where the evidence is strongest, 
research has focussed overwhelmingly on a specific subgroup of AAS users, namely 
those loosely defined as bodybuilders (either competitive or amateur). In particular, 
studies have been undertaken with users who would consider themselves experienced, 
informed and serious about AAS and associated behaviours. In the context of 
Christiansen’s typology (Christiansen et al., 2016), the research is dominated by the 
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experiences and perceptions of the ‘Expert’ type and there remains a lack of evidence 
relating to other subgroups, as well as the possibility of unidentified groups. 
Education system 
Internationally a number of school-based programs with a focus on AAS prevention have 
been implemented and evaluated within classroom and sports team settings (Bates et 
al., 2017a). However, AAS interventions of any nature are not something that children 
or young people (in the UK or internationally) will routinely experience during their 
education. It does not form part of typical substance use programmes and while related 
issues such as body image and eating disorders are recommended as part of UK 
personal, social and health education (PSHE)  (Personal Social Health Education 
Association, 2018), information about AAS is likely to be, at best, extremely limited. 
There is irony in that it does however represent the component with the most evidence 
on interventions delivered within it. Indeed, the vast majority of available evidence on 
interventions designed to influence AAS choices have been delivered within schools, but 
these have little applicability to the experiences of most men who initiate AAS use in 
adulthood. Further, the appropriateness and effectiveness of AAS interventions 
delivered to young people at school age is unclear.  
Consequently, the inclusion of education settings as a component is debatable. It 
arguably represents a potential component rather than one that has a significant impact 
upon users currently and there is little interaction with other components. However, 
when considering options for prevention interventions, schools and other education 
settings provide access to large numbers of young people. Where PSHE covers related 
topics such as healthy eating, physical activity and appearance, there may be 
opportunity to develop protective factors for AAS including critical evaluation and 
resilience skills. During physical education and school sport, teachers and coaches may 
also have the opportunity to establish healthy attitudes and expectations about 
appearance and performance. Interventions within education settings are likely 
therefore to be of a preventative nature with the focus on establishing positive norms 
and delaying the onset of AAS use, rather than providing support for users. 
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AAS support services 
If users have experienced any type of formal intervention, it is likely to have been within 
a drug treatment service or pharmacy NSP setting. In the UK, the focus of the public 
health response to AAS and other IPED use has reflected the approach to other drug use 
since the 1980s and has been to try to increase engagement between users and health 
professionals in such services, primarily to increase the provision of injecting equipment 
(Stimson, 2007). Despite the continued focus on this approach as stated in the most 
recent UK Drug Strategy (HM Government, 2017) and guidance for drugs interventions 
(Independent Expert Working Group, 2017) this is an under researched area and there 
is a lack of evidence on intervention provision through these services. While a limited 
body of research has explored factors such as attitudes towards attending services and 
barriers to engaging with health professionals in a range of settings, there is no evidence 
on, for example, the impact of information provision and advice from staff or leaflets on 
reducing use or cessation. Although there is evidence of substantial numbers of users 
accessing NSPs (McVeigh and Begley, 2016), even the provision of injecting equipment 
itself has not been adequately explored for us to be confident of its impact or factors 
affecting effectiveness. These gaps in the evidence apply to all such support services, 
including pharmacy NSPs, drug treatment settings and specialist IPED clinics. 
Additionally, there are private clinics available that charge for services such as blood test 
profiles, blood-borne virus screening and other health checks and information for which 
no evidence on their impact is available.  
Health & social care and criminal justice services 
It is clear that a range of health and social care providers interact with people who use 
AAS, but their potential as intervention providers to affect AAS and health choices 
amongst users is largely unknown. Similarly to substance use services, a small amount 
of studies have looked at user attitudes and experiences with GPs and other health 
professionals (Zahnow et al., 2017, Pope et al., 2004). Participants in this research 
suggested that health providers in such settings who encounter users could have a role 
in delivering harm reduction messages or supporting use of support services. There was 
evidence that staff in settings such as sexual health, probation and young people’s 
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services may have conversations about steroids with users and that some users will look 
for support from health professionals, in particular GPs. However, formal interventions 
to influence users have not been tested in these environments. For example, research 
has not explored the potential benefits of signposting users identified in health services 
to AAS support services or GPs’ or sexual health workers’ provision of harm reduction 
information.  It is likely that interventions delivered within these settings would focus 
on signposting users to support services or delivering harm reduction within the remit 
of that service. For example, BBV testing and promoting safe sex in a sexual health 
setting. 
Users’ social networks 
There is evidence from a range of research studies of the importance of key agents 
within a typical steroid user’s social network on users’ knowledge, attitudes and choices 
relating to AAS, related behaviours and health (Kimergård, 2014, Maycock and Howat, 
2005, Grogan et al., 2006). This includes their dealer, their friends who use AAS, other 
users they encounter in their communities, work environments, sports teams and social 
lives and, perhaps the people most commonly highlighted as important, more 
experienced users they encounter in their gym. Unwittingly or not, these individuals can 
become role models and provide an example to aspire to. For example, users follow 
advice from others on what steroids and ancillary substances to take and the details of 
their cycle and are motivated by norms relating to steroids within their networks. 
Considering this, it is perhaps surprising that very little research has explored 
approaches to influence social networks of AAS users. Nilsson and colleagues’ 
community-based studies in Sweden (Nilsson et al., 2004, Nilsson et al., 2001) that 
sought to change acceptability and norms relating to AAS use amongst young people are 
an exception to this. Additionally, no research has been carried out to explore whether 
and how individuals within these networks can be used as intervention providers, 
specifically by providing support and information.  
Online sources and virtual communities 
Users’ interactions with social media and the ways that these influence their choices and 
attitudes has not been thoroughly researched. However, we know that many users 
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access and participate in online communities and follow social media influencers. 
Analyses of online forums dedicated to bodybuilding, fitness or steroids demonstrate 
how users (and potential users) can easily encounter and share accounts of personal 
experiences, attitudes and recommendations (Andreasson and Johansson, 2016a, 
Andreasson and Johansson, 2016b, Smith and Stewart, 2012). While members of these 
virtual communities may not necessarily be in favour of AAS use, users who seek 
information about AAS are likely to be exposed to discussions debating and promoting 
AAS and to find support from knowledgeable others for adopting risky practices 
(Andreasson and Johansson, 2016b). It is likely that processes that are at least similar to 
those within offline networks will take place within these online networks and it appears 
from this research that resources such as social media posts, websites and forum 
discussions are being used by some users as sources of information and support. In 
addition to information shared by users, this can also include information provided by 
health or government authorities and academics. For example, research papers were a 
common source of information for some participants in this research. That information 
of this nature can be seen as attractive is promising, and increasing understanding of 
how and where to communicate evidence and research findings to users may help to 
improve its reach and impact with users. A recent prevention initiative involved 
increasing media literacy skills to reduce susceptibility to misinformation about AAS 
(Lucidi et al., 2017) demonstrated that there is awareness about the potential for media 
sources to influence AAS choices. However, there is no evidence exploring how to 
provide interventions using social media or any online sources currently. Increasing 
understanding of how virtual communities operate and how information is 
disseminated and acted upon online will be an important part of potentially utilising 
these environments to deliver interventions.  
Gym & fitness environments 
As with social networks, research has consistently highlighted the influence of sports 
and fitness settings and the people within them on users, but there is again a lack of 
research exploring the potential for interventions to be delivered in these environments. 
The evidence base on interventions to influence or change use is limited currently to 
one off interventions in Iran (Jalilian et al., 2011, Asr et al., 2018).  Efforts to reduce use 
184 
 
have been introduced this century in places including Belgium and the Scandinavian 
countries, where recreational users in gyms have been subjected to ‘anti-doping’ 
measures and testing in practices traditionally associated with attempts to tackle use in 
elite athletes (van de Ven, 2016). The impacts of such efforts are unclear and no formal 
evaluations have been published, although it has been questioned whether such policies 
can create drug free environments and may be counterproductive in efforts to improve 
health (Thualagant, 2015, Christiansen and Bojsen-Møller, 2012). Some participants in 
this research alluded to examples of harm reduction and health promotion efforts within 
gyms in the UK and efforts to build relationships between support services and gyms, 
but there is a lack of empirical evidence to understand the impact of these. The 
normalisation of use in fitness environments needs defining further, but efforts to 
reduce this and the development of more desirable norms associated with steroid use 
and physique are topics for researchers to consider. Additionally, approaches to improve 
the relationships between support services and gyms requires further research. 
Stakeholders identified this as important to achieve to enable effective signposting and 
potentially delivery of interventions within gyms, but approaches to overcome the 
barriers that clearly exist have not been explored. 
Interventions to increase access to support and information  
The proposed map supports identification of different routes to implement 
interventions and assessment of the impacts that these can have. In figure 12, 
behaviours by key agents identified through this research that might be relevant for the 
provision of support and information to users are mapped to different components in 
the map. This demonstrates the complexity involved with any user potentially exposed 
to multiple competing influences and information sources at different times and in 
different environments. All these behaviours represent possible targets for 
interventions that aim to increase the provision of relevant and reliable information and 
support to users and demonstrate that there are many options beyond interventions 
delivered in support services alone. There are overlaps between different components 
with agents in these potentially performing the same behaviours. It would of course not 
be feasible to develop an intervention that includes all these potential 
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Figure 12: Behaviours by key agents to increase information provision and support 
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targets and the appropriateness of each will vary in different locations. Further, they are 
not all likely to be realistic or easy to implement and potential effectiveness will vary. 
However, considering a wide range of potentially relevant possibilities helps to ensure 
that options are not overlooked. The BCW guide (Michie et al., 2011) advises applying 
four criteria to identify which behaviours from the options available to target in an 
intervention. The criteria include i) likely impact, ii) ease of implementation, iii) likely 
spillover and iv) ease of measurement and applying these supports identification of 
targets that are likely to be realistic and have the greatest impact. Issues relating to 
implementation and measurement will likely vary greatly according to local systems 
already in place and local context. For example, if a positive relationship exists with a 
gym owner then interventions in that gym are likely to be more achievable than where 
there is no such relationship or there is hostility, which will require additional work to 
address.  
The map is particularly useful for assessing potential spillover (both positive and 
negative) through the links between different components. Targeting behaviours that 
may have the greatest positive knock on effects, for example those of agents with the 
most influence, can be particularly beneficial. A key theme throughout this research has 
been the importance of social networks of AAS users influencing users’ choices and 
practices. While this has generally been discussed in quite a negative way as explaining 
how and why risk- and harm-increasing attitudes and practices are spread and 
undertaken, it also provides a route to respond to the priorities established here that 
tackles the influences upon AAS choices across the socioecological levels. A small 
proportion of studies within the systematic review in chapter 2 included components 
linked with changing social norms, although due to the limitations of the evidence base 
already discussed it was difficult to determine any association with behaviour change. 
As demonstrated in the map, inducing changes at the social network level may offer a 
way to potentially reach and influence large numbers of users.   
Beyond support services: influencing change through social networks 
Efforts to influence decisions by AAS users need to consider the important social and 
community contexts that will influence choices. Network interventions, which seek to 
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use social networks to bring about behaviour change and produce social influence 
(Valente, 2012), may be a method to reach users including those not engaging with 
services. The potential for peers acting within social networks to provide education and 
social support and to act as role models in efforts to tackle health related issues is well 
established, in particular to reach underserved communities or respond to health needs 
that health care providers cannot fully address at critical times (Dickson-Gomez et al., 
2006, Simoni et al., 2011). Peer-based interventions are valued as approaches to 
increase self-efficacy, provide social support and education, and change norms within 
social groups (Simoni et al., 2011). 
Network interventions have been used in response to many different health needs 
including childhood obesity (Stock et al., 2007), HIV (Dickson-Gomez et al., 2006) and 
adolescent substance use (Valente et al., 2007). They have been prominently used 
relating to HIV including with people who inject drugs (PWID). In one example of a 
network intervention targeting substance users, the Risk Avoidance Partnership (RAP) 
project (Weeks et al., 2009, Li et al., 2012) sought to change the social context in which 
heroin and cocaine users operated in to reduce risk of HIV transmission by changing risky 
practices and increasing prevention efforts. The project was a two-stage intervention 
where peer advocates received a harm reduction and health enhancement intervention 
and training, and then delivered these same messages to those in their social networks 
and communities. The map proposed here and the socioecological framework 
developed in study 2 highlight the competing and interacting influences upon AAS from 
across the ecological spectrum and interventions that can impact upon multiple 
ecological levels are therefore likely to be particularly beneficial. Evaluation of the RAP 
project suggests that positive changes at the individual, social network and community 
levels can be brought about through such an approach (Weeks et al., 2009).  
An advantage of involving peers is the potential to eventually reach large numbers of 
AAS users through the social networks of these men. Peers can access and provide 
interventions in settings that health care providers are likely to have difficulty accessing 
and gaining trust in (Simoni et al., 2011). One clear example of this relating to AAS is the 
gym setting and the difficulty that service providers can have engaging with gym staff as 
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part of attempts to reach users. Diffusion of innovation theory demonstrates the 
potential for new information or practice to spread over time through a social system 
via an initial small number of individuals with large interpersonal networks (Rogers, 
1995). The theory emphasises that those with higher status in a social system and who 
sit in the centre of the various social networks within it, defined as opinion leaders, are 
likely to have the greatest influence and have a significant role in the diffusion of 
information (Rogers, 1995). Those who link different groups within social networks may 
be particularly important (Valente, 2012). Amongst AAS users, those frequently 
characterised as ‘the big guy in the gym’ as well as gym owners and dealers seem likely 
to represent these opinion leaders and therefore may be particularly valuable to recruit 
as agents of change. The credibility of these potential peer providers is one key 
advantage. Theories such as dynamic social impact theory and diffusion of innovations 
theory suggest that individuals who belong to the same group as those whose behaviour 
they are looking to change are more likely to have credibility and exert influence (Latané, 
1996, Nowak et al., 1990, Rogers, 1995). Additionally, they can demonstrate the benefits 
from making the choices that they are hoping to influence in others. For example, peers 
can theoretically provide examples of useful support they have received in services or 
demonstrate a muscular and desirable physique despite adopting less ‘risky’ AAS 
practices.  
Through this, as well as promoting support services if available we can seek to change 
norms within settings such as gyms or sports environments. Within ‘risk environments’ 
where a range of influences combine to promote, support and facilitate AAS use, 
changing norms and the culture that exists may be challenging but ultimately crucial to 
promote healthy and harm-reducing choices. Where trusted, credible and influential 
information providers are adopting and recommending a position or practice, others 
within that social system are more likely to do so as well (Rogers, 2003). It appears that 
many ‘opinion leaders’ in AAS social systems value discussing AAS and related issues 
with others who they encounter. Given that people like to come across to others as 
being knowledgeable and worthy of respect by sharing information that they believe is 
interesting and useful (Berger, 2014, Cappella et al., 2015), it is perhaps unsurprising 
that this is commonplace. Additionally, evidence throughout the studies here point to 
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how AAS-related information acquired through a trusted source can spread within users’ 
social networks. If these opinion leaders can be influenced so that the information they 
provide reflects the priorities identified, it therefore follows that this positive 
information might spread in a similar way. Through effective information and support 
provision, interventions can therefore seek to tackle a range of needs, such as increasing 
adoption of harm reducing strategies, bring about reductions in AAS use and increasing 
use of support services. 
It will be important to further increase understanding of the dynamics in AAS user social 
networks and key environments in order to design and implement effective peer-based 
network interventions. More research examining the relationships within users’ 
networks and how information is disseminated and received will support this. However, 
an approach similar to the RAP project (Weeks et al., 2009) appears promising. For 
example involving users in service delivery or identifying key individuals who can act as 
agents of change within a community (in a gym, for example) and training them to 
provide messages to others in their networks. These individuals can bridge the divide 
between ‘peers’ and ‘professionals’ identified in the map so as well as acting as role 
models they can provide reliable support that discourages risky use and aims to improve 
health. The evidence presented throughout this research suggests that some individuals 
already take on this role and working with them to develop clear messages in response 
to the needs established in this research will ensure that advice and information is 
appropriate. Increasing the number of agents of change in a community may increase 
the potential for effective interventions (Li et al., 2012). 
Beyond local communities, networks extend through electronic communication such as 
social media and forums and, although relationships may differ compared to traditional 
face-to-face communication (Valente, 2012), the use of such social media by users as 
information sources suggests these networks are important. There is potential for these 
messages to ultimately reach many users through different routes and, over time, 
change norms in these networks and subcultures. A second example of how networks 
are already used, and in a positive way, is through secondary distribution of injecting 
equipment. Some users will collect large amounts of equipment during visits to NSPs 
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and then sell or give these to others in their networks (Glass et al., 2019) and examples 
in this research were given of users who collected equipment on behalf of, or from, 
friends. A potential downside to this is that users do not get the information or advice 
that they could receive from service providers if collecting equipment in person. Those 
involved with secondary distribution could distribute written information or pass on 
important messages during these interactions along with injecting equipment, and be 
supported to provide equipment to more users in their networks. However, while 
examples were given in this research of how users can be influenced by the advice of 
others, it could be speculated that if it is not information that those receiving it would 
value or see as matching their aims or preconceptions, then it might not be acted on.  
It was tentatively concluded in the systematic review in chapter 2 that educational 
approaches based solely on information provision may not be effective at changing AAS 
behaviours. The broad approaches discussed here go beyond just providing information, 
but look to change norms with social networks and important environments, with 
consideration to who is providing this support and how. Identifying key individuals 
within specific sites who can act as ‘opinion leaders’ and agents of change will be 
important. The precise nature of the messages they will provide requires further 
research and will need to be adapted to local needs, but the proposed options listed in 
figure 12 reflect the broad harm reduction priorities established in this research. It is 
likely that barriers to these individuals acting as positive influencers and providing these 
messages will need to be addressed. For example while they may be very 
knowledgeable, the advice they give may not always be relevant or appropriate to the 
recipient or in line with the priorities identified here. Supporting these individuals 
through increasing their motivation to establish norms to manage risk and promote 
healthy choices and to work with health professionals is likely to be important. Attitudes 
and barriers towards providing certain messages will vary according to the individual’s 
circumstances and experiences, as explored throughout these studies.  
Increasing access to support services where appropriate 
While recognising the limitations of support services in responding to the needs of users, 
increasing users’ access to available services remains an attractive option. While there 
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are a lack of formal evaluations to demonstrate it, needle and syringe programmes can 
provide users who attend them with injecting equipment and, where engagement 
between users and staff is good, harm reduction advice around injecting and sexual 
health.  Therefore, increasing access to services to continue efforts to minimise risk of 
BBVs and injecting related injuries, and to increase contact between users and health 
professionals, may have benefits (particularly when users have concerns about their 
health or AAS use and where settings are equipped to provide support services through 
knowledgeable, credible and motivated staff). Where it is identified that service uptake 
is low or there are concerns about BBVs, interventions to increase uptake of services 
may be required.  
 In addition to providing injecting equipment and advice relating to injecting and BBVs, 
where services are staffed by providers that have the necessary expertise, confidence, 
motivation and resources to respond to other needs these can be a resource for 
information and support. Despite the lack of evidence on the effectiveness of support 
services (beyond distribution of injecting equipment) and examples of reluctance to 
engage with health professionals and negative experiences in services, there were 
examples given in this study of interactions that had positive outcomes for the AAS 
choices and practices of users. Therefore, increasing access to local support services 
could have positive outcomes for users and in locations where it is identified that many 
users are not accessing services, this is a clear option for an intervention to address.  
The support service to be targeted will depend on what is available locally, which varies 
throughout the UK. Where a specialist IPEDs clinic is available this is likely to be the most 
appropriate option, but as these clinics are relatively rare, the best options will 
frequently be pharmacy NSPs or substance use services. NICE guidance for NSPs 
recommends that level 2 and 3 programmes12 used by IPED users should provide 
‘specialist services’ for this population including advice about side effects and 
alternatives to IPED use, as well as referral to sexual and mental health services and 
                                                          
12 In the UK, needle and syringe programmes are defined as being one of three levels of service. Level 1 
includes services where injecting equipment either loose or in packs with written harm reduction 
information. Level 2 includes ‘pick and mix’ injecting equipment plus health promotion advice. Level 3 
includes level 2 provision plus provision of or referral to specialist services (NICE, 2014). 
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specialist clinics if available locally (National Institute for Health and Care Excellence, 
2014).  
Using the proposed map, a range of behaviours by key agents are identified that might 
be relevant in encouraging attendance at support services (figure 13). Any intervention 
with this aim will need to consider common barriers and enablers for service 
attendance, as identified in chapter 6 (table 4) and the potential behaviours identified 
in figure 13 are based upon these. To have a greater impact and target multiple factors 
identified as important interventions will likely need to go beyond signposting alone. In 
particular, they should include clarification of the aims of services and the benefits of 
service attendance. Identifying a long list of relevant options that might be the focus of 
an intervention is useful to ensure that all potential opportunities to bring about the 
intended change are considered. However, clearly it would not be feasible or necessary 
for any intervention to attempt to incorporate all of them.  
Applying the four criteria developed by Michie and colleagues (Michie et al., 2014) to 
assess which behaviours to target supports two approaches including i) encouraging use 
of support services through the network approach and ii) staff in health and social care 
services promoting support services to users they encounter. Within these two 
approaches, seven specific behaviours identified in figure 13 appear promising. The 
extent to which these specific behaviours met the four criteria is provided in appendix 
13. Where users are accessing specific local health services then an intervention that 
focuses on signposting from these services to support services as available could be 
attractive, as specified in box 5.  
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Box 5: Specificities of an intervention to increase engagement with AAS support services 
Promoting AAS support services 
Who?  
Staff working in health/ social care services who encounter men who use AAS 
 
What do they need to do differently?  
Signpost to AAS support services and promote by providing information on service aims and 
the benefits of attending 
 
When and where do they need to do it?  
During appointments/ discussions with men who use AAS when they visit the service 
 
How often do they need to do it? 
Every time they identify AAS use in a client 
 
According to the COM-B model of behaviour change (Michie et al., 2011); staff will need 
the capability, opportunity and motivation to promote support services to users. This is 
likely to vary greatly by service and therefore what needs to change to implement this 
intervention will differ according to the specificities of the services and staff in question. 
However, evidence presented within the studies here suggests that generally the issues 
as presented in table 5 will likely need to be addressed.  
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Figure 13: Behaviours by key agents to increase uptake 
of support services 
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Table 5: Supporting health service staff to signpost effectively to AAS support services 
COM-B component  Factor influencing effective signposting 
Capability 
(Psychological and 
physical capacity) 
Psychological  Knowledge about support services (location, times) 
 Knowledge about scope of support services 
 Identification of AAS use amongst clients 
 Skills to raise AAS use and engage with clients 
Opportunity 
(Physical and social 
factors external to 
the individual) 
Physical  Limits of existing systems (may prevent formal 
referral) 
 Time as a barrier 
Social  Norms in the service regarding support for AAS 
users 
 Scope of the service  
Motivation 
(Automatic and 
reflective 
processes)  
Reflective  Expectation of the benefits of signposting 
 Confidence engaging with AAS users 
An advantage of an intervention as specified in box 5 is that it should be relatively 
straightforward to implement in health services, have a low burden on staff and fit 
within current practice. Staff would not need any in depth knowledge about AAS and it 
could be a quick interaction. The intervention would be primarily educational to ensure 
that staff are aware of the scope and availability of the support service. In services 
accessed for reasons other than substance use, difficulty in identifying users could be 
tackled through a single standard screening question. A range of options can be 
identified to increase confidence and engagement skills where required. 
Communication training for health professionals that utilises role-play (Lane and 
Rollnick, 2007, Berkhof et al., 2011) for example has been demonstrated to be an 
effective approach.  
In this example, a model of behaviour change has been applied to generate the 
foundation for an intervention that responds to an established need and is evidence-
based. The evidence-base on AAS interventions is frequently characterised by 
approaches that have no or little theoretical grounding and where the justification and 
process of their development is unclear. Using frameworks such as the BCW that guide 
the development of behaviour change interventions in a robust and transparent process 
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will help to ensure that future interventions are suitable, necessary and likely to be 
effective. Future steps to continue the development of the proposed intervention using 
the same model would be identification of intervention functions and appropriate 
behaviour change techniques. 
Recommendations for healthcare practice 
The evidence presented in this study supports some general recommendations for 
health professionals to improve delivery of healthcare to users. This applies to staff in 
AAS support services, as well as GPs and healthcare providers in other health services 
who work with AAS users. Participants in both qualitative studies in this research 
emphasised that users have concerns about being stigmatised and expectations of 
negative attitudes and poor understanding amongst providers related to steroid use. An 
important first step therefore, regardless of setting, is to ensure that healthcare 
providers offer supportive, non-judgemental and positive environments for AAS users, 
as they would for anyone else. Avoidance of language and terminology that may be 
stigmatising and creates barriers between users and providers appears particularly 
important in enabling positive relationships and the provision of advice and support.   
During interactions with users healthcare providers should, generally, provide 
appropriate advice and harm reduction interventions, and motivate behaviour change 
towards cessation (as detailed in box 4 at the start of this chapter). The response will 
need to vary from person to person depending on their motivations, attitudes, health 
and experiences, as well as the skills of the provider and the opportunities for 
intervening that the setting they are in permits. In settings such as substance misuse 
services and General Practice, there may be a greater opportunity to have an in-depth 
conversation and to, for example, motivate change than in NSPs and other types of 
health services where the primary focus of the visit is not to discuss AAS or a related 
health need. In such settings, signposting to an appropriate support service where 
available is a more realistic outcome.  
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Reflections on this research and limitations 
The models used to support this research 
It is clear that changing behaviour is challenging, and any interventions with this aim 
need to be supported by a strong evidence base and deep understanding. Reflecting on 
the studies included in the systematic review, I felt that a limitation of these was the 
lack of theory and evidence underpinning the ideas being tested, and, particularly with 
those targeting non-athletes, potentially a lack of understanding into what actually 
needed to be changed and achieved. A strength of the BCW model is that it necessitates 
a full understanding of a problem in order to bring about change, and applying the early 
stages in the model has given me confidence that the recommendations made here are 
based upon a thorough assessment of what is needed. A difficulty of using the BCW 
model has been that to apply it successfully, the behaviour in question and the problem 
that needs addressing need to be clearly defined. Use of AAS is a broad behaviour with 
much variation and being specific in this way was challenging. However, it forced me to 
address what I had perceived to be an issue with the studies included in the systematic 
review and to think about exactly what it is that any intervention needs to achieve, the 
specifics about where and when that would be, and who the target would be. Thinking 
in this way will help to ensure that interventions are appropriate and based on clear 
needs.  
The conceptual map presented here represents a broad and general picture for the 
typical AAS user in the UK, if such a thing can be said to exist. As highlighted throughout 
this research and the wider evidence base there is much variation amongst users and 
the communities that they live, work and socialise in. Any attempt to generalise to all 
men who use AAS is therefore difficult. However, this represents, to the best of my 
knowledge, the first attempt to apply a systems approach to understanding and 
influencing the choices of AAS users and the first attempt to map the support available 
to them. The map is intended to be useful for stakeholders looking to understand and 
intervene in their own communities and therefore they will need to apply their local 
context to it. Applying the principles of the complex systems approach helped me to 
make sense of the findings throughout this research and to create a tool to use to help 
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respond to the priorities identified. It enabled me to represent the findings from the 
qualitative studies in the context of the socioecological framework and the principles of 
the BCW model approach, supporting the identification of different opportunities for 
interventions beyond what just might seem obvious. In particular, this approach helped 
me to apply the socioecological framework to the needs identified which, although often 
discussed, has not frequently been applied in public health research and interventions 
in comparison to other theoretical models (Glanz and Bishop, 2010).  
It was important to emphasise that AAS use is a complex behaviour with many 
competing influences, because it appeared that this has not always been well recognised 
by those seeking to bring about changes or reductions in use. However, the map was 
defined as including components that the ‘typical’ user can interact with and has some 
control over, which excluded potential components from the outer levels in the 
socioecological framework. Given the recognition of the cultural and societal influences 
upon AAS and body image attitudes (Kanayama and Pope, 2011), considering how to 
extend the boundaries of the map to incorporate these components would be an 
interesting, if challenging, process. Changing social norms and attitudes at a community 
or societal level is likely to be challenging and unlikely to come about through any ‘one 
off’ intervention. Instead, intervening at different points in this broad system relating to 
AAS use may support broader cultural changes over time. Developing systems models 
that include societal factors will be an important step to support the potential for 
interventions to have impacts at a population level (Luke and Stamatakis, 2012).  
Heterogeneity in AAS users and the limitations of the evidence in this study 
A substantial body of evidence was identified and considered in the production of the 
two literature-based studies in this research, which supported the identification of gaps 
in the evidence base for future research to address. A rich dataset was then generated 
through the inclusion of 45 participants across the two qualitative studies. In the first, 
stakeholders offered perspectives from a range of backgrounds, experiences and 
expertise relating to AAS and those who use them. Across the two studies a substantial 
amount of data were gathered and while there was some conflict, areas of consensus 
were established across the different perspectives regarding where intervention is 
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required and what approaches might be effective. For example, clear messages 
regarding harm reduction needs are established.  
However, the findings can of course not be generalised to the needs and experiences of 
all users or stakeholders. The research into AAS use has been dominated by some ‘types’ 
of users, in particular athletes and professional and recreational bodybuilders and those 
who are experienced with these substances. As such, the evidence-base that this 
research utilised was generally under representative of other subgroups of users who 
make up large proportions of the overall population, such as gay men, prisoners, new 
users and older men who are using for reasons such as combatting the effects of aging. 
While participation in study 4 was open to all users, the sample reflected some of the 
same limitations as identified in previous research with users here typically reporting 
between three and six years of experience administering steroids. Discussions were held 
relating to the very early stages of use and ways to effectively engage with, and 
influence, users at this time, which was perceived as important. While three participants 
had initiated their steroid use less than one year previously and therefore offered some 
insight from a new user perspective, findings relating to this stage were predominantly 
based on participants’ reflections on their previous experiences or their perceptions of 
others. Recruiting participants who either were considering starting or had very recently 
done so might have offered further perspectives and insights on this time. Similarly, 
discussions frequently focussed on users who were characterised as more casual with 
their steroid use, or who engaged in other risk behaviours. While there was variation in 
the sample, for example as demonstrated by the amount of research they undertook, 
the overall impression was of a sample that was generally informed and health 
conscious. Additionally, users who participated mostly had at least some experience 
with accessing support services and more inclusion of individuals who had not 
considered, or were unaware of, such services might have added an interesting 
perspective. 
It is perhaps unsurprising that users who participate in research are typically 
experienced with AAS, well informed and interested in the field. Such individuals may 
be more interested in discussing their experiences than those who are less engaged with 
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this culture. Indeed, some participants in this research commented that they welcomed 
the opportunity to discuss the issues covered in their interview.  Further, they may feel 
incentivised by studies, like this one, which aim to inform the development of services 
and to support health amongst users like themselves. During recruitment, stakeholders 
in study 3 were encouraged to identify new users to participate in study 4. However, 
while two gym owners identified potential participants who had very recently started 
using steroids, none of these agreed to take part. One of these gym owners contacted 
me to explain that they had approached these new users, but they did not feel that they 
had anything to say. In a follow up conversation I had with the other gym owner, he 
reported a similar experience and also noted that one had indicated they did not intend 
to use AAS beyond one cycle, so were not interested in the potential benefits of research 
such as this in terms of service provision and supporting health amongst users. With 
hindsight, I feel it would have improved this research to identify more ways to find new 
users and those considering initiating and to encourage them to participate.  
The use of the recruitment list developed through previous studies carried out by the 
Public Health Institute may have contributed to this effect by seeking users who had 
previously taken part in research into their steroid use, although only five participants 
were recruited this way. Similarly, that stakeholders in study 3 were identified from lists 
of conference attendees and then a snowball approach where these participants 
identified further participants may have supported the development of a sample that 
was already engaged with public health research. The inclusion of perspectives from 
individuals who had worked and interacted with users in a wide range of settings was 
intended to ensure that no one perspective dominated the research, but the 
experiences and roles of stakeholders are likely to have influenced findings. That a 
theme coming out of the work was the importance of improving engagement between 
users and services may be unsurprising given that many of the participants worked 
within such settings or in broader public health roles. This may have seemed a logical 
response to those familiar with increasing access to services and health professionals as 
a key aim of harm reduction (Ashton and Seymour, 2010, Stimson, 2007). This may help 
to explain why there has been this long-held focus on providing AAS support services in 
response to use, despite the lack of evidence supporting such an approach.  
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Primary prevention as a public health response to AAS  
As the research developed, it became more focussed towards approaches targeting men 
who are already using AAS rather than primary prevention, where there was also less 
consensus amongst participants. While they were not necessarily positive about it, 
participants in the research generally expressed accepting attitudes towards steroid use. 
A common underlying perception was that risks and harms were manageable and that 
use did not have to be problematic, particularly in comparison to other health related 
behaviours such as physical inactivity or poor dietary choices. Reducing demand for AAS 
may not seem as important for those with this attitude, with the focus instead on 
supporting users to manage their risk and change behaviours to minimise potential 
harms. My own feelings about this have fluctuated during the research and I have given 
much consideration to the idea that use of AAS in itself may not necessarily be 
problematic or something that needs preventing. The steps taken to reduce the 
potential for my own biases to influence findings throughout the research were in part 
recognition of this. Through my reflections on the studies in this research, I have come 
to disagree with some of my participants who suggested that use ‘in moderation’ was 
not potentially problematic. This is particularly in recognition of the difficulty in 
controlling the quality and doses of substances purchased through the illicit market, and 
the growing evidence base regarding health harms and dependence. Further, through 
my interviews with users and stakeholders who worked with them, I have tentatively 
concluded that while supporting users to manage their risk is a very important aim, 
motivating them towards discontinuation should be a prominent part of any 
intervention targeting users.  
That the focus of the research moved towards interventions to reduce harm and bring 
about cessation rather than primary prevention may again have reflected the interests 
and experiences of stakeholders. Including more stakeholders from education or 
sporting backgrounds for example may potentially have steered the research more 
towards prevention approaches and more consensus about what these could look like 
may have emerged. However, participants in studies 3 and 4 did discuss the importance 
of prevention amongst young people before they became interested in, or were 
considering, starting to use AAS. Further, some users discussed how their advice to 
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anyone considering it would simply be not to start, although they did not necessarily 
view their own use negatively. To an extent, the findings from the qualitative studies 
support conclusions from the systematic review of interventions regarding the need to 
further explore and define the aims and objectives of AAS prevention interventions. In 
comparison to the harm reduction and behaviour change messages identified, what 
primary prevention approaches might look like in terms of when and where they should 
take place and who should be involved with delivery was less clear. Some participants 
alluded to the need for school-based prevention. Much of the preventative efforts 
relating to other substances such as alcohol, tobacco and illicit drugs have been 
delivered in educational settings or to adolescents in community or family settings 
(Bates et al., 2017b) so this may seem a natural route to take. However, there are 
differences with AAS users that indicate that a different public health response for 
prevention may be required here. Initiation is typically during adulthood (Pope et al., 
2014a, Sagoe et al., 2014a) and, as demonstrated through the consistently low 
prevalence of use amongst participants in studies included in the systematic review, 
there is little evidence of initiation amongst large numbers of schoolchildren.  
Demonstrating effectiveness of any universal prevention efforts will be challenging and 
such interventions may not be cost-effective, as overall prevalence appears low amongst 
young people in comparison to substances such as cannabis, tobacco and alcohol (Kraus 
and Nociar, 2016). Further, many of those who do initiate in adolescence or as an adult 
may not engage in long-term use. There is additional complexity regarding the focus of 
prevention efforts. In other words, what needs to be changed in order to prevent 
initiation? Recognition of the variability amongst users and in what motivates and 
influences their steroid initiation highlights that there is unlikely to be any one 
prevention approach that will reduce prevalence. Stakeholders in this research 
suggested that for younger people, wider issues such as body image, appearance, peer 
norms and pressures and understanding and critique of media images are associated 
with AAS initiation and therefore should be the focus of interventions during 
adolescence. As identified in the systematic review, these factors have all been part of 
the small number of AAS primary prevention interventions implemented since the 
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1990s. However due to the substantial limitations of this evidence base, it is difficult to 
draw any firm conclusions about what works to prevent use.  
Steroid use is commonly discussed alongside body image and eating disorders (Rohman, 
2009, Olivardia et al., 2004) for which prevention interventions have frequently been 
based upon changing perceptions about media images, critiquing appearance ideals and 
increasing self-esteem (Alleva et al., 2015, Bailey et al., 2014). Such approaches may be 
a more cost-effective approach with measurable outcomes than tackling steroid use 
through steroid-specific prevention interventions. The potential benefits from effective 
prevention interventions therefore go beyond steroid use and more broadly include 
important outcomes such as wellbeing, mental health and esteem. With patterns of 
dependence amongst long-term users (Kanayama et al., 2009a), and similarities 
between disorders such as muscle dysmorphia and behavioural addictions (Foster et al., 
2015), approaches may also be informed by the evidence on preventing addictive 
behaviours and developing resilience. The transferability of messages from these fields 
is worthy of further exploration, and may be more appropriate to consider than 
evidence from, for example, attempts to reduce IPED use amongst athletes that may 
apply approaches with limited relevance to the general population. Using a recent study 
as an example, I question the value of implementing a steroid prevention approach for 
non-athlete adolescents that is based upon anti-doping principles  and messages 
(Medina et al., 2019) rather than attempting to address factors that are associated with 
IPED use and related health and wellbeing outcomes amongst the general population.  
The influence of the UK harm reduction model on this study, and generalisability of 
findings beyond the UK context 
This research focuses on exploring the public health response to AAS in the UK. 
Consequently, the findings are most applicable to this country, its health system, laws 
and, importantly, harm reduction approach to supporting substance users. The health 
service and harm reduction orientated model of healthcare for people who use drugs 
emerged in Merseyside in the 1980s primarily in response to concerns about HIV 
transmission amongst heroin users (Ashton and Seymour, 2010). As described 
previously, this ‘Merseyside model’ focuses on improving the health of people who use 
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drugs by increasing access to healthcare and supporting them to use their drugs safely, 
and has been widely adopted throughout the UK and beyond. While this research 
questions the emphasis on increasing access to services as a way of responding to the 
greatest needs of AAS users and offers alternative approaches, such as influencing social 
networks and reducing the normalisation of AAS use in fitness environments, the focus 
remains on supporting users to improve health and manage risk. Therefore, the context 
in terms of a harm reduction approach remains important. In the UK, AAS are controlled 
as a class C drug under the 1971 Misuse of Drugs Act. Possession is not a criminal 
offence, although it is illegal to manufacture, import or supply AAS, and this perhaps 
support a public health response that goes beyond outright prevention and identifying 
and penalising use.   
Although many of the findings in terms of influences upon users and their needs are 
likely to be relevant outside the UK, the implications and opportunities for interventions 
may be less generalisable, particularly where legislation and underlying attitudes 
towards steroids amongst health authorities are different and more prohibitive. Outside 
the UK, particularly in the Nordic countries, there have been attempts to change the 
culture of steroid use within fitness environments that typically include elements of 
cooperation with police, implementation of ‘anti-doping’ principles and education on 
the risks and harms of steroids. Examples include the PRODIS initiative in Sweden, 
(Molero et al., 2016) and the Clean Fitness Centre program in Norway (Transform, 2017), 
amongst others. The overall intention of reducing steroid use and the normalisation of 
steroids in gyms in such approaches are similar to those recommended in this research, 
but the avenues that lead to these outcomes seem to differ greatly to those suggested 
here.  
There is a fear amongst many steroid users in the UK that increased attention on them 
will lead to increased criminalisation of their substance use. Indeed, this was evident in 
this research with some participants raising concerns about this issue when deciding 
whether to participate. A concern for those hoping to work with users, as health 
professionals or researchers, is increased criminalisation will only serve to drive steroid 
use ‘underground’ and to reduce willingness of users to go to health professionals for 
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support when they need it. It is clear from this research that there are substantial 
barriers to users and gym owners engaging with health professionals already. It seems 
likely that introducing law enforcement and anti-doping principles into the picture will 
lead to greater suspicion and less willingness to engage and work with health 
authorities. Additionally, as noted in this research there is a strong dislike amongst users 
towards being seen as doing something inherently ‘bad’ or wrong, and that this can lead 
to disengagement.  
Consequently, it seems possible that introducing policies that reinforce messages that 
using steroids is fundamentally wrong may have unintended consequences, for example 
reducing access to advice, information and to health professionals amongst those who 
are already using steroids. If some gyms in the UK were to adopt similar anti-doping type 
initiatives to those in Norway and Sweden, for example, it seems plausible that steroid 
users will simply move to using gyms that don’t sign up to such programs.  However, it 
is worth considering that there may also be positive impacts from these approaches, 
particularly in terms of reducing the exposure to pro-steroid attitudes, others users and 
dealers for, for example, new gym users or those who might be susceptible to initiating 
steroid use. This highlights why the UK’s harm reduction approach towards substance 
use is important and has influenced this research, as the focus here is predominantly on 
those who already use steroids and how they can be supported to manage their risk and 
improve their health. The findings may be less applicable for health authorities 
elsewhere who are more focussed on  preventing uptake, or who have a zero-tolerance 
approach to steroid use. However, where authorities and health professionals are 
seeking to support users and to reduce risks and harms amongst them, the findings of 
this study remain applicable. 
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Chapter 8: Conclusion 
This research has identified consensus on some priorities for intervention providers to 
address relating to men who use AAS. A clear priority was established as increasing 
provision of reliable and relevant support to users who are at risk of undertaking 
behaviours that increase their risk of poor health. While the research highlights that 
there is a lack of clarity on what ‘moderate’ AAS use entails and the difficulty of reducing 
harm in the context of the illicit market, interventions to discourage risky use, such as 
reducing doses and encouraging cycles with periods of non-use, are needed. 
Additionally, the need to reduce overall prevalence by reaching new users and 
encouraging and supporting cessation in long-term users was emphasised.  
The similarity of these support needs with those from research from over 20 years ago 
indicates that the current substance use service-based response in the UK, based 
primarily upon the need to reduce risk of BBVs, is insufficient for addressing these 
concerns. In the context of increasing evidence about the risks to both physiological and 
psychological health and continued concerns about uptake, this research highlights the 
need to develop interventions in this area to respond to the priorities established here. 
This includes improving the ways that support is currently provided through healthcare 
and services targeting users, and increasing uptake of these services. Furthermore, it 
makes a clear case for identifying new methods to provide support and information to 
users. A conceptual map of information and support for men who use AAS has been 
designed as a tool to be used by stakeholders to identify options for interventions 
beyond those delivered within health service environments. The socioecological 
framework developed in this research emphasises the ways that social networks and the 
communities they exist within are very influential on AAS choices. This research 
highlights that interventions are needed that utilise these networks and environments 
to reach users and influence their behaviours through establishing positive norms and 
messages.  
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Appendix 2 Completed PRISMA checklist 
Section/topic  # Checklist item  Reported in chapter section  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  Title, rationale 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; 
data sources; study eligibility criteria, participants, and interventions; study 
appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
Full abstract included in 
published article. Summary 
provided in: rationale and 
outline 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  Rationale and outline 
Objectives  4 Provide an explicit statement of questions being addressed with reference to 
participants, interventions, comparisons, outcomes, and study design (PICOS).  
Methods: aims 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web 
address), and, if available, provide registration information including registration 
number.  
Methods: validity and quality 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report 
characteristics (e.g., years considered, language, publication status) used as 
criteria for eligibility, giving rationale.  
Methods: inclusion criteria and 
study selection 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, 
contact with study authors to identify additional studies) in the search and date 
last searched.  
Methods: search strategy 
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Section/topic  # Checklist item  Reported in chapter section  
Search  8 Present full electronic search strategy for at least one database, including any 
limits used, such that it could be repeated.  
Appendix 2 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in 
systematic review, and, if applicable, included in the meta-analysis).  
Methods: inclusion criteria and 
study selection 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, 
independently, in duplicate) and any processes for obtaining and confirming 
data from investigators.  
Methods: data extraction and 
quality assessment 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding 
sources) and any assumptions and simplifications made.  
Methods: data extraction and 
quality assessment; 
Identification of behaviour 
change strategies 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including 
specification of whether this was done at the study or outcome level), and how 
this information is to be used in any data synthesis.  
Methods: data extraction and 
quality assessment 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  Not applicable 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if 
done, including measures of consistency (e.g., I2) for each meta-analysis.  
Methods: analysis 
Risk of bias across 
studies  
15 Specify any assessment of risk of bias that may affect the cumulative evidence 
(e.g., publication bias, selective reporting within studies).  
Not applicable 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, 
meta-regression), if done, indicating which were pre-specified.  
Not applicable 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the 
review, with reasons for exclusions at each stage, ideally with a flow diagram.  
Results: summary of identified 
studies 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., 
study size, PICOS, follow-up period) and provide the citations.  
Results: summary of identified 
studies 
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Section/topic  # Checklist item  Reported in chapter section  
Risk of bias within 
studies  
19 Present data on risk of bias of each study and, if available, any outcome level 
assessment (see item 12).  
Appendix 4 
Results of individual 
studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) 
simple summary data for each intervention group (b) effect estimates and 
confidence intervals, ideally with a forest plot.  
Results: summary of identified 
studies; behaviour change 
strategies; intervention 
effectiveness 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and 
measures of consistency.  
Not applicable 
Risk of bias across 
studies  
22 Present results of any assessment of risk of bias across studies (see Item 15).  Not applicable 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup 
analyses, meta-regression [see Item 16]).  
Not applicable 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main 
outcome; consider their relevance to key groups (e.g., healthcare providers, 
users, and policy makers).  
Results: behaviour change 
strategies; intervention 
effectiveness 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-
level (e.g., incomplete retrieval of identified research, reporting bias).  
Discussion 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, 
and implications for future research.  
Discussion 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., 
supply of data); role of funders for the systematic review.  
No funding provided for this 
review (specified in published 
article) 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA 
Statement. 2009. PLoS Med 6(7): e1000097.  
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Appendix 3 Search strategy for searching in Medline (Ebsco)  
 
Search Search Terms # articles 
S1 MM “Doping in sports” OR MM "Anabolic Agents" 6,889 
S2 (TI (anabolic n4 steroid*) OR PED OR PEDs OR IPED* OR PIED* OR 
(performance N1 enhancing) OR (enhance performance) OR (performance 
N1 enhancement) OR (muscle enhancing) OR (muscle N1 enhancement) OR 
(enhance muscle*) OR (muscular N1 enhancement)) OR (AB (anabolic n4 
steroid*) OR PED OR PEDs OR IPED* OR PIED* OR (performance N1 
enhancing) OR (enhance performance) OR (performance N1 enhancement) 
OR (muscle enhancing) OR (muscle N1 enhancement) OR (enhance 
muscle*) OR (muscular N1 enhancement)) 
37,961 
S3 
S1 OR S2 41,747 
S4 MH “Schools” OR MH "Sports+" OR MH "Youth Sports" OR MH "Athletes" 
OR MH "Prisons" OR MH "Weight Lifting" OR MH "Resistance Training"  
187,335 
S5 TI (school* OR gym* OR athlet* OR sport* OR fitness OR prison* OR 
offender* OR jail* OR (detention N1 (center OR centre))  OR (youth* n2 
(club* OR centre* OR center* OR group*)) OR bodybuilder* OR (body N1 
builder*) OR bodybuilding OR (body N1 building) OR weightlift* OR 
(weight* N2 train*) OR (strength* N2 train*) OR (resistance N2 train*) OR 
(power N2 lift*) OR gay OR homosexual OR LGBT)  
158,107 
S6 AB (school* OR gym* OR athlet* OR sport* OR fitness OR prison* OR 
offender* OR jail* OR (detention N1 (center OR centre))  OR (youth* n2 
(club* OR centre* OR center* OR group*)) OR bodybuilder* OR (body N1 
builder*) OR bodybuilding OR (body N1 building) OR weightlift* OR 
(weight* N2 train*) OR (strength* N2 train*) OR (resistance N2 train*) OR 
(power N2 lift*) OR gay OR homosexual OR LGBT)  
314,122 
S7 (TI (excess* OR addict* OR dependen*) N2 (exercise OR train* OR (physical 
N1 activity)) OR (musc* N1 dysmorph*)) OR (AB (excess* or addict* OR 
dependen*) N2 (exercise OR train* OR (physical N1 activity))) 
3,217 
S8 S4 OR S5 OR S6 OR S7 509,846 
S9 S3 AND S8 6,465 
S10 Limit: date of publication 1990-2016; Human 4,646 
  
230 
 
 
 
Appendix 4 Summary of intervention delivery in included studies 
Citation Intervention Provider Mode of delivery Duration Intensity Fidelity 
Barkoukis et al., 
2016 
Anti-doping culture 
promotion  
Physical education 
teachers 
Group Not reported 10 x 2 hour sessions Not reported 
Elbe & Brand, 
2016 
Ethical decision 
making training  
Online 
Individually 
accessed computer 
programme 
3 weeks 
(average) 
6 sessions Not applicable 
Elliot et al., 
2004, 2006, 
2008 
Ranby et al., 
2009 
ATHENA Coach & peers Group Not reported 
8 x 45 minute 
sessions 
High 
Goldberg et al., 
1990 
Brief educational 
intervention  
Not reported Group Single session 
1x 20 minutes plus 
Q&A session & 
handout 
Not reported 
Goldberg et al., 
1991 
Brief educational 
intervention 
Medical students Group Single session 
1x 20 minutes plus 
Q&A session & 
handout 
Not reported 
Brief fear-based 
intervention 
Goldberg et al., 
1996a; 1996b; 
2000 
MacKinnon et 
al., 2001 
ATLAS 
Coach, peers & 
research staff 
Group 7 weeks  
1x 50 minute 
classroom session & 
1 weight room 
session per week 
Not reported 
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Citation Intervention Provider Mode of delivery Duration Intensity Fidelity 
Goldberg et al., 
2003; 2007 
SATURN Not applicable Not applicable 1 year Not applicable Not applicable 
Jalilian et al., 
2008 
Anabolic steroid 
education  
Peers Group Not reported 
6 x 1 hour sessions; 1 
x 3 hour workshop 
Not reported 
Laure & Lecerf, 
1999 
Health education 
based intervention  
Research team 
(1999); Doctor & 
coach (2002) 
Group Single session 1 x 2 hour session Not reported 
Nilsson et al., 
2001; 2004 
Appearance and 
social norms 
focussed program  
Health workers Group; Media 2 years 
Exposure to the 
intervention 
throughout duration 
Not reported 
Sagoe et al., 
2016 
Hercules  
Anti-doping 
Norway  
Group 12 weeks 
4 x 90 minute 
education sessions; 
12 x weight training 
sessions 
Not reported 
Trenhaile et al., 
1997 
Anabolic steroid 
education 
Not reported Group 2 weeks 
6 x 30 minute 
sessions 
Not reported 
Tricker & 
Connolly, 1996 
Drug education  
Public Health 
official & coach 
Group 10 weeks Not reported Not reported 
Wippert & 
Fleißer, 2016 
Anti-doping 
education 
National Anti-
doping Association 
Group 2 x 1 day 
1 day information 
tour presence in 
school; 1 day 
seminar 
Not reported 
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Appendix 5 Results of study quality assessment 
Quality assessment of all studies included in the review was undertaken using the Effective Public Health Practice Project quality assessment tool. 
Further information on the tool is available at: http://www.ephpp.ca/tools.html. 
Citation Selection bias Study design Confounders Blinding Data collection 
methods 
Withdrawal & 
drop outs 
Global 
Rating 
Barkoukis et al, 2016 Moderate Moderate Weak Moderate Moderate Strong Moderate 
Elbe & Brand, 2016 Weak Moderate Weak Moderate Strong Strong Weak 
Elliot et al., 2004; 2006; 2008; 
Ranby et al., 2009 
Moderate Strong Strong Moderate Strong Weak Moderate 
Goldberg et al., 1990 Weak Moderate Weak Moderate Weak Weak Weak 
Goldberg et al., 1991 Weak Moderate Weak Moderate Weak Weak Weak 
Goldberg et al., 1996a Weak Weak Strong Moderate Strong Weak Weak 
Goldberg, 1996b; 2000; 
MacKinnon 2001 
Moderate Moderate Strong Moderate Strong Moderate Strong 
Goldberg et al., 2003 Weak Weak Strong Moderate Strong Weak Weak 
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Citation Selection bias Study design Confounders Blinding Data collection 
methods 
Withdrawal & 
drop outs 
Global 
Rating 
Goldberg et al., 2007 Moderate Moderate Strong Moderate Strong Weak Moderate 
Jalilian et al., 2008 Moderate Moderate Strong Moderate Strong Strong Moderate 
Laure & Lecerf, 1999 Moderate Weak Weak Moderate Weak Weak Weak 
Laure & Lecerf, 2002 Moderate Moderate Strong Moderate Strong Weak Moderate 
Nilsson et al., 2001; 2004 Strong Weak Weak Moderate Strong Moderate Weak 
Sagoe et al., 2016 Moderate Moderate Moderate Moderate Strong Moderate Strong 
Trenhaile et al., 1997 Moderate Moderate Strong Moderate Strong Strong Strong 
Tricker & Connolly, 1996 Weak Weak Strong Moderate Strong Weak Weak 
Wippert & Fleißer, 2016 Weak Weak Weak Moderate Weak Moderate Weak 
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Appendix 6 Author contribution forms for socioecological framework article 
   
 
 
  
235 
 
 
236 
 
  
237 
 
Appendix 7 Codes assigned during initial analysis in study 3 part A 
 
Initial category Code assigned 
Pattern of use Cycle length 
Ex opiate users 
Increasing use amongst women 
Young people 
Large doses 
Normalisation in society 
Moderation  
Older users 
Using AAS before being ready 
Bodybuilders 
Post cycle period Post cycle as risk period 
PCT promoting harmful behaviour 
Avoiding losses 
Knowledge Health risk knowledge 
Awareness and interest in risks 
Poor knowledge leads to risk  
Nutrition and training knowledge 
Experienced users’ knowledge 
AAS knowledge 
Injecting knowledge 
User attitudes Short-terminism 
Quick fix  
Concern for health 
Copying others 
Masculinity 
Not taking AAS seriously 
Pressure to use  
238 
 
Unrealistic expectations 
Sources of information  Peer to peer information provision 
Online information 
Dealer as information source 
Information bias and critique 
Promoting good information sources 
Information flow in networks 
Health outcomes Addiction 
BBVs  
Early onset of health problems 
Long term health consequences 
Libido 
Social consequences 
Health behaviours and issues Alcohol and AAS 
 Sexual health 
 Sharing needles 
 Body dysmorphia 
 Unhealthy pattern of behaviours 
 Big guy in the gym  
Engagement skills Engagement through conversation 
 Discuss wider health issues 
 Make the most of every contact 
 Planting a seed 
 Language and terminology  
 Non judgemental/ moralising 
 Honesty 
 Tailored feedback and information 
 Opportunity to talk 
Credibility of info provider Credibility through appearance 
 Importance of credibility 
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 Demonstrate knowledge as provider 
 Don’t need to be an expert 
Health care professionals  Disclosing to GP 
 GP knowledge  
 GP and user engagement 
 GP response to AAS harms  
 Endocrinologist role 
 HP confidence 
 Training   
 Service GP engagement 
 Recognising users 
 Screening  
Support services Resources 
 Unattractive 
 Accessibility 
 Pharmacy staff  
 Interventions  
 Drug service staff  
 Increasing uptake 
 Use existing opportunities 
 IPED clinics 
Hidden populations Non-engagers 
 Online equipment purchasing 
 Accessibility of services 
Gyms Educating gym owners 
 Gym owner attitude  
 Gym and service engagement 
 Gym staff as information provider 
 Normalisation in gyms 
 New gym members risk 
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 Significance of gym setting  
Risky settings Quick fix in prison 
 Lack of community follow up 
 Patterns of use in prison 
 NEX in prisons 
 Armed forces  
Drug quality Contamination  
 Online AAS purchasing 
Interventions Early intervention 
 No one size fits all 
 Understand individuals 
 Harm reduction in sport 
 Harm reduction ethics 
 Side effects vulnerability 
 Life changes  
 Go beyond harms 
 Motivate long-term change 
Primary prevention  School-age  
 Body image norms 
 Coping skills  
 Healthy alternatives 
 Delay use 
 Part of wider prevention 
 Unclear focus 
 Prevention and sport 
 Prevention unrealistic 
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Appendix 8 Mind map used during analysis in study 3 part A 
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Appendix 9 “Big Tent” quality criteria as applied in studies 3 and 4 
 
Criteria for 
quality  
(end goal) 
Various means, practices and 
methods through which to achieve 
How achieved or addressed 
Worthy 
topic 
The topic of the research is 
• Relevant 
• Timely 
• Significant 
• Interesting 
The justification for the research is discussed in the context of the current evidence base 
and the gaps in evidence identified in the first two studies in this PhD. The aims of this 
research reflected the findings from these studies. Interventions and support for men using 
AAS have been called for in response to increased AAS use in the UK and worldwide and 
increasing evidence of associated risks and harms for health. The research addresses a clear 
gap in the evidence by exploring what this support should actually be. 
Rich rigor The study uses sufficient, abundant, 
appropriate, and complex 
• Theoretical constructs 
• Data and time in the field 
• Sample(s) 
• Context(s) 
• Data collection and analysis 
processes 
A number of approaches were used to ensure rigor, as described in the sections reporting 
the methods used in studies 3 and 4. For example: The recruitment strategy was informed 
by discussions with participants and designed to ensure that a range of important 
perspectives were included; interviews were comprehensive and typically lasted between 
30 and 60 minutes; and Data analysis was undertaken according to rigorous guidance 
developed by Braun and Clarke (2006) on undertaking thematic analysis. 
Sincerity The study is characterized by 
• Self-reflexivity about subjective 
values, biases, and inclinations of 
the researcher(s) 
• Transparency about the methods 
and challenges 
The COREQ criteria were used to support the reporting of methods to ensure transparency. 
The methods and decisions made during these studies are discussed in detail in the methods 
section. Consideration was given to the potential biases of the researcher and led to the 
initial inductive and data-driven approach for data collection and analysis being utilised to 
minimise these. In the introduction chapter, the pragmatic leanings of the researcher are 
discussed as well as the implications of these for the research. 
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Criteria for 
quality  
(end goal) 
Various means, practices and 
methods through which to achieve 
How achieved or addressed 
Credibility The research is marked by 
• Thick description, concrete detail, 
explication of tacit (nontextual) 
knowledge, and showing rather 
than telling 
• Triangulation or crystallization 
• Multivocality 
• Member reflections 
The research included participants who offered different perspectives on the topic. A range 
of experience and expertise relating to AAS was sought to include stakeholders who had 
worked and engaged with people who use AAS in a variety of settings and roles, and AAS 
users with varying experience and of different ages. The characteristics of participants are 
described in the chapters. During the study, participants were asked to reflect on the study 
findings to that point and to offer their own insights and perceptions on these. The findings 
from the two studies, along with the other studies in this research, were brought together 
in discussion sections and the discussion chapter. These different types of data and multiple 
perspectives and approaches to data collection and analysis were considered together in the 
production of the conceptual map of information provision to provide a more in-depth 
understanding of how this occurs and potential approaches to improve it. 
Resonance The research influences, affects, or 
moves particular readers or a 
variety of audiences through 
• Aesthetic, evocative 
representation 
• Naturalistic generalizations 
• Transferable findings 
Findings were written up and discussed with a ‘critical friend’ and supervisors to ensure that 
they are presented with sufficient clarity and the meaning and significance is clear. In both 
studies findings were presented alongside interpretations, which were supported by 
substantial extracts of the data to help the reader understand where these interpretations 
came from and the perspectives of participants.  
Significant 
contribution 
The research provides a significant 
contribution 
• Conceptually/theoretically 
• Practically 
• Morally 
• Methodologically 
• Heuristically 
The implications and significance of the work were discussed with a ‘critical friend’ and 
supervisors. The work was designed to build upon studies 1 and 2, and to directly inform the 
final stage in the research. In the discussion sections, important areas for future research 
are highlighted, and the implications for practice and policy are discussed. The overall aim 
of the PhD was to inform interventions to improve health outcomes for people who use AAS 
so it was important that as well as extending knowledge, together the studies had clear and 
meaningful implications for future interventions with this aim.  
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Criteria for 
quality  
(end goal) 
Various means, practices and 
methods through which to achieve 
How achieved or addressed 
Ethical The research considers 
• Procedural ethics (such as human 
subjects) 
• Situational and culturally specific 
ethics 
• Relational ethics 
• Exiting ethics (leaving the scene 
and sharing the research) 
The most substantial ethical issue for these studies were perceived to relate to procedural 
ethics. Ethical consent was sought from the LJMU ethics committee for all parts of the 
studies. Approval was obtained prior to each study beginning. During study 4, some 
participants raised concerns about how study findings would be used in the context of their 
concerns about how AAS are portrayed in the media and the criminalisation of AAS. This 
influenced consideration of how the research findings were presented, and all participants 
were given the opportunity to review the findings and to provide any comments.  
Meaningful 
coherence 
The study: 
• Achieves what it purports to be 
about 
• Uses methods and procedures 
that fit its stated goals 
• Meaningfully interconnects 
literature, research questions/foci, 
findings, and interpretations with 
each other 
The detailed description of study development and processes in the presentation of 
methods demonstrate how the study was designed to meet the stated aims, and how the 
studies informed and built upon one another. The methods used are discussed and justified 
in these same chapters. The discussion of findings in each chapter relating to study aims and 
the discussion of the processes and outcomes in the overall discussion (chapter 7), and 
development of the conceptual map, demonstrate how the studies achieved their stated 
purpose.  
 
From: Tracy SJ. Qualitative Quality: Eight “Big Tent” Criteria for Excellent Qualitative Research. 2010. Qualitative Inquiry, 16(10): 837-851.
245 
 
Appendix 10 Consolidated criteria for reporting qualitative studies (COREQ): 
32-item checklist 
 
One COREQ checklist was completed for studies 3 and 4, due to the similarities in 
responses on many criteria. 
 
 
Item 
 
Guide 
questions/description 
Response 
Domain 1: Research team and reﬂexivity  
 
Personal Characteristics  
1. Interviewer/ 
facilitator 
Which author/s 
conducted the interview 
or focus group?  
All data collection was undertaken by the 
PhD student 
2. Credentials What were the 
researcher’s credentials? 
E.g. PhD, MD  
The research was a current PhD student 
with an MSc in Health Psychology who 
had worked as a public health researcher 
for 7 years prior to starting the PhD 
3. Occupation What was their 
occupation at the time of 
the study?  
PhD student 
4. Gender Was the researcher male 
or female?  
Male 
5. Experience and 
training 
What experience or 
training did the 
researcher have?  
The researcher was experienced carrying 
out focus groups and interviews relating 
to substance use, experiences of health 
care and service provision. 
Relationship with participants  
6. Relationship 
established 
Was a relationship 
established prior to study 
commencement?  
In both studies the researcher discussed 
the aims and focus of the research with 
all participants by email or telephone 
prior to data collection. 
7. Participant 
knowledge of the 
interviewer  
What did the participants 
know about the 
researcher? e.g. personal 
goals, reasons for doing 
the research  
All participants were aware the 
researcher was undertaking a PhD and 
the purpose of the study they were taking 
part in. In study 4 some participants 
wanted reassurance as to the purpose of 
the research, how findings would be used, 
and the opinions of the researcher on 
criminalising steroid use before 
participating. Clarification on these points 
was provided. 
8. Interviewer 
characteristics 
What characteristics were 
reported about the inter 
viewer/facilitator? e.g. 
Bias, assumptions, 
interests in the topic  
The interviewer’s biases and beliefs are 
discussed in the thesis. The interviewer 
took steps to reduce the impact of their 
own bias and assumptions and these are 
described in the text. 
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Item 
 
Guide 
questions/description 
Response 
Domain 2: study design  
 
Theoretical framework  
9. Methodological 
orientation and 
Theory  
What methodological 
orientation was stated to 
underpin the study? e.g. 
grounded theory, 
discourse analysis, 
ethnography, 
phenomenology, content 
analysis  
Study 3 followed an inductive and data 
driven thematic analysis approach using 
unstructured interviews. To follow up on 
these in study 4, a more structured and 
deductive approach was used. Full details 
provided in the methods sections. 
Participant selection  
10. Sampling How were participants 
selected? e.g. purposive, 
convenience, 
consecutive, snowball  
Full details of the recruitment approach 
are provided in the methods sections. 
11. Method of 
approach 
How were participants 
approached? e.g. face-to-
face, telephone, mail, 
email  
Full details of the recruitment approach 
are provided in the methods sections. 
12. Sample size How many participants 
were in the study?  
Study 1 included 33 participants and 
study 2 included 12 participants 
13. Non-participation How many people 
refused to participate or 
dropped out? Reasons?  
Full details of participation and drop out 
are provided in the results sections. 
Setting 
14. Setting of data 
collection 
Where was the data 
collected? e.g. home, 
clinic, workplace  
The majority of interviews were carried 
out remotely on the telephone or by 
skype. A smaller number were carried out 
face to face in the participants’ place of 
work.  
15. Presence of non-
participants 
Was anyone else present 
besides the participants 
and researchers?  
Not generally. Some of the interviews in 
study 3 took place in public places, but no 
other people joined in the discussion. 
16. Description of 
sample 
What are the important 
characteristics of the 
sample? e.g. 
demographic data, date  
The samples are described in the results 
sections. 
Data collection  
17. Interview guide Were questions, prompts, 
guides provided by the 
authors? Was it pilot 
tested?  
Interviews were unstructured in study 3 
part A. Study 3 part B and study 4 used 
semi-structured interviews. In study 4, 
questions were pilot tested with a former 
steroid user who participated in study 3. 
18. Repeat interviews Were repeat inter views 
carried out? How many?  
No – one interview was carried out per 
participant. 
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Item 
 
Guide 
questions/description 
Response 
19. Audio/visual 
recording 
Did the research use 
audio or visual recording 
to collect the data?  
Yes – all interviews were audio recorded. 
20. Field notes Were ﬁeld notes made 
during and/or after the 
inter view or focus 
group? 
Yes – notes were made during interviews 
on points to follow up. During 
transcription, notes were made on points 
to follow up with subsequent participants 
and on aspects of the interviews that 
went particularly well or badly. 
21. Duration What was the duration of 
the inter views or focus 
group?  
In study 3A and 4 interviews lasted 
typically around 40 minutes. In study 1B, 
interviews lasted typically 30 minutes. 
22. Data saturation Was data saturation 
discussed?  
No, the aim of the work was not to reach 
saturation as the topic was very broad. 
Instead, the aim was to identify 
consensus on the priorities identified and 
then for participants in study 3 part B and 
study 4 to reflect on these. 
23. Transcripts 
returned 
Were transcripts 
returned to participants 
for comment and/or 
correction?  
Participants were asked if they would like 
to review transcripts. Four users in study 
4 said they would, but did not provide any 
comments back. 
Domain 3: analysis and ﬁndings  
Data analysis  
 
24. Number of data 
coders 
How many data coders 
coded the data?  
1 
25. Description of the 
coding tree 
Did authors provide a 
description of the coding 
tree?  
No coding tree was used 
26. Derivation of 
themes 
Were themes identiﬁed 
in advance or derived 
from the data?  
 
Themes were mainly derived from the 
data. In study 4, they were closely linked 
with interview topics. 
27. Software What software, if 
applicable, was used to 
manage the data?  
None. Data was sorted into themes using 
Excel initially. 
28. Participant 
checking 
Did participants provide 
feedback on the ﬁndings?  
No, but participants in part B of study 3 
and study 4 reflected on findings from 
study 3 and provided their perceptions on 
these. All participants were offered the 
opportunity to review transcripts (see 23). 
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Item 
 
Guide 
questions/description 
Response 
Reporting  
 
29. Quotations 
presented 
Were participant 
quotations presented to 
illustrate the 
themes/ﬁndings? Was 
each quotation 
identiﬁed? e.g. 
participant number  
 
 
Yes – quotations are provided throughout 
and linked to a participant. 
30. Data and ﬁndings 
consistent 
Was there consistency 
between the data 
presented and the 
ﬁndings?  
Findings were discussed with a ‘critical 
friend’ to identify if findings and 
conclusions match the data provided.  
31. Clarity of major 
themes 
Were major themes 
clearly presented in the 
ﬁndings?  
Summaries of major themes are provided 
and then findings are presented by major 
theme with clear headings. Thematic 
maps are provided in the results. 
32. Clarity of minor 
themes 
Is there a description of 
diverse cases or 
discussion of minor 
themes?       
Discussion is provided of minor themes 
and conflicting responses between 
participants 
 
From: Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research 
(COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality 
in Health Care. 2007. 19 (6): 349 – 357. 
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Appendix 11 Semi structured interview schedule for study 3 part B 
 
Interview schedule for NSP staff participant13 
 Could you tell me a bit about what your role is? What are your experiences working 
with people who use steroids? How often do you come across them? 
The role of the service regarding steroid users 
 What do you see the role of services such as yours for working with steroid users? 
Do you think issues around steroids use fall within your scope/remit? 
 What sort of things do you talk about with someone who uses steroids? 
 Would you like do more? Do you think it would be worth doing more? 
 It is suggested that often in needle exchanges, people who use steroids have a fairly 
quick transaction with minimal interaction and discussion. What do you think about 
that? 
 Do you think that staff feel confident working with steroid users?  
Barriers and facilitators to engaging with users 
 How do you find identifying steroid use in service users? 
 How do you find engaging with people who use steroids?  
Do you feel confident? How would you rate your knowledge?  
 How you do think users feel about engaging with you about their steroids? Do they 
listen to you? 
 Are there any other barriers to engaging with steroid users in your service? 
 Have you found any useful ways to overcome these? 
Increasing access to support 
 How do you think you could attract more users to services like yours? How can you 
promote them? 
 Are you linked in with support services for steroid users? Would you know where to 
signpost them for further support? 
 
 
  
                                                          
13 The interview schedule was modified slightly for participants with different expertise and experience 
working in different settings. This enabled participants to reflect on findings from the study that were 
relevant to their specific setting. 
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Appendix 12  Semi structured interview schedule for study 4 
User interviews – semi structured interview questions 
1. Can you tell me a bit about why you train? What are your goals? 
 
2. I’ll start by reading you a statement – I would then like you tell me if you broadly agree 
or disagree.   
Statement 1 
 
Knowledge and sources of information 
3. Do you feel like you have good knowledge and understanding about steroids? For 
example what to use to get the gains that you want, and how much, health risks and 
so on.  
 
4. What about other people who use steroids – do they tend to have good knowledge? 
Statement 2, Statement 3  
 
5. What about the impacts of long-term use and coming off steroids – do you think 
people have good understanding about post cycle therapies and things like that?  
Statement 6 
 
6. What do you do if you want to find something out relating to steroids - where would 
you look, who would you ask? How important is this to you? 
 
7. What about other people – is research important to them? Where do they get 
information?  
Statement 4 
 
8. Where do you buy your steroids from?  
Statement 5 
 
Health advice and support services 
9. Would you speak/ have you spoken to a doctor about anything related to your steroid 
use? Why/ why not?  
10. If a doctor asked you about steroids would you talk openly with them? Why/ why not? 
11. Do you see doctors as reliable & credible sources of information about steroids? Why/ 
why not?  
Statement 7, Statement 8 
 
12. Do you/ have you used a needle exchange? Pharmacy or drugs service? How do you 
find the experience?  
13. There’s a perception that lots of people who use steroids don’t really like using 
exchanges or drugs services at all… do you think that’s fair?  
Statement 9 
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Gyms 
14. Do you use a gym? There’s a perception that steroids are quite ‘normal’ in many gyms. 
Do you agree with that? Statement 10. 
15. Would you approach people like gym staff or trainers, or the big guys in the gym, to 
talk about steroids? Has that changed over time? Statement 12. 
16. Do you think people in your gym are credible sources of information about steroids? 
(staff, other gym users) Statement 12. 
 
Summary statements from study 3 used during interviews 
 
Priorities/ needs for health services to address: 
1. Steroid use in moderation is not really a problem – the focus should be on harm 
reduction, particularly people who are taking high amounts and doing long cycles 
without a proper break to let body recover. In general, messages should be about 
encouraging ‘safe’ practices – sensible doses and cycles, recovery time, PCT, safe 
injecting etc. 
  
2. For some, particularly young guys, they have poor understanding about steroids 
and how they work, injecting sites, training and diet. They can be obsessed with 
making quick changes to their bodies and aren’t interested in long term health, 
don’t take steroids seriously – which can lead to unnecessary risk taking e.g. high 
doses. Health professionals should look to delay steroid use in people who are not 
ready/ do not need to use (e.g. could make natural gains, haven’t done their 
research).  
 
3. Perceptions and understanding about long term health harms is often (but not 
always) poor amongst people using steroids. Often they do not think that they are 
at risk themselves or do not believe in the associated harms or think they are 
exaggerated. 
 
4. Lots of people get their information from friends who maybe don’t have great 
knowledge themselves, a dealer, or the internet, and don’t really question it – 
taking it as face value when there is a lot of bad information out there.  
 
5. Buying steroids over the internet rather than from someone you know can be a 
problem – quality/ strength can vary and risk of contamination etc. Purchasing 
online is seen as an easy option compared to approaching a dealer for some.  
 
6. Post cycle: improve knowledge about PCT. Some using PCT when they don’t need 
to and some not using PCT when they would benefit, and suffering with health 
problems (e.g. low mood, loss of libido). 
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GPs and use of health services 
7. People who use steroids often haven’t had good experiences talking with their GP 
about their steroid use or related issues – GP can have poor 
knowledge/understanding which can lead to unhelpful responses. Increase GP 
understanding and awareness about steroids and health harms to address this. 
 
8. People who use steroids don’t like to go to the GP about any side effects or 
concerns: they may have had negative experiences, do not think it is a ‘manly’ 
thing to do, be worried about disclosing their steroid use. 
 
9. People who use steroids often don’t like using needle exchanges in pharmacies 
and drug services: attitudes and poor knowledge in staff puts them off, it can be a 
negative experience. Need to ensure non-judgemental staff and a non-moralising 
approach.  
 
 Gyms 
10. Steroid use is seen as normal and acceptable in many gyms – this increases 
accessibility and likelihood of someone starting to use, and allows the spread of 
information (sometimes not good advice). 
 
11. Increasing links between steroids services and gyms would increase access to 
needle exchange and advice and support, but many gym owners and gym users 
don’t want to be associated with a ‘drugs service’. Promoting services as ‘men’s 
health’ services (or similar)  could be more attractive. 
 
12. People ask and listen to gym owners and bigger guys in the gym about steroids. If 
they could link in with services could they provide harm reduction/ and advice? 
They might not: want to have that role, feel comfortable/ confident to do so, want 
to be associated with a drugs service.  
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Appendix 13   Identifying behaviours to target in an intervention to increase uptake of services  
 
Specific behaviour Application of criteria: i) Likely impact; ii) Ease of implementation; iii) Likely spill over; 
iv) Ease of measurement) 
COM factors1 in users relating to 
service access addressed  
 
Staff signpost to 
support services 
 
Staff in a range of health and social care services (e.g. pharmacy, sexual health, 
probation, social work, young people’s services) encounter users who are not engaging 
with support services. Challenges may be in identifying users, but where this is 
successful then implementation should be straightforward and there is potential that 
these users will then pass information on to others. Number of users signposted should 
be straightforward to measure. 
 
 
Psychological capability (knowledge 
about service location, opening hours) 
Staff provide 
information on the 
benefits of 
attending support 
services 
These two behaviours are similar and could be performed alongside signposting. 
Signposting alone may not be enough to influence some users to attend support 
services and combining this with information clarifying service aims and the benefits of 
attending is likely to have a greater impact. Implementation is more difficult as it has 
more requirements such as staff time, knowledge and motivation. There may be further 
benefits through spill over if users are more convinced about the value of services. 
Psychological capability 
(understanding of the aims of the 
service; understanding of what the 
service offers); Reflective motivation 
(Expectation of benefits from 
attending; expectation of staff 
knowledge and attitude; expectation of 
stigma); Physical opportunity (Belief 
that support services are for them) 
 
 
Staff provide 
information on the 
aims of support 
services 
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Specific behaviour Application of criteria: i) Likely impact; ii) Ease of implementation; iii) Likely spill over; 
iv) Ease of measurement) 
COM factors1 in users relating to 
service access addressed  
 
Service users 
signpost other 
users to support 
services 
Service users can potentially reach large numbers of non-engaging users through their 
social networks and shared key environments. Impact and spill over is therefore 
potentially high. Evidence suggests that users are often influenced by the opinions and 
recommendations of their peers, including regarding services. For service users, 
informing others in their networks about where services are available could be part of 
conversations already being held. Measuring implementation and impact may appear 
more difficult, but it would be possible to identify where new service users heard about 
a service and why they have attended by asking them when they attend.  
To enable this, service staff could support current service users to promote the service 
to others. 
Psychological capability (knowledge 
about service location, opening hours); 
Physical opportunity (Belief that 
support services are for them); Social 
opportunity (culture relating to 
support seeking; peers attitudes 
towards engaging with health 
professionals; perceptions about 
stigma) 
Service users share 
positive service 
experiences 
These three behaviours are similar and should be deliverable alongside ‘service users 
signpost other users to support services’. Implementation is more difficult because it 
asks more of service users than signposting alone, and requires more knowledge to do 
so. However, the impact is likely to be greater than with signposting alone. Measuring 
impact would again involve identifying why new service users were attending.     
Psychological capability 
(understanding of the aims of the 
service; understanding of what the 
service offers); Physical opportunity 
(Belief that support services are for 
them); Social opportunity (culture 
relating to support seeking; peers 
attitudes towards engaging with health 
professionals; perceptions about 
stigma); Reflective motivation 
(Expectation of benefits from 
attending; expectation of staff 
knowledge and attitude; expectation of 
stigma) 
Service users 
provide information 
on the aims of 
services 
Service users 
provide information 
on the benefits of 
service attendance 
1Factors related to capability, opportunity and motivation as defined in the COM-B model (Michie et al., 2011) and presented relating to user uptake of support 
services in table 4, chapter 6. 
